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Abstract
The aim of this project was to identify and characterise a novel Plasmodium 
falciparum protein that plays a role in the invasion of host cells. Published 
genome, proteome and transcriptome data were used to select a novel protein for 
study. The data was filtered according to a set of criteria designed to identify 
uncharacterised proteins with features that would be expected of an invasion 
molecule, e.g. presence of a signal peptide and membrane anchor, as well as a 
late blood-stage expression profile. The gene product encoded by PF08J0008 
was ultimately selected for study.
Two regions of PF08_0008, from the N- and C-termini, were expressed in a 
recombinant form in E. coli and used to generate specific polyclonal antibodies in 
mice and rabbits. These antibodies have been used in a variety of experiments to 
characterise PF08_0008. Indirect immunofluorescence assays have shown that 
PF08_0008 is located at the parasite’s apical end in both segmented schizonts 
and free merozoites. Immunoprecipitation and Western blot analyses have shown 
that PF08_0008 is proteolytically processed prior to schizont rupture. Fragments 
of PF08_0008 are detectable in culture supernatant, suggesting that shedding of 
this protein from the merozoite surface occurs. There is also preliminary evidence 
to suggest a role for PF08_0008 as an erythrocyte-binding molecule. The 
membrane anchorage of PF08_0008 has also been investigated, as it has 
sequence characteristics of both a type I membrane protein and a GPI-anchored 
protein. As part of this investigation, a line of parasites has been established in 
which endogenous PF08_0008 is expressed as a C-terminal fusion with a triple 
haemagglutinin epitope tag.
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Chapter 1: Introduction
1. Introduction
1.1 Malaria: a global health problem
Malaria is a potentially fatal disease that still devastates poverty-stricken nations 
more than a century after the protozoan parasite Plasmodium was identified as its 
causative agent. Plasmodium is transmitted by a female mosquito of the genus 
Anopheles to a vertebrate host. Depending on the particular Plasmodium 
species, the vertebrate host can be a rodent, primate, bird or reptile.
The human malaria burden is not evenly distributed across the world - it falls 
primarily on the tropics, in particular South America, South and South-east Asia 
and much of Africa (Guerra et al., 2006). This is due to the incidence of 
Plasmodium-susceptible species of mosquito in these regions, which is largely 
attributable to climate.
Malaria was successfully eradicated from the northern parts of the United States 
and Southern Europe during the first half of the twentieth century, mainly through 
the destruction of mosquito breeding grounds, improved sanitation and some 
directed vector control (reviewed in Rieckmann, 2006). The use of the residual 
insecticide DDT eliminated malaria from the southern United States in the 1940s. 
Following the success of this program, in 1955 the World Health Organisation 
(WHO) commenced an ambitious malaria eradication program, aiming to 
eliminate the disease from many of the afflicted nations.
Amazingly, no attempts to eliminate malaria in sub-Saharan Africa were made, as 
it was considered an unfeasible proposition. Efforts in countries such as Sri 
Lanka and India were initially very successful, but these programs were 
unsustainable and ultimately failed. In 1972 the global eradication campaign was 
declared a failure by the WHO. This failure likely impacted the generosity of 
international donors and discouraged scientists. Indeed, of 1,223 new drugs 
developed between 1975 and 1996, only 3 were antimalarials (Trouiller & Olliaro, 
1998), and so unsurprisingly there was little change in malaria mortality and 
morbidity during this time.
14
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However, various social, political and environmental factors in combination with 
the emergence of insecticide-resistant mosquitoes and, most importantly, 
drug-resistant parasites, have exacerbated the already desperate situation, so 
that the malaria burden is now increasing (Greenwood & Mutabingwa, 2002).
An accurate estimation of mortality remains elusive, since many cases of malaria 
go undocumented. However, recent estimates suggest that just over 2.5 billion 
people live at risk of infection by P. falciparum (Guerra et al., 2006), the species 
of the parasite which is responsible for the vast majority of deaths. It is believed 
that there are in the region of 500 million clinical episodes of falciparum infection 
each year, with the vast majority of the estimated 1 million fatalities occurring in 
children under the age of five, in sub-Saharan Africa (Snow et al., 2005). The 
number of P. vivax infections, the most common Plasmodium infection found 
outside Africa, is thought to be in the region of 80 million per year (Mendis et al., 
2001), with around 2.6 billion individuals currently living at risk (Guerra et al., 
2006). Although P. vivax infections rarely cause death, they can result in a 
debilitating illness that can recur many years later.
In addition to the associated mortality, malaria also contributes to long-term 
health problems such as anaemia, premature births, developmental 
abnormalities, and deficiencies in the intellectual development of children. The 
direct healthcare costs of malaria morbidity, combined with its effect on 
productivity, means that there is also a massive economic burden on affected 
nations. Estimates suggest that the annual gross national product of malaria- 
endemic countries has risen 2% less than in malaria-free countries in the last 35 
years (Sachs & Malaney, 2002), and that the disease costs Africa around 
$12 billion every year (WHO, 2003).
1.2 Life cycle of the parasite
Plasmodium belongs to the phylum Apicomplexa, which includes other parasites 
of human and veterinary importance such as Toxoplasma, Theileria, Eimeria, 
Babesia, and Cryptosporidium. Five species of Plasmodium are known to infect 
humans: P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi.
The life cycle of the parasite is complex and consists of both vertebrate and 
mosquito stages (figure 1.1). In the human host, infection begins with the
15
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injection of infectious sporozoites into the body by a mosquito. Sporozoites are 
deposited in the dermis. Some will enter capillaries and travel to the liver, 
whereas others remain in the dermis or enter the lymphatic system (Amino et al., 
2006). Sporozoites reaching the liver pass through the layer of sinusoidal cells 
lining the liver capillaries, before passing through a number of hepatocytes and 
ultimately coming to rest in a final liver parenchyma cell. Parasites then mature 
over a number of days in a membrane-bound compartment, differentiating into 
thousands of merozoite forms. It has recently been postulated that merozoite- 
filled vesicles or ‘merosomes’ bud off from the infected hepatocyte and are used 
to safely deliver the parasites to the liver sinusoid lumen, so that they can be 
released directly into the circulation, avoiding phagocytosis by resident Kupffer 
cells (Sturm et al., 2006). In P. vivax infections, liver stage parasites may remain 
dormant in the form of hypnozoites, and their activation can lead to a relapse 
years following the original infection.
Circulating merozoites released from the liver invade red blood cells and enter 
the asexual erythrocytic cycle. Parasites that have entered erythrocytes 
differentiate and multiply over a defined period of time, 48 hours in the case of 
P. falciparum, passing through various discrete developmental stages: ring 
stages, trophozoites and finally the schizont. Rupture of the schizont at the end of 
the 48 hour cycle results in the release of 16-32 merozoites into the circulation, 
which can then go on to invade a new erythrocyte, thus propagating the asexual 
blood stage of the parasite.
Some merozoites, upon invasion of a new red blood cell, will not replicate and will 
instead differentiate into male and female sexual forms in a process known as 
gametocytogenesis. Interestingly, it is thought that all individual merozoites from 
a single schizont are committed to asexual multiplication, female sexual 
development or male sexual development, before they undergo erythrocyte 
invasion (reviewed in (Talman et al., 2004)). Male microgametocytes and female 
macrogametocytes can be taken up into the midgut of the Anopheline vector if 
the mosquito takes a blood meal from an infected individual. Differentiation into 
microgametes and macrogametes then follows, with fertilisation of macrogamete 
by microgamete to form a zygote. A motile ookinete develops from the zygote, 
which actively invades the midgut epithelium and migrates to the extracellular 
space between the epithelium and the basal lamina of the gut. Here it comes to 
rest and develops into an oocyst. Sporozoites develop within the oocyst and are
16
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released into the haemocoel, from which they can migrate to the salivary glands. 
Following invasion of the salivary gland epithelium, sporozoites are ready to infect 
another vertebrate.
17
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Figure 1.1: Life cycle of Plasmodium falciparum
Figure from Bannister & Mitchell (2003).
(1) Infectious sporozoites are injected into the human host by a female Anopheline 
mosquito taking a blood meal. Sporozoites can enter a capillary and travel to the liver via 
the bloodstream, or they may remain in the dermis or enter the lymphatic system (Amino 
et al., 2006).
(2) Parasites reaching the liver first cross the layer of sinusoidal cells lining the liver 
capillaries before passing through a number of hepatocytes and ultimately coming to rest 
in a final liver parenchyma cell. Liver stage parasites differentiate and multiply over a 
period of around a week in a structure known as a hepatic schizont.
(3) Thousands of merozoites are delivered to the sinusoid lumen via merozoite-filled 
vesicles called ‘merosomes’ (Sturm et al., 2006) (not illustrated in this figure). This allows 
them to be released directly into the circulation, avoiding phagocytosis by resident Kupffer 
cells.
(4) Individual merozoites invade erythrocytes where they multiply asexually over a period 
of 48 hours, passing through discrete developmental stages such as ring stages, 
trophozoites and finally the schizont. Rupture of the schizont at the end of the 48 hour 
cycle results in the release of 16-32 merozoites, each of which can then invade an 
erythrocyte.
(5) Following erythrocyte invasion, some merozoites differentiate into microgametocytes 
or macrogametocytes, the male and female sexual forms of the parasite respectively.
(6) Gametocytes enter the midgut of the mosquito when a blood meal is taken from an 
infected individual. Differentiation into microgametes and macrogametes follows, with 
fertilisation of macrogamete by microgamete, to form a zygote. A motile ookinete 
develops from the zygote, which can migrate to the extracellular space between the 
mosquito midgut epithelium and the basal lamina of the gut. Here it comes to rest and 
develops into an oocyst. Sporozoites develop within the oocyst and are released into the 
haemocoele, from which they migrate to the salivary glands.
(7) After the invasion of the salivary gland epithelium, sporozoites are ready to infect 
another vertebrate as in (1).
18
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1.3 Pathology of malaria
P. falciparum infections are responsible for the vast majority of malaria mortality, 
and it is the asexual blood stage of the parasite that is exclusively responsible for 
the clinical symptoms. Malaria can vary dramatically in its seriousness, from an 
asymptomatic infection, to a symptomatic febrile illness easily controlled by 
chemotherapy or the host immune system, to severe malaria and death.
Severe P. falciparum malaria is an ill-defined, extremely complex, multi- 
syndromic disorder. A common feature of severe malaria, and the principle 
determinant of survival, is metabolic acidosis which is often a result of a reduction 
in oxygen delivery to tissues. This oxygen deprivation can occur as a result of 
parasite-activated pro-inflammatory cytokine cascades, increased erythrocyte 
destruction, a decrease in the deformability of uninfected erythrocytes and a 
decrease in overall blood volume (reviewed in (Miller et al., 2002)). The ability of 
parasite-infected erythrocytes to cytoadhere to, and therefore obstruct, small 
blood vessels is also of great importance. Trophozoite- and schizont-infected 
erythrocytes are covered in knob-like protrusions, which enable contact with host 
cells (Luse & Miller, 1971), via a parasite-encoded molecule called Plasmodium 
falciparum erythrocyte membrane protein 1 (PfEMPI) (Newbold et al., 1999), 
leading to sequestration of parasites in various organs including the heart, lung 
and kidney. Cytoadherence of parasites in the small blood vessels of the brain 
may be a cause of cerebral malaria. Pregnancy-associated malaria (PAM), a 
cause of massive maternal and infant morbidity, is a consequence of the 
expression of parasite variant surface antigens (VSAs), that specifically bind to 
placental receptors including chrondoitin sulphate A (CSA). The interaction 
between CSA and PfEMPI molecules is well established. Expression of one 
variant of PfEMPI in particular, VAR2CSA, is frequently associated with placental 
malaria, but other PfEMPI variants also contribute to this complication (Duffy et 
al., 2006, Salanti et al., 2003).
A relatively small proportion of malaria episodes proceed to severe disease, 
around 1%, yet the absolute number is considerable. There are a number of 
parasite, host, geographic and social factors that can contribute to the clinical 
outcome of a malaria infection. For example, the drug resistance profile of the 
parasite, expression of parasite or host molecules important in cytoadherence, 
the presence of host immunity, and access to treatment.
20
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1.4 History of malaria treatment
Quinine, an alkaloid extracted from the bark of the South American Cinchona 
tree, is the earliest known antimalarial to be used by Europeans and its use as a 
remedy is thought to date back to as early as the seventeenth century. Resochin, 
a quinine substitute, was developed in 1934 by a German scientist, Hans 
Andersag, and was at first disregarded as a candidate due to erroneous concerns 
over its toxicity. During Word War II US scientists obtained a supply of a German- 
developed compound called Sontochin, and following a few structural 
modifications chloroquine was born, although it was later discovered to be 
identical to the original Resochin.
Chloroquine was quickly identified as a cheap, safe and efficacious treatment for 
malaria, both radical cure and prophylaxis. However, in the late 1950s, within a 
decade of its introduction, chloroquine-resistant parasites were discovered in 
South America and South-east Asia and had reached Africa by the 1970s. The 
impact of chloroquine resistance on malaria mortality is astonishing, with a two­
fold increase in the number of cases of severe malaria and death attributable to 
its emergence (Trape et al., 2002). Yet despite this, chloroquine still remains the 
first-line treatment in many countries - a fact that can be explained by the 
enormous disparity in the cost of chloroquine versus alternative antimalarials.
It is now generally accepted that combination therapy utilising drugs with different 
modes of action is the most suitable approach to malaria chemotherapy and 
prophylaxis. The plant Artemisia annua has been the source for the development 
of a new set of antimalarial compounds, and artemisinin-based combination 
therapies (ACT) are the regimen of choice of the WHO for the treatment of 
uncomplicated P. falciparum malaria.
1.5 Vaccine development
There are a variety of different types of malaria vaccine currently under 
development, targeting different aspects of the parasite biology (Matuschewski, 
2006). Pre-erythrocytic vaccines aim to prevent hepatocyte invasion by 
sporozoites or to destroy infected cells, and erythrocytic stage vaccines are 
designed to eliminate, or limit the severity of, the blood-stage infection.
21
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Transmission-blocking vaccines aim to prevent the spread of malaria, by 
preventing the infection of mosquitoes that feed on malarious individuals.
The development of an anti-cytoadhesion vaccine is theoretically possible, and is 
an attractive proposition. However, the cytoadherence-associated protein 
PfEMPI is encoded by 60 members of the var multi-gene family. Any vaccine 
based on this molecule would therefore be very difficult to design, since var 
expression switching by the parasite allows evasion of the host immune system 
and a persistent infection can be maintained. Designing an anti-placental- 
adhesion vaccine on the other hand may be less problematic, due to the specific 
molecular nature of the interaction between parasite and host.
Antigens can be considered candidates for use in vaccines if they are essential 
for the propagation of the parasite life cycle, if they are associated with naturally- 
acquired immunity, or if they have been shown to be protective in animal models. 
Understandably, many of the parasite molecules thought to be involved in the 
invasion of host cells have been included in attempts to develop anti-malarial 
vaccines. These include thrombospondin-related anonymous protein (TRAP), 
which is known to be important in sporozoite invasion of hepatocytes, merozoite 
surface protein 1 (MSP1) and apical membrane antigen 1 (AMA1), which are both 
essential parasite molecules thought to be critical in merozoite invasion of 
erythrocytes.
It is likely that multi-component vaccines, which utilise more than one parasite 
antigen, will be important in overcoming the problems associated with antigen 
polymorphism. Since the vaccines that have entered clinical trials have so far 
failed to generate substantial, long-lived protection, it is obvious that considerable 
work will need to be done to reach the goal of an affordable, effective vaccine. In 
the meantime it will be useful to continue work to identify novel targets for further 
study.
1.6 An overview of the conserved molecular mechanism of Plasmodium 
host cell invasion
The Plasmodium developmental stages that are required to actively invade their 
host cell are the sporozoite, merozoite and ookinete. Although they are 
morphologically distinct, they possess certain shared characteristics. These
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include a polarised morphology and a set of secretory organelles located at their 
apical end (figures 1.2a and 1.2b). The molecular mechanisms that drive motility 
and/or invasion of these zoites are also thought to be highly conserved (Baum et 
al., 2006).
Zoites possess a membrane-anchored actin-myosin motor complex located 
between the parasite plasma membrane and the inner membrane complex (IMC), 
and homologues of the component molecules are found in all apicomplexan 
parasites. The motor consists of an unconventional class XIV myosin A (MyoA), 
which can interact with filamentous actin (F-actin) via its head domain. The actin- 
myosin motor is anchored to the outer membrane of the IMC by a complex 
consisting of MyoA tail-interacting protein (MTIP) (Bergman et al., 2003, Green et 
al., 2006b) and glideosome-associated proteins 45 and 50 (GAP45 and GAP50) 
(Baum et al., 2006).
Invasion is dependent on the regulated release of proteins from the apical 
organelles, including extracellular adhesin molecules that bind host cell receptors. 
The motor provides the driving force for movement, but in order for this action to 
be productive and forward-propelling, a link to the extracellular adhesins is 
necessary. In sporozoites an adhesin called thrombospondin-related anonymous 
protein (TRAP), a type I membrane protein, is critical. TRAP binds sulphated 
glucosaminoglycans on the liver cell surface, and importantly it is linked to the 
actin-myosin motor through its cytoplasmic tail, via an interaction with the F-actin- 
binding protein aldolase (Buscaglia et al., 2003). In ookinetes, a similar function is 
likely performed by the circumsporozoite/TRAP-related protein (CTRP) (Dessens 
et al., 1999). In merozoites, a third member of the TRAP family, MTRAP, is 
thought to function similarly (Baum et al., 2006) (see figure 1.2c). Although it has 
been shown to bind to aldolase in vitro, MTRAP has not been shown to have any 
erythrocyte binding capability. It is therefore possible that MTRAP binds to the 
erythrocyte surface indirectly via other parasite proteins, for example an 
erythrocyte binding antigen such as EBA175, and therefore acts as a link 
between extracellular adhesins and the motor. Force generated by the motor 
allows invasion to occur and the extracellular adhesins are simultaneously 
‘treadmilled’ to the posterior of the parasite via their connection with the motor. 
The adhesins are ultimately cleaved by a protease, allowing the parasite to enter 
the host cell.
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1.7 Erythrocyte invasion
Since the human pathology of malaria is inextricably linked to the asexual blood 
stage of the parasite, there have been intense efforts to elucidate the molecular 
mechanisms of erythrocyte invasion in order to uncover potential drug and 
vaccine targets. However, the process remains largely undefined.
1.7.1 Initial attachment
Studies utilising light and electron microscopy have suggested that invasion 
begins with an initial contact between the merozoite and erythrocyte, which is 
thought to be a weak, reversible, low-affinity adherence occurring with a relatively 
large distance between the two cells (~12 nm) (Bannister & Dluzewski, 1990). It 
is thought that a large glycophosphatidylinositol (GPI)-anchored assembly of 
fragments of MSP1 and its associated proteins is responsible for the initial low- 
affinity interaction, although definitive evidence is lacking (Goel et al., 2003, Li et 
al„ 2004).
1.7.2 Reorientation
Reorientation of the parasite occurs, so that the apical end of the merozoite, and 
hence the secretory organelles, are juxtaposed to the erythrocyte surface. A 
molecule that has been proposed to play a pivotal role in this stage is AMA1, a 
protein that is secreted onto the merozoite surface before invasion begins. 
Although it has been shown that AMA1 is highly conserved across the 
apicomplexan phylum, and is known to be an essential determinant of 
P. falciparum invasion (Triglia et al., 2000), its precise role is still unknown. It has 
been proposed that secretion of AMA1 from the apical organelles onto the 
merozoite surface, and its subsequent diffusion throughout the membrane, 
results in the creation of an AMA1 concentration gradient, with the amount 
present decreasing from the apical to posterior end (Thomas et al., 1990). 
Theoretically, any adhesive interactions occurring between AMA1 and the 
erythrocyte surface could therefore serve to reorientate the parasite to its 
required position, although such interactions have not been demonstrated 
conclusively. Additionally it has been shown that in the presence of a monoclonal 
antibody raised against P. knowlesi AMA1, merozoites fail to reorientate. The 
next step in the invasion process, which is the formation of a tight junction
26
Chapter 1: Introduction
between the two cells, also fails to occur in the presence of this antibody, strongly 
implicating AMA1 in either of those processes (Mitchell et al., 2004). In summary, 
the existing evidence suggests that AMA1 is likely to be a critical link between the 
initial weak interactions between the parasite and the erythrocyte, and the tighter, 
more specific interactions that follow.
1.7.3 Tight Junction Formation
Following reorientation, an irreversible tight junction forms between the apical 
prominence of the merozoite and the erythrocyte membrane, with a separation of 
around 4 nm (Bannister et al., 1986). This junction is composed of high-affinity 
interactions between parasite ligands released from the apical organelles, and 
erythrocyte receptors. Members of two P. falciparum protein families are likely to 
function as the parasite ligands at the tight junction. These are the Duffy-binding- 
like erythrocyte-binding protein (DBL-EBP), and P. falciparum reticulocyte-binding 
protein homologue (PfRH) families.
These proteins provide a variety of invasion pathways for the merozoite, as each 
protein interacts with a different erythrocyte receptor. Two members of the 
DBL-EBP family, EBA175 and EBA140, adhere to the sialic acid residues of 
glycophorin A (Sim et al., 1994) and glycophorin C (Maier et al., 2003) 
respectively, and a third member, EBA181 is believed to bind a different, but as 
yet undefined, trypsin-resistant erythrocyte receptor W  (Gilberger et al., 2003b). 
The N-terminal cysteine-rich domain of EBA175, region II, mediates binding to 
glycophorin A (Sim et al., 1994), and it is believed that similar domains in EBA140 
and EBA181 perform similar functions.
P. vivax proteins PvRBPI and PvRBP2 are specifically responsible for the 
reticulocyte-preference of this parasite (Galinski et al., 1992, Galinski et al., 
2000), and homologues present in P. yoelii, the Py235 protein family, adhere to 
mouse erythrocytes, albeit through an undefined mechanism (Ogun & Holder, 
1996). The PfRH family of proteins are homologues of the PvRBP and Py235 
proteins and three of the six members are believed to play roles in invasion. 
PfRH1 binds to an undefined ligand ‘Y’ on erythrocytes (Rayner et al., 2001) and 
is essential for sialic acid-dependent invasion (Triglia et al., 2005). PfRH2b is 
essential for invasion via an unknown receptor ‘Z’ (Duraisingh et al., 2003b), 
although it has not been shown to have any binding activity. W2mef parasites are
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able to switch from sialic acid-dependent to -independent invasion, by selection 
on neuraminidase-treated erythrocytes which lack sialoglycoproteins. This 
reversible switching has been shown to be correlated with, and dependent on, 
the expression of PfRH4 (Stubbs et al., 2005).
None of the genes encoding the DBL-EBP or PfRH proteins is essential for 
parasite growth, as they can all be successfully disrupted individually (Duraisingh 
et al., 2003a, Duraisingh et al., 2003b, Gilberger et al., 2003b, Reed et al., 2000, 
Stubbs et al., 2005, Triglia et al., 2005). This demonstrates the redundancy that 
exists within the process of invasion, and the ability of the parasite to invade via 
different pathways. This redundancy is highly beneficial to the parasite, since 
natural variation within the host means that parasites cannot rely on one 
particular invasion pathway. For example, an immune response may block a 
particular receptor-ligand interaction, and certain erythrocyte proteins and 
glycoconjugates are highly polymorphic within human populations, or may not 
always be present (Miller et al., 2002).
As mentioned previously, extracellular adhesins are required to connect with the 
actin-myosin motor for successful invasion to occur. The cytoplasmic tails of the 
DBL-EBP proteins do not seem to be directly linked to the actin-myosin motor 
(Gilberger et al., 2003a), and it is proposed that in merozoites a protein called 
MTRAP may form a link between the DBL-EBP and PfRH adhesins and the 
motor via aldolase, although this remains to be determined (Baum et al., 2006).
1.7.4 The moving junction
As invasion progresses, the ring-shaped tight junction established at the apex 
moves over the parasite towards the posterior end. The developing invagination 
of the host plasma membrane allows the parasite to enter its parasitophorous 
vacuole (PV). The moving junction itself is believed to be composed of a complex 
of parasite secretory organelle-derived molecules that function to exclude host 
cell membrane proteins from the nascent parasitophorous vacuole membrane 
(PVM) (Mordue et al., 1999). In T. gondii, the moving junction complex consists of 
TgAMAI and at least one rhoptry neck protein, TgRON4 (Alexander et al., 2005). 
Similarly in P. falciparum, PfAMAI co-immunoprecipitates with the Plasmodium 
homologue of TgRON4, suggesting a comparable complex exists in the malaria 
parasite (Alexander et al., 2006).
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The removal or ‘shedding’ of the electron-dense coat from the surface of the 
merozoite is evident at the point of invasion (Aikawa et al., 1978, Bannister et al., 
1975) and is likely to occur simultaneously with translocation of the moving 
junction over the surface of the parasite. Moreover, it has been shown that 
PfSUB2, a membrane-bound member of the subtilisin-like protease family, is 
responsible for the shedding of MSP1, the major merozoite surface coat 
constituent, as well as AMA1, which is also located on the surface of merozoites 
(Harris et al., 2005). Plasmodium thrombospondin-related apical merozoite 
protein (PTRAMP), another merozoite surface molecule, is a third substrate for 
PfSUB2, although the function of PTRAMP and the significance of its shedding is 
unknown (Green et al., 2006a).
PfSUB2 acts by cleavage at a juxtamembrane site within the ectodomain of its 
target molecule. It is proposed that PfSUB2 accumulates at the moving junction, 
shedding its target molecules as the parasite propels itself into the red blood cell, 
in a process described as ‘shaving proteolysis’.
1.7.5 Disengagement of adhesive interactions
The current model for Toxoplasma tachyzoite invasion includes a shedding 
mechanism distinct from that of PfSUB2. Tachyzoite adhesive micronemal 
proteins (MICs) that bind to host cell ligands are translocated towards the rear of 
the parasite during invasion (Carruthers et al., 1999), via an interaction with the 
actin-myosin motor. The MICs come into contact with a recently characterised 
molecule called TgROM5, a rhomboid, at the posterior of the parasite during the 
final stages of invasion. Rhomboids are a class of protease that function by 
cleaving their substrate within the transmembrane domain and it has been shown 
that TgROM5 is responsible for the cleavage of MIC adhesins (Brossier et al., 
2005).
Similarly, it has recently been shown that two Plasmodium rhomboid enzymes, 
PfROMI and PfROM4, are responsible for the cleavage of a wide range of 
adhesins implicated in invasion, also within their transmembrane domains (Baker 
et al. 2006). For example, EBA175 is cleaved by PfROM4 in an event that is 
essential for parasite growth (O'Donnell et al., 2006).
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In summary, it appears that during invasion, Plasmodium proteases act through 
two distinct mechanisms, but in a coordinated fashion, in order to allow the 
progression of the parasite into its vacuole within the host cell:
• PfSUB2 removes the merozoite surface coat at the moving junction,
• PfROMI and PfROM4 disengage adhesive interactions between 
erythrocyte ligands and parasite receptors.
1.8 Apical organelles and their complement
The apical organelles of the invasive sporozoite and merozoite consist of 
rhoptries, micronemes, and dense granules. Rhoptries are paired club-shaped 
vesicles, whereas micronemes are more numerous with up to 40 per cell. 
Micronemes are smaller in size than rhoptries and are clustered around the 
rhoptry ducts. Importantly, these vesicles secrete their contents from the zoite 
apex at the point of host cell invasion. Dense granules (DG) are microspheres 
with a diameter of approximately 200 nm and secretion of DG-resident proteins is 
thought to occur at a sub-apical location, following the fusion of DG and parasite 
plasma membranes.
It has been shown in Toxoplasma that there is a sequential secretion of proteins 
from the different sets of organelles: microneme contents are secreted initially, 
followed by the rhoptry- and ultimately dense granule-resident proteins 
(Carruthers & Sibley, 1997). This led to the suggestion that proteins are 
functionally segregated: micronemal proteins are either adhesins or molecules 
that link the parasite surface to the actin-myosin motor, rhoptry proteins are 
responsible for the formation of the PVM, and dense granule proteins are 
involved in host cell modification.
Although this suggestion may be broadly accurate, and is supported by evidence 
such as the absence of rhoptries in ookinetes, which do not utilise a PV, it is likely 
that there is significant overlap in the roles played by proteins from these 
organelles (Kats et al., 2006). For example, although the DBL-EBP family of 
adhesive proteins are microneme-resident, the rhoptry neck protein PfRH1 is also 
thought to act as an adhesin through binding to an undefined glycosylated 
erythrocyte receptor (Rayner et al., 2001).
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1.8.1 Microneme proteins of P. falciparum
The best characterised of the microneme proteins are the DBL-EBP family of 
proteins and AMA1, whose roles have already been discussed. MTRAP, which is 
potentially the link between the merozoite motor complex and extracellular 
adhesins, is also micronemal, along with the merozoite ‘sheddase’ PfSUB2. 
Apical sushi protein (ASP) is a recently described GPI-anchored protein, which 
has also been localised to the micronemes. ASP has a sushi-domain, which is 
known to be involved in protein-protein or protein-ligand interactions in other 
species (O'Keeffe et al., 2005). However, a specific role for this protein has yet to 
be defined.
Micronemal proteins are presumed to be trafficked initially via a classical 
N-terminal signal sequence that allows them to cross the endoplasmic reticulum 
and enter into the secretory pathway. However, the details of specific trafficking 
to the micronemes are yet to be fully elucidated. The DBL-EBP proteins are 
single span transmembrane proteins with a cytoplasmic domain and ectodomain. 
It has recently been shown that a C-terminal cysteine-rich region of the 
ectodomain of these proteins is responsible for targeting to the micronemes 
(Treeck et al., 2006). It seems likely that other micronemal proteins that do not 
possess this domain are trafficked by alternative mechanisms.
1.8.2 Processing and shedding of microneme proteins
The proteolytic processing of apicomplexan microneme proteins is widespread, 
and is often essential for their correct functioning. In Toxoplasma gondii, 
microneme proteins exist as complexes, which are ultimately released onto the 
parasite surface following a rise in intracellular calcium levels (Carruthers & 
Sibley, 1999). Most of these proteins are subject to proteolytic modifications 
following their entry into the secretory pathway (Dowse & Soldati, 2004). For 
example, the TgMIC2/TgM2AP complex is proteolytically processed and 
ultimately shed in a process involving three distinct microneme proteases that is 
essential for successful invasion (Brossier et al., 2003, Zhou et al., 2004).
This phenomenon also occurs in Plasmodium, with AMA1 processing widely 
studied and shown to be a multi-step process essential for successful invasion. 
The initial processing of PfAMAI occurs shortly after its trafficking to the
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micronemes, by way of an N-terminal cleavage event (Howell et al., 2001, Narum 
& Thomas, 1994). Other micronemal proteins that appear to be processed in a 
similar manner include MTRAP (Baum et al., 2006) and ASP (O'Keeffe et al., 
2005). Some micronemal proteins are subject to further proteolysis, which results 
in them being shed into culture supernatant. For example, the N-terminally 
truncated form of AMA1, which is transferred to the parasite surface, is ultimately 
shed in two alternative forms, following further proteolysis by PfSUB2 (Harris et 
al., 2005, Howell et al., 2003). Interestingly, PfSUB2 is also responsible for the 
shedding of MSP1 (Harris et al., 2005) and PTRAMP into culture supernatant 
(Green et al., 2006a).
It has been shown that two of these shedding events are critical for invasion. Anti- 
AMA1 antibodies that inhibit shedding can also inhibit invasion (Dutta et al., 2005, 
Dutta et al., 2003). It has also been shown that the shedding of EBA175 is 
essential for propagation of the asexual blood stage (O'Donnell et al., 2006).
Since shedding of AMA1 occurs predominantly via a juxtamembrane cleavage 
just 29 residues away from the predicted transmembrane region (Howell et al., 
2005, Howell et al., 2003), a short ‘stub’ of AMA1 ectodomain is generated, which 
remains anchored to the parasite surface via its intact transmembrane domain. It 
has been shown that this stub is carried into newly invaded ring stage parasites, 
where it remains associated with the parasite plasma membrane (Howell et al., 
2005). This is reminiscent of the fate of MSP119, the residual stub of MSP1, which 
has also been identified in ring stage parasites (Blackman et al., 1990) and 
localises to the food vacuole (Ling et al, manuscript in preparation). Whether 
these residual stubs serve any function in the ring stage parasite remains to be 
determined.
1.9 GPI-anchored proteins of P. falciparum
1.9.1 The GPI-anchor and its addition
The addition of a GPI-anchor to proteins is a widespread phenomenon in both 
lower and higher eukaryotes (Eisenhaber et al., 2001), including Trypanosoma 
and Plasmodium parasites, and serves to anchor proteins in the plasma 
membrane of a cell. The GPI moiety itself is a complex glycolipid and its structure 
is shown in figure 1.3a.
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Addition of a GPI-anchor requires the presence of an N-terminal signal sequence, 
which allows co-translational insertion of the polypeptide into the endoplasmic 
reticulum (ER). Before anchorage can occur, the entire polypeptide chain is 
translocated across the ER membrane and into the lumen (Dailey & Bulleid, 
2003a). Once in the lumen, a C-terminal GPI-anchor signal sequence is 
recognised by a transamidase complex.
The GPI-anchor signal sequence consists of four components, detailed in figure 
1.3b (Eisenhaber et al., 2001): briefly, a C-terminal hydrophobic region is 
preceded by a short hydrophilic spacer that is linked to the anchor addition site 
(residue co). The transamidase complex catalyses the concomitant removal of the 
GPI-anchor signal sequence, by way of a proteolytic cleavage between residues 
w and uj+1 , and its replacement with a pre-synthesised, membrane-bound GPI- 
anchor (figure 1.3c). The protein is thus anchored, and is exposed initially to the 
luminal side of the endoplasmic reticulum, and ultimately the cell exterior.
Single-pass transmembrane proteins are thought to be anchored in a similar but 
distinct way. The transmembrane domain itself consists of a hydrophobic region 
followed by a ‘stop transfer’ sequence that consists of charged residues. The 
protein is co-translationally passed through the translocon pore of the ER 
membrane and into the lumen, until the ribosome encounters and recognises the 
‘stop transfer’ sequence (High & Dobberstein, 1992). This triggers the blockage of 
the translocon pore on the luminal side, and lateral translocation of the 
polypeptide within the ER membrane occurs, resulting in the integration of the 
transmembrane domain into the lipid bilayer (Martoglio et al., 1995).
The transmembrane and GPI-anchor signal sequences both contain hydrophobic 
regions, and there are characteristics shared between the two. It is likely that 
subtle differences in the hydrophobic region of a GPI-addition sequence prevent 
its recognition and lateral translocation within the ER membrane, as if it were a 
transmembrane domain (Dailey & Bulleid, 2003b). Nonetheless, one might expect 
GPI-addition sequences to be wrongly assigned as transmembrane domains by 
algorithms. For example, bioinformatic analysis of the ASP amino acid sequence 
predicted a C-terminal transmembrane anchor (O'Keeffe et al., 2005), although it 
was later experimentally shown to be GPI-anchored (Gilson et al., 2006).
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Figure 1.3: GPI-anchor structure and addition in P. falciparum
a) The presumed structure of the P. falciparum GPI-anchor. Diagram from Naik et 
al. (2000). Molar proportions of the three fatty acids are indicated. Two fatty acids 
within a hydrophobic phosphatidylinositol group act as the membrane anchor. A 
carbohydrate linker consisting of mannose and glucosamine connects the 
phosphatidylinositol group to the C-terminal residue of the anchored protein via a 
phosphoethanolamine residue.
b) The sequence requirements for GPI-anchor addition. Cleavage of the signal 
sequence occurs between residues w and uj+1. The cleavage site itself (coloured 
pink, residues u)-1 to co+2) consists of amino acid residues with small side 
chains, and is followed by a moderately polar spacer region (yellow, residues 
co+3 to w+9). A hydrophobic tail is found approximately 9 or 10 residues 
C-terminal of the w site (green), and extends to the C-terminus of the protein. An 
unstructured linker is found from residues w-11 to w-1 (blue).
c) Diagram from Dailey & Bulleid (2003a). The entire polypeptide chain of a GPI- 
anchored protein is fully translocated into the lumen of the endoplasmic reticulum, 
prior to anchor addition. The GPI signal sequence is recognised by a membrane- 
bound transamidase complex that catalyses the removal of the GPI signal 
sequence and its replacement with a pre-synthesised GPI-anchor.
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1.9.2 GPI-anchored proteins in Plasmodium
All of the extracellular forms of P. falciparum are covered in proteins that are 
either known or presumed to be GPI-anchored. For example Pfs48/45 on the 
gamete surface (Kocken et al., 1993), Pfs25 and Pfs28 on the surface of the 
ookinete (Kaslow et al., 1988, Tomas et al., 2001), and circumsporozoite protein 
(CSP) on the sporozoite surface (Dame et al., 1984). 11 GPI-anchored proteins 
have been identified in the merozoite to date, MSP1 and MSP2 (Gerold et al., 
1996), MSP4 (Marshall et al., 1997), MSP5 (Marshall et al., 1998), MSP10 (Black 
et al., 2003), rhoptry-associated membrane antigen (RAMA) (Topolska et al., 
2004), ASP, Pf92, Pf38, Pf34 and Pf12 (Gilson et al., 2006). MSP8 is also 
presumed to be GPI-anchored (Black et al., 2001).
Most P. falciparum GPI-anchored proteins appear to be surface antigens, as 
opposed to apical organeliar molecules. Exceptions to this include rhoptry- 
associated membrane antigen (RAMA) (Topolska et al., 2004), and ASP, a 
microneme protein. Interestingly, Pf38 (Sanders et al., 2005) and MSP10 (Black 
et al., 2003), appear to display both surface and apical distributions.
1.9.3 Importance of GPI-anchored molecules in immunity
It is widely accepted that the GPI moiety of P. falciparum proteins is a potent 
activator of the innate immune system, and promotes the production of a variety 
of pro-inflammatory cytokines (Nebl et al., 2005). Since the host immune 
response is a key contributing factor in malarial pathogenesis during infection, 
GPI-anchored proteins are regarded as critical toxins.
GPI-anchored proteins feature prominently in the list of potential candidate 
antigens for use in anti-malarial vaccines. In addition, the P. falciparum GPI 
moiety itself is considered a candidate constituent of a potential anti-toxin 
vaccine, and has been shown to protect mice in vivo from the pathogenesis of a 
P. berghei infection (Schofield et al., 2002). In theory, such anti-toxin vaccines 
may circumvent the problems associated with the design of vaccines designed to 
neutralise parasite proteins. These problems include antigenic variation, 
functional redundancy, and the time taken by the host to acquire immunity.
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1.10 The post-genomic era of research
The fruitless efforts to develop a licensed malaria vaccine, along with the 
emergence of drug-resistant parasites and insecticide-resistant mosquitoes 
highlight the urgency with which new points of attack to combat malaria need to 
be identified. The arrival of the P. falciparum genome sequence (Gardner et al., 
2002), along with its transcription (Bozdech et al., 2003, Le Roch et al., 2003) 
and proteomic (Florens et al., 2002, Lasonder et al., 2002) profiles, has provided 
scientists with a great opportunity to identify novel drug and vaccine candidates.
1.10.1 Transcriptome data
Two independent DNA microarray studies were published in 2003 and have 
provided invaluable information with regards to the expression levels of genes 
throughout the intra-erythrocytic blood cycle and other developmental stages. 
One of the main findings of these two studies is that groups of genes with similar 
levels and temporal patterns of expression can be assembled into ‘clusters’, with 
each member of a particular cluster proposed to be functionally related.
The Bozdech et al. study (2003), which utilised asexual stages of P. falciparum 
clone HB3, revealed that the majority of intra-erythrocytic expression profiles 
show some degree of periodicity, with a maximum and minimum level of 
transcript abundance at defined points within the 48 hour cycle. Few genes are 
transcribed at a steady level throughout. Phaseograms show a cascade of 
continuous transcription throughout the cycle, with no clearly defined boundaries, 
and in general, timing of gene expression is appropriate for the function of the 
resultant protein. For example, genes involved in DNA replication and synthesis 
are maximally expressed at the early-schizont stage, when they would be 
required by the parasite. Additionally, the expression of all genes presumed to be 
involved in invasion, for example, AMA1, MSP1 and EBA175, is sharply induced 
to a large amplitude in mid- to late-schizont stages. This cascade of expression 
profiles is likely to correspond to a programmed cascade of cellular processes 
and allow the necessary molecules to be present at the appropriate time to fulfil 
their role in the parasite.
The Le Roch et al. study (2003) utilised RNA from sporozoite, merozoite and 
gametocyte stages, in addition to six asexual blood stages, from P. falciparum
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3D7 parasites. By grouping genes together on the basis of their time of 
expression in the life cycle using a /(-means clustering algorithm, the authors 
were able to demonstrate that membership in a particular cluster was highly 
predictive of function, based on the distribution of proteins with known functions. 
For instance, genes assigned to cluster 15 were highly expressed in the schizont 
stage and representative members included AMA1, MSP1, EBA140 and PfSUB2, 
suggesting that members of this cluster may function in invasion.
A further transcriptome study covering the P. falciparum sporozoite, asexual intra- 
erythrocyctic and gametocyte stages was published in 2005 and used an 
algorithm called ontology-based pattern identification (OPI) (Young et al., 2005). 
This algorithm utilises gene annotations as well as temporal expression patterns 
to generate clusters of genes, with a view to enabling the functions of 
hypothetical genes to be predicted.
1.10.2 Proteome data
Several high-throughput mass spectrometry-based studies of the proteome of 
P. falciparum have been published (Florens et al., 2002, Lasonder et al., 2002), 
and importantly the results appear to correlate with the transcriptome data 
described above.
The Florens et al. (2002) study utilised multi-dimensional protein identification 
technology (MudPIT), a technique that combines high-resolution liquid 
chromatography and tandem mass spectrometry, and identified around 2400 
parasite proteins, nearly half of all predicted gene products, from sporozoites, 
merozoites, trophozoites and gametocytes. The Lasonder et al. (2002) mass 
spectrometric proteome study was able to confidently identify 1289 parasite 
proteins from asexual blood stages, gametocytes and gametes.
However, there are some discrepancies between transcriptome and proteome 
data. For example, >50% of proteins appeared stage specific in the Florens et al. 
(2002) study, whereas <30% of transcripts in the Le Roch et al. (2003) study 
were described as being unique to one stage. Also, there are significant temporal 
discrepancies between mRNA and protein abundance in P. falciparum (Le Roch 
et al., 2004). However these two inconsistencies can be explained by the differing 
sensitivities of the transcriptome and proteome methods, and the possibility of
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post-transcriptional control respectively. There is no doubt that these data still 
remain invaluable resources in their own right. The existence of such data sets 
also makes it relatively easy to identify proteins found in particular stages of 
interest, for example those only expressed in sporozoites and merozoites.
1.10.3 The ‘GPI proteome*
A couple of recent studies have been important in the attempt to generate a GPI- 
anchored proteome of P. falciparum. Proteome analysis of purified detergent- 
resistant membrane (DRM) domains from P. falciparum schizonts, which are 
highly enriched in GPI-anchored proteins, enabled the identification of novel 
merozoite surface-resident, putative GPI-anchored proteins such as Pf38 and 
Pf12 (Sanders et al., 2005). A different approach which employed radiolabelled 
GPI precursors was also able to identify novel GPI-anchored proteins, including 
the non-surface-resident proteins RAMA and ASP (Gilson et al., 2006).
It is highly likely that there are additional, unidentified GPI-anchored proteins 
present in schizonts and merozoites. The authors of the Gilson et al. (2006) study 
estimated that MSP1 and MSP2 constitute around two-thirds of the merozoite 
surface-resident GPI-anchored proteins, and therefore identifying proteins 
present at a much lower copy number is a task which may prove difficult.
1.11 Aims of this project
The present study aims to identify and characterise a novel P. falciparum protein 
that is involved in the invasion of erythrocytes.
Functional genomics has effectively revolutionised the manner in which 
potentially important genes, in particular, those implicated in host cell invasion, 
are identified and studied. Comparison of the P. falciparum nuclear genome with 
other genomes revealed that around 60% of the -5300 predicted genes encode 
proteins with no assigned function (Gardner et al., 2002). Consequently, there is 
a formidable number of novel potential drug and vaccine targets to contend with. 
It is therefore necessary to make efficient use of the wealth of data available and 
refine the list of potential novel targets by considering some important points.
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For instance, it is worth thinking about the common features shared by the molecules 
that are already known or are highly likely to be involved in the invasion process. 
These include:
• The presence of a signal peptide, indicating transport through the secretory 
pathway, possibly to apical organelles or the parasite surface
• The presence of a single transmembrane domain, as exemplified by AMA1, 
and the PfRH and DBL-EBP protein families
• A late blood stage expression profile, suggestive of a role in erythrocyte 
invasion
Sporozoites and merozoites are both actively invasive, and although the cells they 
invade may differ, the basic machinery of invasion is conserved between them (Baum 
et al., 2006). Therefore it should be considered that genes expressed in both stages 
could be critical in host cell invasion. Indeed, it has been shown that AMA1, which is 
expressed and critical in the asexual blood stage, is also expressed in sporozoites 
and has a critical role in the invasion of the hepatocyte (Silvie et al., 2004).
The main aims of this project are:
• To utilise published proteome, genome and transcriptome data to identify by 
bioinformatic means, a gene of interest for study as detailed below:
1. Published proteomic data (Florens et al., 2002) will be used initially to 
identify uncharacterised P. falciparum proteins expressed only in 
merozoite and sporozoite fractions that possess a predicted single 
transmembrane domain and signal peptide.
2. The amino acid sequences of candidate proteins will be analysed to 
identify any conserved domains or features of interest, as well as 
orthologues that may be present in other Plasmodium or 
apicomplexan species.
3. Transcriptome data for the genes encoding the identified candidate 
proteins will be retrieved and analysed to determine if any genes 
display a late blood stage expression profile.
4. A decision on the choice of gene for study will be taken based on the 
outcome of performing steps 1-3.
• To characterise the chosen gene and its corresponding protein with respect 
to:
o  location within the parasite
o  proteolytic processing, if any
o  potential role in invasion, if any.
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2. Materials and Methods
2.1 General Materials
2.1.1. Chemicals
All chemicals and ingredients used throughout the project were obtained from 
Sigma unless stated otherwise.
2.1.2 Solutions
Commonly used solutions included:
PBS: 137 mM NaCI, 3 mM KCI, 8 mM Na2HP04) 1.5 mM
KH2P04 in dH20
1 x TBE: 90 mM Tris-Borate, 2 mM EDTA in dH20, pH 8.0
Luria-Bertani broth (LB): 1% w/v bacto-tryptone, 0.5% w/v bacto-yeast
extract, 170 mM NaCI in dH20, autoclaved 
LB-Amp: As LB, with 100 pg ml'1 ampicillin
LB-Kan: As LB, with 25 pg ml'1 kanamycin
LB-Agar: As LB with 1.5% w/v agar
LB-Amp/Agar LB-Agar prepared as above, autoclaved and cooled
before the addition of 100 pg ml "1 ampicillin 
LB Kan/Agar LB-Agar prepared as above, autoclaved and cooled
before the addition of 25 pg ml -1 kanamycin
2.1.3 Centrifuges
E. coli cultures were spun down in disposable polypropylene centrifuge tubes 
(Corning) in a Beckman J-6B refrigerated centrifuge with rotor JS5.2. Bacterial 
protein extraction centrifugation steps were carried out in a Beckman J2-21 
refrigerated centrifuge with a JA-20 rotor and reusable polypropylene Oak Ridge 
centrifuge tubes (Nalgene).
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For phenol/chloroform extraction of DNA (cf. 2.5.1), precipitated DNA was 
pelleted in Corex tubes by centrifugation in a Beckman J2-21 refrigerated 
centrifuge with a JA-20 rotor.
For centrifugation of small volumes (£2 ml), a Heraeus Biofuge Pico 
microcentrifuge was used, with rotor #3325B, unless refrigeration was required, in 
which case a Heraeus Biofuge Fresco microcentrifuge was used with rotor 
#3328.
For the buffer exchange and/or concentration of solutions >2 ml, a Heraeus 
PrimoR refrigerated centrifuge was used with rotor #7591 and 20 ml Vivaspin 
centrifugal concentrators with an appropriate molecular weight cut-off (Sartorius). 
For buffer exchange and/or concentration of small volumes (^2 ml), 500 pi 
Vivaspin centrifugal concentrators with an appropriate molecular weight cut-off 
were used with either one of the microcentrifuges detailed above.
For the extraction of membrane-associated proteins, centrifugation steps were 
carried out in a Beckman TL-100 ultracentrifuge, with a TLA-100.3 rotor, using
1.5 ml polyallomer microfuge tubes (Beckman).
When handling parasites, a Sigma 4-10 centrifuge was used with rotor #11140. 
For smaller volumes a Heraues Biofuge Pico microcentrifuge was used, with rotor 
#3325B.
2.2 Bioinformatics
2.2.1 Identification of a candidate gene for study and initial 
bioinformatics
Data from the Florens et al. (2002) proteomic study, which identified 2415 
proteins from four developmental stages of P. falciparum, were used in order to 
select an uncharacterised P. falciparum gene for study. A set of criteria was 
designed in order to identify proteins from this dataset that may play a role in host 
cell invasion:
• Proteins must be predicted to contain a signal peptide
• Proteins must be predicted to have a single transmembrane domain
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• Proteins must have been detected in merozoite and sporozoites fractions 
only.
The dataset was sorted based on the criteria above, and this resulted in the 
identification of PF08_0008 as a suitable gene for study. Information on 
PF08J0008 was gathered from the Plasmodium genome resource PlasmoDB 
(http://plasmodb.org), as well as a number of published transcriptome studies 
(Bozdech et al., 2003, Le Roch et al., 2003, Llinas et al., 2006).
The biological sequence alignment editor BioEdit (Tom Hall, Ibis Therapeutics) 
was used to create a hydrophobicity plot for PF08_0008, using the Kyte & 
Doolittle (1982) method, with a window size of 13.
A number of algorithms were used to predict any transmembrane anchorage of 
the chosen protein: TMHMM2 (http://www.cbs.dtu.dk/services/, (Krogh et al., 
2001)), TOPPRED2 (http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html, 
(Claros & von Heijne, 1994)) and TMPRED (http://ch.embnet.org, (Hofmann & 
Stoffel, 1993)).
Two web-based GPI prediction servers were used to determine the likelihood of 
PF08_0008 being a GPI-anchored protein: the Big-TT GPI prediction server 
(http://mendel.imp.ac.at/gpi/gpi_server.html, (Eisenhaber et al., 1999)) and DGPI 
(http://129.194.185.165/dgpi/DGPI_demo_en.html, (Kronegg & Buloz, 1999)). 
The PSIPred tool (bioinf.cs.ucl.ac.uk/psipred, (McGuffin et al., 2000)) was used to 
predict secondary structure in the PF08_0008 C-terminus.
The PlasmoAP tool (http://plasmoDB.org, (Foth et al., 2003)) was used in order to 
predict the likelihood that PF08_0008 is targeted to the parasite apicoplast. The 
SignalP server (http://www.cbs.dtu.dk/services/SignalP, (Nielsen et al., 1997)) 
was used to predict the presence of a signal peptide at the N-terminus of 
PF08_0008.
2.2.2 Database searching and sequence alignment
Searches for similar protein sequences were carried out using the basic local 
alignment search tool (BLAST) (Altschul et al., 1990), available at the National 
Centre for Bioinformatics (http://ncbi.nlm.nih.gov/BLAST/), with default search
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parameters. Sequences of relevant hits from Plasmodium species were 
downloaded from PlasmoDB and were aligned using the BioEdit sequence 
alignment software. Multiple alignments were carried out using ClustalW 
(Thompson et al., 1994).
The Simple Modular Architecture Research Tool (SMART) (http://smart.embl- 
heidelberg.de/, (Schultz et al., 1998)) and ProSite (http://expasy.ch/prosite (Hulo 
et al., 2006)) searchable databases were used to identify conserved protein 
domains in PF08_0008.
2.3 Plasmodium falciparum culture
All solutions were pre-warmed to 37°C before use. The magnet-purification of 
schizonts, purification of merozoites, preparation of culture supernatant and 
metabolic labelling of parasites were carried out by Muni Grainger (NIMR, 
Division of Parasitology).
2.3.1 Parasites and media
RPMI w/o: RPMI 1640 enriched with 27 mM NaHC03, 25 mM
HEPES, 25 pg ml*1 gentamycin, 50 pg ml'1 hypoxanthine 
and 2 mg ml'1 glucose (Gibco)
RPMI w/Albumax: As above supplemented with 5 mg ml'1 AlbuMAX (Gibco)
Human erythrocytes (typically 0+) were obtained from the National Blood 
Transfusion Service and were stored at 4°C, for no longer than 1 month. Cells 
were washed three times in RPMI w/o before use, with centrifugation at 
2700rpm/1483g for 10 minutes.
2.3.2 Continuous culture
Phosphate buffer: 700 mM Na2HP04, 515 mM KH2P04, pH 7.2
P. falciparum asexual stages were cultured in human erythrocytes and RPMI 
w/Albumax. Typically a 175 cm2 flask was used, with a culture volume not 
exceeding 100 ml. Parasitemia was maintained at or below 15% and the 
haematocrit used was typically 1-2%. Cultures were gassed with a mixture of 7%
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C02, 5% 0 2) and 88% N2 and incubated at 37°C. Culture medium was replaced 
typically every 2 days. Cultures were harvested by centrifugation at 
1600rpm/521g for 8 minutes, the old medium aspirated off and fresh medium 
added.
Cultures were analysed by staining thin blood smears. Smears were briefly fixed 
with methanol. Stain was made up by diluting Giemsa’s staining solution (BDH) 1 
in 5 in phosphate buffer, then passing through a 0.2 pm filter. Smears were 
stained for 5 minutes then rinsed with water, dried and viewed by light 
microscopy.
2.3.3 Synchronisation of parasites and purification of schizonts
Isotonic Percoll: 1 volume 10 x PBS, 9 volumes Percoll (GE Healthcare)
70% isotonic Percoll: 7 volumes isotonic Percoll, 3 volumes RPMI w/o. 0.2 pm
filtered and stored at 4°C.
Sorbitol: 5% w/v sorbitol in PBS, 0.2 pm filtered and stored at 4°C.
A crude synchronisation was achieved by centrifuging the culture at
1600rpm/521g for 8 minutes, then resuspending the pellet in 5 volumes of
sorbitol. Following a 10 minute incubation at room temperature, cells were 
centrifuged at 1300rpm/344g for 3 minutes. Sorbitol was aspirated and cells were 
resuspended in fresh RPMI w/o and centrifuged for a further 3 minutes at 
1300rpm/344g. Medium was aspirated and cells returned to culture.
Cultures were tightly synchronised using a two-stage approach. A late blood- 
stage culture was centrifuged at 1600rpm/521g for 8 minutes, the pellet was 
resuspended in 5 volumes of RPMI w/o and layered on top of 10 ml 70% isotonic 
Percoll. Following centrifugation at 2200rpm/986g for 11 minutes, the layer of 
schizonts was removed and resuspended in RPMI w/o. Schizonts were
centrifuged for a further 5 minutes at 1800rpm/660g. Medium was aspirated off 
and schizonts were returned to culture for a period of 1-4 hours. Remaining 
schizonts were lysed with sorbitol treatment.
A MACS type D depletion column was used in combination with a SuperMacs II 
magnetic separator (Miltenyi Biotec) to purify schizonts from uninfected
erythrocytes. The column was washed with ethanol, followed by dH2Q, and was
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equilibrated with RPMI w/Albumax. Infected erythrocytes from late blood-stage 
P. falciparum cultures were harvested by centrifugation and re-suspended in an 
equal volume of RPMI w/Albumax. The cell suspension was then passed through 
the MACS column under gravity flow. The column was washed with four column 
volumes of RPMI w/Albumax until no erythrocytes could be seen in the flow­
through. The column was removed from the magnetic separator and washed with 
50 ml RPMI w/Albumax in order to allow collection of schizonts. If required for 
protein analysis, schizont material was harvested by centrifugation, the medium 
aspirated off and the cellular material stored at -70°C until used.
Parasites to be used in invasion inhibition assays were synchronised using a 
two-stage magnet purification approach. Late blood-stage parasites were purified 
from culture using the MACS depletion column as described above, and returned 
to culture for 2 hours. Remaining schizonts were then removed from the culture 
using the MACS depletion column, and the flow-through containing newly- 
invaded ring stages and uninfected erythrocytes was retained and returned to 
culture.
2.3.4 Metabolic labelling of parasites
Tightly synchronised late blood-stage schizonts were magnet purified as in 2.3.3, 
then resuspended to a 2-3% haematocrit in RPMI w/Albumax, free of methionine 
and cysteine, except for a supplement of 100 pCi ml'1 [35S]methionine and 
[35S]cysteine (Pro-Mix, GE Healthcare). Parasites were cultured in the presence 
of the radiolabel for 2 hours. If required for protein analysis, schizont material was 
harvested, washed in PBS, then harvested again and stored at -70°C until used. 
When returning labelled parasites to culture, schizont material was washed in 
RPMI w/Albumax.
In pulse-chase experiments, parasites were labelled as above for 10 minutes and 
returned to culture for 2 hours. Samples were taken at 0, 15, 30, 60 and 120 
minutes following the return to culture and were washed in PBS, harvested, and 
stored at -70°C until used.
For labelling of GPI-anchored proteins, purified schizonts were resuspended to a 
2-3% haematocrit in glucose-free RPMI w/Albumax supplemented with 10 mM 
fructose, 50 pCi ml'1 D-[6-3H(N)]glucosamine hydrochloride and 50 pCi ml'1
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D-[2-3H]mannose, and incubated at 37°C for 2 hours. Parasites were washed in 
PBS, harvested and stored at -70°C until used.
2.3.5 35S-labellinq of parasites in the presence of brefeldin A
Magnet-purified schizonts were resuspended to a 2-3% haematocrit in RPMI 
w/Albumax in the presence of 5 pg ml'1 brefeldin A (BFA) from a stock solution of 
1 mg ml'1 in methanol, or a corresponding amount of methanol alone for control 
cultures. The cultures were incubated for 1 hour at 37°C, then harvested and 
transferred to fresh medium, containing BFA or methanol but free of methionine 
and cysteine, except for a supplement of 100 pCi ml'1 Pro-Mix. Cultures were 
incubated for a further 1 hour at 37°C. The metabolically labelled parasites were 
washed in PBS, harvested by centrifugation and stored at -70°C until used.
2.3.6 Preparation of free merozoites
RPMI w/serum: As RPMI w/o, supplemented with 10% v/v pooled human AB+
serum (obtained from the National Blood Transfusion Service)
Tightly synchronised magnet-purified schizonts were returned to culture at a 
2-3% haematocrit in RPMI w/serum. The culture was regularly examined by 
microscopy and merozoites were purified at an appropriate time. Most schizonts 
and uninfected erythrocytes were removed from the culture by centrifugation four 
times at 1600rpm/521g for 5 minutes. Supernatants containing merozoites and 
residual schizonts and erythrocytes were passed down the MACS depletion 
column as described above, and the flow-through containing merozoites was 
retained. Merozoites were harvested by centrifugation of the flow-through at 
5000rpm/4670g for 5 minutes. Parasites were resuspended in PBS and 
transferred to microcentrifuge tubes, centrifuged again at 5000rpm/4670g and the 
merozoites stored at -70°C until used. When preparing merozoites for use in 
processing assays (cf. 2.7.7), the purification was carried out as above, except 2 
mM EGTA was present at all stages following the elution of schizonts from the 
MACS column.
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2.3.7 Preparation of culture supernatants
Tightly-synchronised magnet-purified schizonts were placed back into culture at a 
2-4% haematocrit in RPMI w/o, and were closely monitored by thin blood smear 
until schizont rupture had occurred. Cellular material was pelleted and the 
supernatant clarified by successive 10 minute centrifugation steps at 
2000rpm/814g, 5000rpm/4670g and 13,000rpm/16,060g. Supernatant was 
concentrated 10 x in a 20 ml centrifugal concentrator with a 5 kDa molecular 
weight cut-off, and stored at -20°C in 200 pi aliquots until used.
2.3.8 Crvopreservation and thawing of parasites
Freezing solution: 0.11 M NaCI, 0.17 M D-sorbitol, 28% v/v glycerol
High parasitemia ring-stage cultures were centrifuged at 1600rpm/521g for 8 
minutes. Medium was aspirated and 300 pi aliquots of cells were transferred to 
CryoTubes (Nalgene). 700 pi freezing solution was added to each tube drop- 
wise, with gentle mixing. Tubes were immersed in N2<i) for storage.
To resuscitate, vials were taken from N2(i) and thawed at 37°C. The contents were 
transferred to a fresh tube. 0.2 ml of 12% w/v NaCI in PBS was added per ml of 
culture, drop-wise. 10 ml of 1.6% w/v NaCI in PBS per ml of culture was then 
added, followed by 10 ml 0.9% w/v NaCI, 0.2% w/v glucose in PBS per ml of 
culture - both solutions were added drop-wise. The culture was centrifuged at 
1200rpm/293g for 5 minutes. The supernatant was aspirated and cells
resuspended in 10 ml RPMI w/o. Following a further centrifugation at 
1200rpm/293g for 5 minutes, the RPMI w/o was removed and replaced with 
RPMI w/Albumax, adding enough fresh erythrocytes to establish a 1-2%
haematocrit culture.
2.3.9 Transfection of P. falciparum
Cytomix: 120 mM KCI, 0.15 mM CaCI2, 2 mM EGTA, 5 mM MgCI2, 10 mM
K2HP04/KH2P04 (pH 7.6), 25 mM HEPES (pH 7.6)
WR99210: 20 pM stock (Jacobus Pharmaceuticals)
TE: 10 mM Tris-HCI, 1 mM EDTA (pH 8.0)
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Sterile DNA for transfection was prepared by mixing 100 pg DNA, 1 ml ethanol 
and 40 pi 3 M sodium acetate (pH 5.2), and incubating at -20°C for 24 hours. The 
DNA mixture was then centrifuged at 13,000rpm/16,060g at 4°C for 30 minutes. 
The DNA pellet was washed with 500 pi cold, sterile 70% ethanol and centrifuged 
at 13,000rpm/16,060g at 4°C for 15 minutes. The DNA pellet was air-dried then 
resuspended in 30 pi sterile TE and stored at 4°C until required.
30 pi sterile DNA in TE was mixed with 370 pi sterile cytomix. DNA in cytomix 
was mixed with 200 pi packed parasitised erythrocytes (5-10% ring stage 
parasitemia) and transferred to a 0.2 cm electroporation cuvette. Parasites were 
pulsed at a voltage of 0.310 kV and capacitance of 950 pF, with resistance set to 
infinity, using a Bio-Rad Gene Pulser. Electroporated parasites were then 
transferred to a flask containing 10 ml RPMI w/Albumax at a haematocrit of 3%. 
Parasites were gassed and incubated at 37°C. WR99210 was added 24 hours 
after electroporation, to a final concentration of 20 nM. For the first 5 days post­
transfection, both drug and medium were replaced daily.
Transfected parasites were cultured as normal, under drug pressure, until live 
parasites could be detected by thin blood smear. This point is referred to as the 
end of cycle 0. Parasites were then cultured for 3 weeks in the absence of drug 
pressure. Drug pressure was then re-applied until parasites re-emerged in the 
culture. This point is referred to as the end of cycle 1. This process of no drug 
pressure/drug pressure was repeated a further 2 times, until the end of cycle 3 
had been reached. At the end of each cycle, parasite stocks were created (cf. 
2.3.8) and genomic DNA prepared from the culture (cf. 2.4.1).
2.3.10 Cloning of mixed parasite population by limiting dilution
The parasitemia of a sorbitol-synchronised ring-stage culture was calculated by 
counting a thin blood smear. A haemocytometer was used to determine the 
number of cells, both infected and uninfected, present per ml of culture. The 
culture was diluted to a concentration of 3 x 10'3 parasites pi'1, in RPMI 
w/Albumax with a 2% haematocrit, and 100 pi was aliquoted into the wells of a 
96-well plate. This gave a theoretical number of 0.3 parasites per well. Plates 
were placed in a gassing chamber and gassed for 2 minutes, before incubation at 
37°C.
49
Chapter 2: Materials and Methods
Medium in the plates was first replaced after 5 days. This was repeated after 7 
days, and again on day 12, with the addition of WR99210 at the usual 
concentration of 20 nM and an extra 0.5 pi packed erythrocytes per well. Medium 
was typically replaced every 5 days thereafter.
From day 21 onwards, thin smears were made from individual wells, and were 
examined for evidence of infection by Giemsa staining and light microscopy. If 
parasites were evident, the 100 pi cultures were transferred to a 6 well plate, in a 
volume of 5 ml RPMI w/Albumax and 2% haematocrit, and were ultimately 
cultured in 100 ml volumes.
2.4 Preparation and analysis of nucleic acids
2.4.1 Isolation of DNA from P. falciparum
Buffer A: 50 mM sodium acetate (pH 5.2), 100 mM NaCI, 1 mM EDTA
Parasitised erythrocytes were centrifuged at 1600rpm/521g for 8 minutes. The 
cell pellets were resuspended in 4 volumes Buffer A at room temperature, and 
mixed thoroughly. 1 volume 18% SDS (BioRad) was added and the cells mixed 
by flicking the tube, before a 2 minute incubation at room temperature. 6 volumes 
of a 25:24:1 mixture of phenol:chloroform:isoamyl alcohol were added to the 
samples, which were then mixed by inversion and centrifuged at 2000rpm/815g 
for 10 minutes. The aqueous layer was removed to a Corex tube and 1/10 
volume 3 M sodium acetate (pH 5.2) and 2.5 volumes of cold ethanol were 
added. Samples were incubated overnight at -20°C.
DNA pellets were recovered by centrifugation at 10,000rpm/12,096g for 15 
minutes at 4°C, and were air-dried following removal of supernatant. The pellets 
were resuspended in 500 pi TE, transferred to a 1.5 ml microcentrifuge tube, and 
500 pi of a 25:24:1 mixture of phenol:chloroform:isoamyl alcohol was added. 
Samples were centrifuged at 8000rpm/6081g for 5 minutes. The upper aqueous 
layer was transferred to a fresh 1.5 ml tube and 500 pi cold isopropanol and 50 pi 
3 M sodium acetate were added in order to precipitate the DNA. Centrifugation at 
8000rpm/6081gfor 10 minutes pelleted the DNA, which was then washed in 1 ml 
cold 70% ethanol, before a final spin at 8000rpm/6081g for 10 minutes.
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Supernatants were discarded and the DNA pellet air-dried before resuspension in 
50 pi TE and storage at 4°C in screw-top 1.5 ml tubes.
2.4.2 Agarose gel electrophoresis
DNA loading buffer: 25% v/v glycerol, 50% v/v 10 x TBE, 0.02% v/v
bromophenol blue
DNA ladder: 1 kb or 100 bp DNA ladder (New England BioLabs)
diluted in DNA loading buffer to 100 pg ml'1. 0.5 pg 
loaded per lane.
Horizontal gels were made up by dissolving Agarose MP (Roche) in 0.5 x TBE 
with heating, typically to a concentration of 1% w/v. Ethidium bromide (Bio-Rad) 
was added to a concentration of 0.4 mg ml'1. Gels were set in casts and combs 
(Pharmacia). DNA samples were mixed 4:1 with DNA loading buffer, loaded into 
gels and electrophoresed at a constant voltage of 4-5 V cm'1, supplied by an EPS 
500/400 DC Power Supply (Pharmacia). When sufficient separation had 
occurred, the DNA bands were visualised using a UV transilluminator. The DNA 
ladders described above allow an estimation of DNA concentration in samples. 
The mass of DNA in each band of the ladder is known, and by comparing the 
intensity of sample DNA bands with the intensity of a similar sized ladder marker, 
the mass of DNA in the sample loaded can be estimated.
2.4.3 Polymerase Chain Reaction
The in vitro amplification of specific DNA sequences was achieved through use of 
the polymerase chain reaction (PCR). Oligonucleotide primers were obtained 
from Sigma Genosys and the genomic DNA template was prepared as detailed in
2.4.1.
DNA fragments were typically amplified using AmpliTaq DNA polymerase 
(Applied Biosystems), or Expand (Roche) if a proof-reading enzyme was 
required, according to the manufacturers’ instructions. A typical reaction volume 
of 50 pi consisted of 1 x PCR buffer, a final primer concentration of 0.4 pM, a final 
dNTP concentration of 0.2 mM, and 5 U AmpliTaq or 2.6 U Expand. The 
concentration of MgS04 varied between reactions but was typically 1.5 mM.
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PCRs were carried out using an Eppendorf Mastercycler gradient machine, with 
programs similar to the following:
1. 94°C for 5 minutes
2. 94°C for 30 seconds
3. (Tm-5)°C for 30 seconds
4. 72°C for 1 minute per kb of sequence
5. Repeat steps 2-4 a further 29 times
6. 72°C for 10 minutes
7. Hold at 4°C
The annealing temperature of the primers (Tm) was estimated using the formula: 
Tm = [4 x (G+C)] + [2 x (A+T)]
where G, C, A and T represent the number of bases of guanine, cytosine, 
adenine and thymine respectively, present in the oligonucleotide.
PCR products were separated and their size verified by agarose gel 
electrophoresis (cf. 2.5.2). When PCR products were to be used for cloning, they 
were purified from agarose using either the QIAquick or MinElute gel extraction 
kits (Qiagen), according to the manufacturer’s instructions. QIAquick-purified 
DNA was eluted in 50 pi 10 mM Tris-HCI (pH 8.5) and MinElute-purified DNA in 
10 pi 10 mM Tris-HCI (pH 8.5).
2.4.4 Restriction digest
DNA was digested with restriction endonucleases according to the 
manufacturer’s protocol. All enzymes were obtained from New England Biolabs. 
DNA was typically incubated with enzymes in a total volume of 20 pi containing 
1 x restriction buffer supplied by the manufacturer, supplemented with 100 pg ml'1 
BSA if required. Restriction fragments were separated from unwanted DNA by 
agarose gel electrophoresis and the gel was visualised. If required, the band 
corresponding to the desired product was excised and purified from the gel slice 
using the QIAquick gel extraction kit or MinElute kit. Purified DNA was again 
electrophoresed alongside a molecular mass standard to allow an estimation of 
concentration to be made.
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2.4.5 Southern blot analysis
1 x SSC:
Denaturation buffer: 
Neutralising buffer: 
Hybridisation buffer:
STE buffer:
Wash solution I: 
Wash solution II:
150 mM NaCI, 300 mM Ua3C6H50 7, pH 7.0
1.5 M NaCI, 0.5 M NaOH
1.5 M NaCI, 0.5 M Tris-HCI pH 7.4, 1 mM EDTA pH 8.0 
6 x SSC, 5 x Denhardts solution, 0.5% v/v SDS, 200 p.g 
ml'1 herring sperm DNA
100 mM NaCI, 10 mM Tris-HCI pH 8.0, 0.1 mM EDTA 
6 x SSC, 0.1% SDS 
2 x SSC, 0.1% SDS
Hybridisation buffer and wash solutions were heated to 65°C before use.
Genomic DNA was prepared from cloned parasite populations as described in
2.4.1. Equal quantities (~5 pg) of genomic DNA prepared from wild-type 3D7 
parasites, parasites from cycles 0-3 and 5 parasite clones, namely 9, B4, F8, C7 
and C9 were digested with Seal and Swal. Digested DNA was elecrophoresed on 
a large 0.8% agarose gel overnight at a constant voltage of 1 V cm"1. The gel was 
shaken gently for 10 minutes in 0.25 M HCI, followed by a 5 minute wash in 
dH20. The gel was then shaken gently in denaturation buffer for 1 hour, with a 
change of buffer after 30 minutes, followed by 1 hour in neutralising buffer, with a 
change of buffer after 30 minutes.
Hybond-N membrane (GE Healthcare) was pre-wet in dH20  then shaken for 15 
minutes in 10 x SSC. A wick was made of two large sheets of Whatman 3MM 
paper on a solid support, the ends of the wick being in a tank of 10 x SSC. Four 
more layers of Whatmann 3MM paper, cut to the same size as the gel, were 
placed on top of the wick, and the gel was placed on top. The layer of Hybond-N 
membrane was placed on top of the gel and on top of the membrane was placed 
multiple layers of Whatman 3MM paper and paper towels. A weight held the set­
up in place overnight to allow transfer of DNA to the membrane.
Following blotting, the membrane was shaken for 5 minutes in 0.4 M NaOH then 
for 1 minute in neutralising solution, after which the membrane was air-dried. 
DNA was crosslinked to the membrane by applying 1200 J using a Stratalinker 
UV crosslinker (Stratagene). The membrane was then wrapped in cling film and 
stored at -20°C until used.
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The membrane was defrosted, washed in 2 x SSC, 0.1% SDS for 10 minutes and 
transferred to a hybridisation tube. The herring sperm DNA was heated to 95°C 
for 10 minutes and was added to 20 ml pre-heated hybridisation solution, to a 
final concentration of 200 pg ml'1. Hybridisation solution was transferred to the 
hybridisation tube and the membrane was incubated at 65°C in a Hybaid oven for 
3 hours.
Two probes were generated by two independent digestions of the transfection 
vector pHH1-PF08_0008HA3 (cf. 2.5.1). A double digest with Xho\ and BglW 
generated an 841 bp probe, and a double digest with Xmn\ and EcoRI generated 
an 807 bp probe. Following purification, probes were labelled using the 
DECAprime II Random Priming DNA Labeling Kit (Ambion) according to the 
manufacturer’s instructions. DNA was denatured by boiling for 10 minutes in 
dH20  before being added to the reaction mixture. Briefly, 30 ng denatured DNA 
was incubated with 1 x decamers, 1 x reaction buffer (-dATP), 5 U exonuclease- 
free Klenow enzyme, and 1.11 MBq [a-32P]dATP (GE Healthcare) in a total 
volume of 25 pi, for 3 hours at 37°C. Labelled probes were then diluted to a
volume of 50 pi with STE buffer and purified using ProbeQuant G-50 spin
columns (GE Healthcare) according to the manufacturer’s instructions. Following 
purification, probes were denatured by boiling for 5 minutes. The membrane was 
then incubated with 20 ml fresh hybridisation solution and a heat-denatured 
labelled probe, in a Hybaid oven overnight at 65°C.
Following removal of the labelled probe and hybridisation solution, membranes 
were washed at 65°C in the Hybaid oven with wash solution I for 30 minutes, 
twice. Two 30 minute washes with wash solution II were then carried out. The 
membrane was drained, wrapped in cling film and exposed to a sheet of Kodak 
Biomax MR film at -70°C for an appropriate length of time.
A plasmid integration event was confirmed by sequencing a PCR product 
amplified from the genomic DNA of a clonal population of parasites. The forward
primer used was from 5’ of the region of PF08_0008 cloned into the
pHH1-T996HA3 vector, and the reverse primer was from 3’ of the triple HA tag 
coding sequence.
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2.5 Construction of plasmids
2.5.1 Transfection construct
The Xho\~ and Bg/I I-digested pHH1-T996HA3 plasmid was a gift from Pippa 
Harris (NIMR Division of Parasitology) (Harris et al., 2005). P. falciparum 3D7 
genomic DNA was used as a template to amplify an 829 bp DNA fragment from 
the 3’ end of PF08J0008 using oligonucleotide primers:
HAf (5’-GCGCAGATCTCCTACAGGTAA-3’) and 
HAr (5’-GCGCCTCGAGATTTAACAAGT-3’).
Restriction sites introduced for cloning are underlined. Xho\ and BglW sites were 
introduced to the 5’ and 3’ ends of the PCR product respectively. The fragment 
amplified consists of the extreme 3’ 829 bp of the gene, excluding the terminal 
STOP codon. A MgS04 concentration of 4 mM was used for the amplification.
Gel-purified PCR product was digested with Xho\ and BglW restriction 
endonucleases and ligated into the pre-digested pHH1-T996HA3 plasmid. The 
reaction volume of 10 p.l consisted of 400 U T4 DNA ligase (New England 
Biolabs), 1 x T4 DNA ligase reaction buffer, digested vector and PCR product, 
with a vector.insert molar ratio of approximately 1:5. The ligation was carried out 
overnight at 4°C.
2.5.2 Ligation-independent cloning
Ligation-independent cloning (LIC) allows PCR products to be annealed into 
vectors without the need for restriction enzyme digest, through the use of vectors 
and PCR products with complementary overhangs. 2 regions of PF08_0008 were 
chosen for expression in a heterologous system using the LIC expression vectors 
pET 30 and pET 32 (Merck). One region is situated at the N-terminal end of the 
protein (N-terminal domain (NTD)) and one at the C-terminal end (C-terminal 
domain (CTD)). Regions of predicted low-complexity and hydrophobicity were 
avoided.
The pET 30 vector allows expression of recombinant protein as an N-terminal 
fusion with the His and S epitope tags. The pET 32 vector allows expression of 
recombinant protein as an N-terminal fusion with the His, S and thioredoxin 
epitope tags. The His and S tags enable the detection and purification of fusion
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proteins, and the thioredoxin tag is believed to enhance the solubility of the fusion 
protein.
The coding sequence for the NTD and CTD regions was amplified from genomic 
DNA by PCR using the following sets of primers:
NTDf (5’-GGTy47TG/4GGGTCGCTGTGATATACAAAAAATAGCAG-3’) and 
NTDr (5’-AGAGGAGAGTL4GAGCCTTGTTCTTCATCTTCCTCAAT-3’);
CTDf (5’-GGTA7TGAGGGTCGCGCAAAAGCTTATTGTAAGAA-3’) and 
CTDr (5’-AGAGGAGAGTTAGAGCCGCCTTTGCATTTGGTCCTT-3’).
The PCR was carried out as detailed in 2.4.3. The sequence in italics denotes 
LIC-compatible overhangs that are incorporated into the PCR product.
The PCR products corresponding to the N- and C-terminal regions of PF08_0008 
were cloned into the pET 30 and 32 vectors respectively, according to the 
manufacturer’s instructions. Briefly, 0.2 pmol of purified PCR product was treated 
with T4 DNA polymerase in the presence of dGTP to generate vector-compatible 
overhangs and allow efficient cloning into the LIC vector of choice through a 
simple annealing reaction.
2.5.3 Transformation of competent cells
S.O.C: 0.5% w/v yeast extract, 2.0% w/v tryptone, 10 mM NaCI, 2.5 mM KCI,
10 mM MgCI2, 20 mM MgS04, 20 mM glucose.
Ligation mixtures were transformed into E. coli One ShotTOPIO competent cells 
(Invitrogen) according to the manufacturer’s instructions. Briefly, 50 pi aliquots of 
cells were thawed on ice, and 1-4 pi ligation mixture was added. Cells were 
incubated on ice for 30 minutes and in a 42°C water bath for 30 seconds. Cells 
were returned to ice and 250 pi S.O.C. added. Following incubation at 37°C with 
shaking at 225 rpm for 1 hour, 200 pi of the transformation reaction was spread 
over a LB-Amp/Agar or LB-Kan/Agar plate as appropriate, pre-warmed to 37°C. 
pET 30 contains a gene encoding kanamycin resistance, and both pET 32 and 
pHH1-T996HA3 contain a gene encoding ampicillin resistance. Plates were 
inverted and incubated overnight.
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2.5.4 Colony screening
A number of colonies were selected for a colony PCR screen. The conditions for 
the colony PCR were as initially used to amplify the insert. Reaction mixtures 
included the primers used to amplify the insert, however, no template was added 
to the reaction mixtures. Instead, individual bacterial colonies were picked using a 
disposable plastic colony picker. Cells were used to inoculate a referenced 
second LB Amp/Agar or LB Kan/Agar plate as appropriate, then dipped into tubes 
containing the PCR reaction mixture, cross-referenced with the second plate. 
PCR products from the selected colonies were analysed by agarose gel 
electrophoresis and positive colonies were identified by the presence of an 
appropriately-sized DNA fragment.
Plasmid DNA from colonies was isolated using a QIAprep Spin Miniprep kit 
(Qiagen), according to the manufacturer’s instructions. Briefly, single colonies 
from the reference plate were used to inoculate 5 ml LB-Amp/Kan. Cultures were 
incubated for 12 hours at 37°C with shaking at 225 rpm. The cells from 1.5 ml of 
culture were pelleted by centrifugation at 13,000rpm/16,060g for 10 minutes, and 
the supernatant removed. The cell pellet was lysed under alkaline conditions. The 
cell lysate was neutralised and adjusted to high-salt conditions, which 
precipitated denatured proteins, cellular debris and genomic DNA. Centrifugation 
cleared the precipitate and the soluble plasmid DNA was then bound to the 
QIAprep silica membrane. Endonucleases and salts were removed in washing 
steps and DNA eluted in 50 pi 10 mM Tris-HCI, pH 8.5.
Restriction digests were carried out on the purified plasmid DNA samples using 
enzymes that cut either side of the ligated fragment. Digested plasmid DNA was 
subject to agarose gel electrophoresis, and the presence of an 
appropriately-sized fragment was indicative of a plasmid that had been 
successfully ligated to the insert.
Glycerol stocks of the positive colonies were made by mixing 200 pi glycerol with 
800 pi of a 5 ml culture, inoculated from the reference plate as described above. 
Stocks were stored in CryoTubes at -70°C.
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2.5.5 Sequencing of constructs and parasite genomic DNA
Sequencing of plasmid constructs was carried out using the Advanced 
Biotechnology Centre (ABC) DNA sequencing service at Imperial College, 
London. One pg plasmid DNA, or 120 ng PCR product, was supplied to ABC with
12.8 pmol of the appropriate primer in a final volume of 12 jnl. Samples were 
sequenced following a BigDye v3.1 sequencing reaction and were subsequently 
run on an Applied Biosystems 3100 capillary sequencer.
In the case of the plasmid to be used for transfection, the sequencing primers 
used were:
CAMf 5’-TAAGAAAAACGAACATTAAGCTGCC-3’ and 
PbDTr 5’-G CATGCAAGCTTATAATTATTAATAGGTAC-3’.
These primers span the XhoUBglW cloning site. Expression constructs were 
sequenced with the T7 promoter primer (Merck) on the sense strand, the primer 
NTDsr 5-TT GTT CTT CAT CTT CCT CAAT-3’
for the antisense strand of the NTD pET 30 construct, and the primer
CTDr 5'-AGAGGAGAGTTAGAGCCGCCTTTGCATTTGGTCCTT-3’
for the antisense strand of the CTD pET 32 construct. PCR product amplified
from parasites expressing PF08_0008-HA3 was sequenced with the forward
primer
5’-CAGCTTTACAAGTTACAAAT-3’ 
and the reverse primer
5’-AAGAAAAACGAACATTAAGCTGCCATATC-3\
Sequences were analysed using AutoAssembler software (Applied Biosystems).
2.5.6 Preparation of plasmid DNA for transfection
Plasmid DNA was isolated from a sequence-verified E. coli glycerol stock using 
the QIAfilter plasmid maxi kit (Qiagen). Cells were streaked onto a LB-Amp/Agar 
plate and incubated overnight at 37°C. Individual colonies were selected to 
inoculate 5 ml LB-Amp cultures, and cultures were incubated at 37°C, with 
shaking at 225 rpm, for 8 hours. 500 pi of these cultures were used to inoculate 
500 ml LB-Amp cultures, which were incubated overnight under the same 
conditions.
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Purification of plasmid DNA was carried out as per the kit protocol. Cultures were 
centrifuged at 4000rpm/4050g for 10 minutes to pellet the bacterial cells. The 
same alkaline lysis, neutralisation, clearing, binding and washing steps as the 
QIAprep Miniprep kit were carried out. DNA was eluted into a high-salt buffer then 
de-salted and concentrated by isopropanol precipitation. DNA pellets were 
washed in 70% ethanol, air-dried and dissolved in 500 pi dH20. Plasmid DNA 
was quantified by UV spectrophotometry at 260 nm.
2.6 Analysis of proteins
2.6.1 Total Plasmodium falciparum protein preparation
Reducing sample buffer: 1 M Tris-HCI pH 6.8, 4% v/v SDS, 20% v/v glycerol,
Purified schizont or merozoite material was resuspended in 2 x reducing or non­
reducing sample buffer. Mixtures were passed through a 27 gauge needle, 
heated at 95°C for 5 minutes and stored at -20°C if not used immediately.
2.6.2 Extraction of membrane-associated proteins
High pH carbonate buffer: 0.1 M Na2C03 pH 11.0
Purified schizonts or merozoites were resuspended in 20 volumes high pH 
carbonate buffer, passed through a fine-gauge needle and centrifuged at 
50,000rpm/135,240g for 30 minutes at 4°C. Supernatants were removed and 
pellets were re-extracted with 20 volumes carbonate buffer followed by a further 
30 minute spin at 50,0000rpm/135,240g at 4°C. Supernatants from both 
centrifugation steps were combined, buffer exchanged into PBS and 
concentrated by 50% using a centrifugal concentrator. Pellets and supernatant 
fractions were resuspended in 20 volumes 2 x reducing or non-reducing sample 
buffer and stored at -20°C if not used immediately.
Non-reducing sample 
buffer:
0.2 M DTT, 0.01% bromophenol blue 
1 M Tris-HCI pH 6.8, 4% v/v SDS, 20% v/v glycerol, 
0.01% bromophenol blue
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2.6.3 Separation of proteins bv SDS-PAGE
Coomassie:
Destain: 
Resolving gel:
Stacking gel:
0.1% w/v Coomassie blue, 45% v/v methanol, 10% v/v 
acetic acid
45% v/v methanol, 10% v/v acetic acid
10% v/v acrylamide, 0.37 M Tris-HCI pH 8.8, 0.1% v/v
SDS, 0.0026% v/v ammonium persulphate, 0.0005% v/v
TEMED
3% v/v acrylamide, 0.12 M Tris-HCI, 0.1% v/v SDS,
0.05% v/v APS, 0.001% v/v TEMED 
10 x Running buffer: 0.25 M Tris-HCI, 2 M glycine, 1% w/v SDS
Protein samples were separated by SDS-PAGE using the NuPAGE mini-gel 
system with the XCell Surelock Mini-Cell (Invitrogen). Pre-cast NuPAGE 10% or 
12% Bis-Tris polyacrylamide gels (Invitrogen) were used with 1 x MES or 
1 x MOPS running buffers as appropriate. Proteins to be separated were mixed 
with an equal volume of 2 x reducing or non-reducing sample buffer, and heated 
at 95°C for 5 minutes before loading. A protein standard (SeeBlue or SeeBlue 
Plus2 (Invitrogen)) was loaded for molecular mass estimation. A voltage of 200 V 
was applied until the dye front had reached the bottom of the gel, at which point it 
was removed from the gel system. Proteins could be visualised by staining the 
gel for 30 minutes with Coomassie blue with gentle shaking, and then by de­
staging until complete.
For separation of immunoprecipitated proteins, large slab gels were used. Gels 
were typically 10% acrylamide. The resolving gel was poured into a vertical gel 
casting apparatus (Hoefer Scientific Instruments) to set for 1 hour, after which a 
stacking gel was made up and poured on top. A comb was inserted to create 
wells before setting. When set, gels were fixed to vertical electrophoresis 
apparatus and the reservoirs filled with 1 x running buffer. A constant current of 
25 mA was applied until the dye front had reached the bottom of the gel. The gels 
were then fixed as detailed in 2.7.6.
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2.6.4 Western blotting of proteins
T ransfer buffer:
Washing solution: 
Blocking solution: 
Antibody diluent solution:
10% v/v methanol, 1 x NuPAGE transfer buffer 
0.1% v/v Tween-20 in PBS
10% w/v Marvel milk powder in washing solution 
5% w/v Marvel milk powder in washing solution
Proteins were separated by SDS-PAGE as described in 2.6.3. The blot was set 
up in an XCell II blot module (Invitrogen) containing the following components in 
order, all of which were pre-soaked in transfer buffer except for the gel: 2 gel­
sized sponges, a piece of gel-sized Whatman 3MM paper, a piece of gel-sized 
Protran nitrocellulose membrane (Schleicher & Schuell), the SDS-polyacrylamide 
gel placed face down on the membrane, another piece of Whatman 3MM paper 
and 2 more sponges. The blot module was positioned vertically in an XCell 
SureLock Mini-Cell, with the blot set-up so that the nitrocellulose was on the 
same side of the gel as the anode. A voltage of 30 V was applied for 2 hours.
The membrane was removed and incubated with shaking at room temperature in 
blocking solution for 60 minutes. The membrane was then incubated with the 
primary antibody, diluted to the appropriate concentration, for one hour under the 
same conditions. The membrane was washed for 10 minutes in washing solution, 
three times. The nitrocellulose was then incubated for 30 minutes with a 
secondary antibody-HRP conjugate, diluted to the desired concentration. The 
membrane was then washed for 10 minutes, three times as before. Binding of 
antibody to the membrane was visualised by using enhanced chemiluminescence 
(ECL) western blotting detection reagents (GE Healthcare). Treated nitrocellulose 
was then exposed to Kodak Biomax MR film for an appropriate length of time and 
developed.
If required, the distance travelled along the gel by the bands corresponding to the 
molecular mass standards were measured and plotted against the 
logio(molecular mass). Standard curves could then be used to calculate the 
molecular mass of polypeptides using their gel migration distances.
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2.6.5 Immunofluorescence assays (IFA)
Fixing solution: 
Permeabilisation solution: 
Blocking solution: 
Antibody diluent:
4% v/v formaldehyde in PBS 
0.1% v/v Triton X-100 in PBS 
3% w/v BSA in PBS
1% w/v BSA, 0.05% v/v Tween 20 in PBS
Magnet-purified P. falciparum schizonts were used to make schizont smears on 
glass slides, which were wrapped in foil and stored at -20°C until required. Slides 
were dried at 37°C for 5 minutes and wells were marked using a water repellent 
marker pen. Slides were fixed for 30 minutes and washed for 5 minutes in PBS. 
Cells were then permeabilised for 10 minutes, washed in PBS for 5 minutes more 
and incubated overnight at 4°C in blocking solution.
Antibodies were diluted in the solution indicated above, and were used to probe 
slides for 60 minutes at 37°C under humid conditions. Dual labelling experiments 
were carried out by incubating slides with both antibodies simultaneously. 
Following incubation with primary antibodies slides were subjected to three five 
minute washes in PBS. Secondary antibodies were used to probe the slides for 
30 minutes at 37°C under humid conditions. In the case of dual labelling 
experiments, secondary antibodies were incubated sequentially. Slides were 
subjected to three five minute washes in PBS and were briefly immersed in 
0.5 mg ml"1 DAPI in PBS to stain nuclei. Slides were mounted in Citifluor, sealed 
and visualised under oil immersion using an Axioplan 2 Imaging system (Zeiss). 
Images were captured with Axiovision software and prepared for publication with 
Adobe Photoshop.
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2.6.6 Immunoprecipitation of proteins
NP40 lysis buffer:
SDS lysis buffer: 
Wash Buffer I:
Wash Buffer II: 
Fixing solution:
1% NP40, 50 mM Tris-HCI pH 8.0, 5 mM EDTA, 5 mM 
EGTA, 150 mM NaCI
1% SDS, 50 mM Tris-HCI pH 8.0, 5 mM EDTA 
1% NP40, 50 mM Tris-HCI, pH 8.0, 5 mM EDTA, 500 mM 
NaCI, 1 mg ml'1 BSA
1% NP40, 50 mM Tris-HCI, pH 8.0, 5 mM EDTA 
25% v/v isopropanol, 65% v/v acetic acid in dH2Q
For the immunoprecipitation of protein complexes, pellets of metabolically 
labelled schizont material (-100 pi, prepared as detailed in 2.3.4 and 2.3.5) were 
resuspended in 1 ml NP40 lysis buffer supplemented with 1 x Complete protease 
inhibitors (Roche), and incubated on ice for 1 hour, followed by centrifugation at 
13,000rpm/16,060g at 4°C for 25 minutes. Protein G Sepharose 4 Fastflow (GE 
Healthcare) was washed 4 times in NP40 lysis buffer and 150 pi 50% slurry was 
used to pre-absorb the soluble fraction of the parasite material by rotating for 1 
hour at 4°C. Following centrifugation at 13,000rpm/16,060g for 2 minutes at 4°C, 
the supernatant was separated into 100 pi aliquots. 8 pi antiserum was added per 
aliquot, along with protease inhibitors to 1 x, and NP40 lysis buffer up to a total 
volume of 500 pi. Samples were rotated overnight at 4°C. For the 
immunoprecipitation of proteins from SDS-treated parasite material, the protocol 
was essentially the same, except schizont pellets were initially resuspended in 
100 pi SDS lysis buffer and heated to 95°C for 5 minutes. NP40 lysis buffer was 
then added to 1 ml and the protocol continued as above, from the first 
centrifugation step.
50 pi 50% protein G slurry was added to samples the following day, which were 
then rotated at 4°C for 60 minutes to immunoprecipitate proteins. Samples were 
then centrifuged at 13,000rpm/16,060g at 4°C for 20 minutes, washed twice with 
wash buffer I and four times with wash buffer II. Following the removal of 
supernatant, samples were resuspended in 50 pi 2 x sample buffer and 
separated by SDS-PAGE. Gels for autoradiography were fixed for 20 minutes 
then shaken in Amplify (GE Healthcare) for 20 minutes, dried at 70°C for two 
hours using a slab gel dryer (Hoefer Scientific Instruments) and exposed to 
Biomax MR film at -70°C for an appropriate length of time.
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2.6.7 Depletion of culture supernatant with erythrocytes
200 pi aliquots of 10 x culture supernatant were incubated in the presence or 
absence of 120 pi washed 0+ erythrocytes, with shaking at 225 rpm at 37°C for
1 hour. Following centrifugation at 2000rpm/380g for 10 minutes, supernatants 
were removed, added to 120 pi fresh erythrocytes and incubated for a further 
hour. Samples were subjected to three successive centrifugation steps, at 
2000rpm/380g, 8000rpm/6082g, and 13,000rpm/16,060g, each for 10 minutes, 
with the supernatant being retained at each step and cellular material discarded.
2 x sample buffer was added to samples, which were then heated to 95°C for 5 
minutes, separated by SDS-PAGE and subject to Western blot analysis.
For the elution of proteins bound to the surface of erythrocytes, 400 pi aliquots of 
supernatant were incubated with 60 pi 0+ erythrocytes for 1 hour at 37°C. The 
supernatant was removed following centrifugation at 2000rpm/380g for 10 
minutes, replaced with 400 pi fresh supernatant and the incubation repeated. 
Erythrocytes were isolated through centrifugation at 2000rpm/380g for 10 
minutes, and were washed three times in PBS. 20 pi 2 M NaCI was added to the 
cells drop-wise to elute proteins from the erythrocyte surface. Following a further 
centrifugation step the supernatant was recovered and resuspended in 2 x 
reducing sample buffer. Eluted proteins were separated by SDS-PAGE and 
subject to Western blot analysis.
2.6.8 Merozoite processing assay
Processing buffer: 50 mM Tris-HCI pH 7.6, 5 mM CaCI2
Processing of proteins on the surface of merozoites can occur independently of 
erythrocyte invasion. The preparation of merozoites in the presence of the 
calcium-chelating agent EGTA reversibly inhibits this processing.
Merozoite pellets, prepared in the presence of EGTA, were removed from storage 
at -70°C and immediately placed into ice. The cells were washed three times in 
1 ml ice cold processing buffer, with centrifugation at 13,000rpm/16,060g for 2 
minutes at 4°C. Pellets were resuspended in 150 pi processing buffer and divided 
into aliquots of 18 pi in pre-chilled microcentrifuge tubes on ice. 2 pi processing 
buffer or 100 mM EGTA were added separately to frozen aliquots, which were
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thawed and immediately returned to ice for 5 minutes. Merozoites were then 
incubated at 37°C for 2 hours. After the 2 hour incubation another aliquot was 
taken from -70°C to ice, and 2 pi 0.5 M EGTA was added -  this was the control 
sample (t=0) which would demonstrate the background level of processing that 
had already occurred in merozoite samples before incubation at 37°C. The 
control merozoite sample was thawed as above and all samples were centrifuged 
at 13,000rpm/16,060g for 5 minutes at 4°C. 15 pi supernatant was removed from 
each sample and mixed with an equal volume of 2 x reducing sample buffer, 
boiled for 5 minutes then separated by SDS-PAGE and subject to Western blot 
analysis. Densitometry was performed on the resultant bands using the ImageJ 
program (Wayne Rasband, National Institutes of Health), in order to estimate the 
level of processing occurring in samples relative to the t=0 control.
2.7 Expression of recombinant PF08 0008 fragments
2.7.1 Expression host transformation
When colonies containing the correct-sized insert had been identified, their 
plasmid DNA was transformed into an expression host, E. coli BL21 (DE3) cells 
(Merck), according to manufacturer’s instructions. Briefly, cells were thawed on 
ice, 20 pi were transferred to pre-chilled polypropylene microcentrifuge tubes and 
1 pi plasmid DNA was added. Cells were incubated on ice for 5 minutes, then for 
30 seconds in a 42°C water bath. Cells were returned to ice for 2 minutes then 
80 pi S.O.C was added. Following incubation at 37°C with shaking at 225 rpm for 
1 hour, 50 pi of the transformation was spread over a pre-warmed LB Amp/Agar 
or LB Kan/Agar plate as appropriate. Plates were incubated overnight.
2.7.2 Small-scale recombinant protein solubility test
5 ml LB-Kan or LB-Amp as appropriate were inoculated with a colony from the 
expression host plates and incubated overnight at 37°C with shaking at 225 rpm. 
50 pi of the overnight culture was added to 1 ml LB-Kan/Amp and the cultures 
incubated in microcentrifuge tubes for 1 hour at 37°C, with shaking at 225 rpm. 
Cultures were split into two 500 pi aliquots and IPTG added to a final 
concentration of 1 mM to one of the aliquots. All cultures were incubated for a 
further 90 minutes at 37°C, then centrifuged at 13,000rpm/16,060gfor 10 minutes
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to pellet the cells. Culture supernatants were removed and the pellet 
resuspended in 300 pi BugBuster (Merck), with the addition of 1 pi Benzonase 
Nuclease (Merck). Cell lysates were shaken at room temperature for 20 minutes 
then centrifuged at 4°C for 20 minutes at 13,000rpm/16,060g. The soluble protein 
fraction was removed from the pellet into a separate tube. Pellet fractions were 
resuspended in 300 pi 27% v/v BugBuster in dH20  and all fractions were stored 
at -20°C until used.
Proteins were separated by SDS-PAGE and visualised by Coomassie staining as 
described in 2.6.3. Western blots were carried out as detailed in 2.6.4 using a 
rabbit anti-His primary antibody (Santa Cruz Biotechnology) and a goat anti-rabbit 
HRP-conjugated secondary antibody (Bio-Rad). Bacterial clones that were shown 
to express a correctly sized and tagged recombinant protein were stored for 
future use as glycerol stocks (cf. 2.5.4).
2.7.3 Large-scale expression and purification of recombinant 
protein
Buffer B: 8 M urea, 0.1 M NaH2P04, 10 mM Tris-HCI, pH 8.0
Washing buffer: 50 mM NaH2P04, 300 mM NaCI
For large scale purification of insoluble protein, glycerol stocks were streaked out 
onto LB-Kan/Agar or LB-Amp/Agar plates as appropriate and incubated 
overnight. 5 ml overnight cultures were generated from individual colonies on the 
resultant plates, and used to inoculate 1 litre cultures of LB-Kan/LB-Amp, which 
were incubated at 37°C with shaking until an OD of 0.6 was reached. Cultures 
were then induced with 1 mM IPTG and grown for 4 hours.
Cultures were harvested by centrifugation at 4000rpm/4050g to pellet the cells. 
Cells were lysed in BugBuster in the presence of Benzonase and 1 x Complete 
protease inhibitors, according to manufacturer’s instructions. The resultant 
soluble protein fraction was discarded. The pellet of insoluble protein was 
resuspended in 50 ml Buffer B and incubated at room temperature with shaking 
until the suspension had cleared. The suspension was centrifuged at 
13,000rpm/20,442g for 20 minutes at 4°C to separate residual insoluble protein, 
and the supernatant was saved for purification.
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Disposable plastic gravity-flow columns (Pierce) were packed with Ni-NTA 
agarose (Qiagen) and equilibrated with 3 column volumes of Buffer B. The 
supernatant was passed down the column and flow-through collected. The 
column was subsequently washed with 10 column volumes of washing buffer 
supplemented with 10 mM imidazole, 5 column volumes of washing buffer 
containing 20 mM imidazole and finally 5 column volumes of washing buffer 
containing 50 mM imidazole. The His-tagged protein was eluted into 3 column 
volumes of washing buffer with 250 mM imidazole. All wash steps were collected 
and were analysed by SDS-PAGE and Coomassie staining, along with the 
flow-through and eluted fractions.
When the purity of the eluted fraction had been confirmed by SDS-PAGE, purified 
protein was dialysed against 3 litres of PBS, with 2 changes, using SnakeSkin 
dialysis tubing (Pierce) over a period of approximately 24 hours. Equal volumes 
of dialysed protein and BSA protein standards of known concentrations were 
analysed by SDS-PAGE. Following Coomassie staining, the relative intensities of 
the bands corresponding to the protein standards were calculated by 
densitometry using the ImageJ program, and used to calculate the concentration 
of the two recombinant proteins.
2.8 Generation of polyclonal antisera
For each antigen, five eight-week old female Balb/c mice per antigen were 
immunised intra-peritoneally with 50 pg protein mixed 1:1 with Freund’s complete 
adjuvant. Mice were boosted 3 times at 3 week intervals with 100 pg protein in 
Freund’s incomplete adjuvant. 3 weeks after the final boost, mice were killed 
according to a schedule 1 method. Serum was obtained from total blood by 
centrifugation at 6000rpm/3421gr for 20 minutes at 4°C, then stored at -20°C. 
Mice immunisations were carried out with the help of Sola Ogun (NIMR, Division 
of Parasitology).
New Zealand White rabbits were immunised subcutaneously by Harlan Sera Lab 
in accordance with their 77 day immunisation protocol. 3 rabbits per antigen were 
immunised with 200 pg protein in Freund’s complete adjuvant, then boosted 5 
times at 2 week intervals with 200 pg protein in Freund’s incomplete adjuvant. 
Antibodies were obtained from Harlan as IgG, purified from the terminal bleeds
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with protein A, and were stored in the presence of 0.1% sodium azide at -20°C. 
Sodium azide-free antibodies were obtained by buffer exchange into PBS using a 
PD-10 desalting column (GE Healthcare) according to the manufacturer’s 
instructions, followed by a centrifugal concentrator.
2.8.1 Purification of IgG
1 ml HiTrap Protein G columns (GE Healthcare) were used according to the 
manufacturer’s instructions, to purify IgG from antisera and pre-immune sera if 
necessary. Briefly, columns were washed with 10 ml PBS, the serum was applied 
and the column washed with a further 10 ml PBS. IgG was eluted with 5 ml 0.1 M 
glycine, pH 2.7, in 500 pi fractions, into tubes containing 100 pi 1.0 M Tris-HCI pH
9.0. Samples of each fraction were analysed by SDS-PAGE and Coomassie 
staining, and fractions containing IgG were pooled and buffer exchanged into 
PBS.
2.9 Invasion inhibition assays
Parasites were synchronised using a two-stage magnet purification as detailed in 
2.3.3. Parasites were cultured in type 0+ human erythrocytes for invasion 
assays. Following synchronisation, cultures were diluted in fresh blood to a 
parasitemia of 0.5%, with a 1% haematocrit. At approximately 36 hours post­
invasion, 90 pi parasite culture were seeded into 96-well plates, in the presence 
of PBS, 1 mg ml'1 pre-immune rabbit IgG, 12.5 mM EGTA, or either of the test 
rabbit antibodies anti-CTD or anti-NTD, with a total culture volume of 100 pi. 
Antibodies were diluted in PBS. 100 pi of a 1% haematocrit culture of uninfected 
erythrocytes was also plated. Parasite cultures were seeded in triplicate. Test 
antibodies were used at final concentrations of 1 mg ml'1, 0.5 mg ml'1 and 
0.25 mg ml'1, and were diluted in rabbit pre-immune IgG to a final concentration 
of 1 mg ml'1 total IgG as appropriate.
Following incubation at 37°C for approximately 42 hours in a gassed, humidified 
chamber, 50 pi of each culture was resuspended in 200 pi 10 pg ml'1 ethidium 
bromide in PBS, and cells were stained in the dark for one hour. Cells were 
pelleted by centrifugation at 4000rpm/1520g for one minute, the supernatant was 
removed and cells were resuspended in 400 pi PBS. Samples were processed 
using a FACSCalibur flow cytometer (BD Biosciences). Parasitemia was
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calculated using the CellQuest Pro software (BD Biosciences) by first gating for 
intact erythrocytes by side scatter and forward scatter, and then determining the 
proportion of ethidium bromide-positive cells. Mean parasitemia and standard 
deviation were calculated and used to determine the invasion efficiency for each 
condition relative to the PBS control.
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3. Identification o f PF08 0008 as a gene for study
3.1 Identification of a candidate gene for study from proteomic data
Data from the Florens et al. proteomic study of 2002 were analysed in order to 
begin the identification of a candidate gene for study. This study confidently 
identified 2415 P. falciparum proteins across four stages of the parasite life cycle 
(sporozoite, merozoite, trophozoite and gametocyte), through multi-dimensional 
protein identification technology (MudPIT).
The raw data from this study were filtered according to a set of criteria designed 
to identify those proteins likely to play a role in the invasion of host cells, and this 
is illustrated in figure 3.1a. In the first two steps, proteins possessing a signal 
peptide and a single transmembrane domain were ‘pulled out’ of the data set. No 
additional analysis of the raw data was required at this stage, as signal peptide 
and transmembrane domain predictions were already present in the data set. 
This stage of the filtering process identified 92 proteins and should include 
proteins that are targeted either to the secretory organelles or to the parasite 
surface, as is typical of proteins known to be involved in invasion. The presence 
of a single transmembrane domain is also typical of proteins involved in invasion 
such as AMA1, and the PfRH and DBL-EBP protein families. AMA1 and EBA140 
were included in this set of 92 proteins, as expected given that both proteins 
possess a signal peptide and a single transmembrane domain - this indicated that 
the initial stages of the filtering process were working as expected.
A broad functional classification of each identified protein was included in the 
original dataset, and of the 92 proteins that were predicted to possess a signal 
peptide and single transmembrane domain, only 40 were assigned as 
hypothetical. This set of 40 proteins was filtered further to identify those that were 
detected in merozoite and sporozoite protein preparations only. The rationale for 
including this step was that the basic machinery of invasion is believed to be 
conserved between merozoites and sporozoites (Baum et al., 2006).
From the 2415 proteins initially identified in this proteomic study, only two were 
identified that fulfilled all of the set criteria. These were PF08_0008 and 
PF14 0016.
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Figure 3.1: Identification of an uncharacterised gene for study from 
proteomic data
a) Data from the Florens et al. proteomic study of 2002 were filtered according to 
a set of criteria. The number of proteins initially identified in the study was 2415. 
This number was reduced by identifying only those that fulfilled a set of 4 criteria. 
The characteristics required of a protein for it to pass through each stage of data 
filtering are shown on the right of the figure. The presence of a transmembrane 
domain and signal peptide were predicted using TMHMM (Krogh et al., 2001) and 
SignalP (Nielsen et al., 1997), respectively. The number of proteins fulfilling each 
criteria are shown in the coloured boxes. The white boxes contain the PlasmoDB 
Gene ID of the two proteins that fulfil all of the criteria listed.
AMA1 and EBA140, which both contain a single transmembrane domain and 
possess a signal peptide, were present after the second filter was applied, in the 
set of 92 proteins. They were not present in the dataset after the third filter was 
applied, which only allowed hypothetical proteins to enter the next stage, thus 
verifying the initial stages of the filtering process.
b) The amino acid sequence of PF08_0008. The signal peptide predicted by 
SignalP (residues 1-21) is indicated in red, and the transmembrane domain 
predicted by TMHMM (residues 715-737) is indicated in blue.
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Further investigation into these two candidates was carried out. The PF14_0016 
and PF08_0008 protein sequences were retrieved from PlasmoDB, and a BLAST 
search was carried out to determine if either of these protein sequences shared 
any similarity with other proteins, whether from Plasmodium or other species.
When a combined BLAST and conserved domain search is carried out on the 
amino acid sequence of PF08_0008 using the NCBI-BLASTP server, the top four 
significant hits are with hypothetical proteins from P. vivax, P. chabaudi, 
P. berghei, and P. yoelii. There are no significant hits with proteins from other 
species. This result suggests that PF08_0008 is conserved across different 
Plasmodium species, and could imply a conserved function for the protein in the 
parasite life cycle. No conserved domains were detected in PF08_0008.
Three of the top four BLAST hits for PF14_0016 were with members of the early 
transcribed membrane protein (ETRAMP) family (Spielmann & Beck, 2000). 
Upon further investigation it appears that PF14_0016 is a member of this protein 
family and is encoded by efra/77p14.1 (Spielmann et al., 2003). Importantly, 
ETRAMPs are small, highly charged integral parasitophorous vacuole membrane 
(PVM) proteins, that are believed to be important in the formation of different 
microdomains at the parasite-erythrocyte interface, post-invasion (Spielmann et 
al., 2006). These proteins are therefore of no direct relevance in the search to 
find a protein involved in invasion.
The focus of this study has therefore become the protein encoded by 
PF08_0008. The amino acid sequence of PF08_0008 is shown in figure 3.1b.
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Number of proteins Filter
2 4 1 5
Signal peptide and at least 
one transmembrane domain
1 9 8
Signal peptide and single 
transmembrane domain
AMA1 & EBA140  ----------1 9 2
Assigned as ‘hypothetical’
r_4o~
Peptides detected only in 
merozoite and sporozoites 
fractions
PF14 0016
MKYYTSLYVAL11ALCQAVSALIRNSNTPQAFLI PEIJsll^ EKNEFNNNEKNEMlsnsMLNNE 6 0 
FNNNEENCDIQKIAEEMMENLLNENDMYTNIMLSLQNRLSDDYLCSEPKYENICIHEKDK 120 
ISLSFPCSNPKYEKLIHKFTFKKLCNSKAAFNNTLLKSFIEEDEEQNTFSLMLKQFKILL 180 
TCVDDELKDIYKESIDLLVDLKTSITELTQKLWSGKMVNVLKKREFLITGILCELRNGNK 240 
SPLISKSLEFENLGILKMNNEELLNEAYNAFSDYYYFFPYFIQKLLEKGGMIERLIKIHE 300 
NLTKYRTKDMVNKINAQSKGEVLNNEDILNKLNAYKHYTKHGATSFIQSREVKIVNQNVN 360 
NDDTTKNQQQNVNNNEKLNNNtMfl^QQVls^^ 420
NQVFMlNYNt^QVNNNNNNNQQVlMlNNYNNQLNN^ 480
THTNNILYNPLYSINPEKPKDIIKLLKDLIKYLHIVKFENNEPTTNIDEEGIRKLLENSF 540 
FDLNDDILIVRLLLKPQTVILTVIQSFMLMTPSPSRDAKAYCKKALINDQLVPTODTNIL 600 
SEENELVNNFSTKYVLIYEKMRLQELKEHEESKLKMKYSKTNLSALQVT1SIPQNNRDKNDA 660 
SNKNNNPNNSSTPLIAWTDLSGEKTEDIINNNVDIATLSVGVQNTFQGPNAKAGSLINH 720 
LSYATFLFFSFILINLLN
1 PF08_0008
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3.2 Transcriptome data
In order to provide additional support to the case for choosing PF08_0008 as the 
protein for study, information was retrieved from the two genome-wide 
transcription studies that were published in 2003 (Bozdech et al., 2003, Le Roch 
et al., 2003).
The Bozdech study of the intra-erythrocytic transcriptome utilised a microarray 
with probes of 70-mer oligonucleotides that were representative of the predicted 
P. falciparum open reading frames (ORFs). Strain HB3 was used for the initial 
transcriptome analysis, but a subsequent study utilised the 3D7 and Dd2 strains 
of P. falciparum (Llinas et al., 2006). The data for PF08J0008 from both of these 
studies, in a combined form, can be found on PlasmoDB, and is shown in figure 
3.2a.
It can be seen that after 35-40 hours post invasion, depending on the strain in 
question, the log(Cy5/Cy3) ratio becomes a positive value. This indicates an 
excess of the PF08J0008 transcript in the Cy5 (experimental) sample relative to 
the Cy3 (reference) sample. This remains true for all strains tested until the end 
of the intra-erythrocytic blood stage. These results demonstrate that PF08_0008 
is maximally expressed in the latter stages of the intra-erythrocytic blood cycle.
The authors of the initial transcriptome study (Bozdech et al., 2003) used the data 
generated to predict a set of proteins that may be important as vaccine 
candidates or in the process of invasion. The expression profiles of seven of the 
best current malaria vaccine candidates (AMA1, MSP1, MSP3, MSP5, EBA175, 
RAP1 and RESA1), some of which are known to play a role in invasion, were 
compared with the entire transcriptome. ORFs were ranked based on the 
similarity of their expression profile to those of the seven vaccine candidates and 
the top 5% (262 ORFs) were highlighted. This gene set contained 28 genes 
previously associated with antigenicity or merozoite invasion. However, 189 
genes in this set are currently of unknown function, and PF08_0008 is one such 
gene.
The Le Roch study utilised a custom oligonucleotide array including 260,596 25- 
mer probes from predicted coding sequences, with probes placed, on average, 
every 150 bases on both DNA strands across the entire P. falciparum genome. In
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addition to analysing asexual intra-erythrocytic forms of P. falciparum, this study 
also used RNA prepared from sporozoites, merozoites and gametocytes.
Data for PF08J0008 from this study is shown in figure 3.2b. Absolute expression 
values published were calculated using the match-only integral distribution 
(MOID) algorithm. Since the chip used contained multiple probes per gene, a 
quantitative estimation of a gene’s transcript abundance can be obtained and 
used to compare expression between stages. For this array, moderate levels of 
gene expression are indicated by absolute values in the region of 100-1000, with 
low levels of expression indicated by values less than 100 and high expression 
levels by values above 1000.
Results from both the temperature- and sorbitol-synchronised methods appear to 
show that the maximal expression of PF08J0008 occurs in the schizont and 
sporozoite stages. Merozoites prepared from sorbitol-synchronised parasites also 
showed high levels of PF08J0008 expression relative to other stages. Again, this 
would be typical of a gene that is involved in invasion. Using the above 
classification, the level of gene expression for PF08_0008 is moderate.
One of the aims of the Le Roch study was to demonstrate that genes with similar 
function have similar expression profiles. This was with a view to rapidly 
assigning functions, with a reasonable level of confidence, to the many thousands 
of uncharacterised genes. Cluster analysis was performed on the data based on 
the timing of gene expression, and it was found that membership in a particular 
cluster was highly predictive of the cellular function of the gene product. For 
example, cluster 15 from this study contained 130 genes that were highly 
transcribed at the schizont stage and contained most genes that have known or 
presumed roles in cell invasion including EBA140, PfSUB2, six of the eight 
merozoite surface proteins (MSPs) and AMA1. Importantly, PF08J0008 was also 
placed in this cluster.
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Figure 3.2: Published transcriptome data available for PF08_0008
a) The expression profile of PF08_0008 throughout the intra-erythrocytic blood 
stage is shown for P. falciparum strains 3D7 (red), HB3 (blue) and Dd2 (orange), 
the result of two spotted microarray studies (Bozdech et al., 2003, Llinas et al., 
2006). Log ratios of Cy5 (experimental time-point cDNA) to Cy3 (reference pool 
of cDNA from all time-points) are shown on the y-axis. This figure is a modified 
form to that found at the PF08_0008 entry at http://plasmodb.org.
b) Graph showing the absolute expression values of PF08J0008 for different 
lifecycle stages of P. falciparum (Le Roch et al., 2003). Expression values were 
calculated using the match-only integral distribution (MOID) algorithm. Results for 
asexual blood stages synchronised using two different methods are shown in 
different colours - sorbitol synchronisation results in pink and temperature 
synchronisation results in blue. Result for sporozoites shown in green. Grey 
values indicate results that were below the confidence threshold. S = sporozoites, 
ER = early rings, LR = late rings, ET = early trophozoites, LT = late trophozoites, 
ES = early schizonts, LS = late schizonts, M = merozoites, G = gametocytes.
a) 2
-m - HB3 
3Dr 
-m - DD2
5 10 15 20 25 30 35 40 45
Hours post-invasion
b)
360
JZL
Life cycle stage
76
Chapter 3: Identification of PF08J0008 as a gene for study
3.3 Conclusions
The dataset of the Florens et al. (2002) proteomic study was filtered to identify 
uncharacterised P. falciparum proteins, detected only in merozoite and sporozoite 
fractions, that possess a predicted signal peptide and single transmembrane 
domain and thus have characteristics of P. falciparum proteins known to be 
involved in invasion. Of 2415 proteins present in the initial dataset, only two 
fulfilled all of the criteria: PF08_0008 and PF14_0016, the latter being ultimately 
excluded since it is a member of the ETRAMP family of proteins that function 
post-invasion.
Data from both of the transcriptional studies described above concur, and 
suggest a late blood-stage expression profile for PF08J0008. Both sets of 
transcriptome data also support the result from the proteomic study indicating 
PF08_0008 is present in merozoites, and the Le Roch study supports the 
proteomic result indicating the presence of the protein in sporozoites.
Taken together, the available proteome and transcriptome data show that 
PF08_0008 displays the characteristics expected of a protein involved in the 
process of host cell invasion, and this protein was therefore the focus of the 
remainder of the project.
77
Chapter 4: Bioinformatic characterisation of PF08_0008
4. Bioinformatic characterisation o f PF08 0008
4.1 Introduction
Following the choice of gene for study, a variety of bioinformatics tools were used 
in order to gather information on PF08_0008 that could be important in the design 
of future experiments. Published high-throughput studies that have been used to 
identify P. falciparum GPI-anchored proteins and protein-protein interactions are 
also discussed below.
4.2 PF08 0008 is not predicted to be targeted to the apicoplast
The PlasmoAP tool, available at http://plasmoDB.org was used in order to predict 
the likelihood that PF08JD008 is targeted to the relict, non-photosynthetic plastid 
in the parasite that is known as the apicoplast. Transport to the apicoplast is 
dependent on the presence of a bipartite signal, consisting of a classical 
N-terminal signal sequence, followed by a transit peptide. The transit peptide of 
apicoplast-targeted proteins has certain characteristics such as a net positive 
charge and an enrichment of lysine and asparagine residues. These rules were 
used to develop the PlasmoAP tool (Foth et al., 2003). When the PF08_0008 
amino acid sequence is input, the server predicts that it is unlikely to be an 
apicoplast-targeted protein.
4.3 Predictions of transmembrane domains within PF08 0008
Four web-based algorithms were used to determine whether PF08_0008 is likely 
to possess any transmembrane domains. The results are summarised in figure 
4.1a. There appears to be no overall consensus between the programs used, 
although the same two hydrophobic regions of the protein are consistently 
recognised as potential transmembrane regions. These regions correspond to 
two of the three most prominent peaks on the hydrophobicity plot of PF08_0008 
(figure 4.1b).
All four algorithms also predicted a transmembrane domain at the extreme 
N-terminus of the protein. However, the SignalP server 
(http://www.cbs.dtu.dk/services/SignalP/) predicts with a probability of 0.985 that
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the initial 21 residues of the PF08_0008 sequence represent a classical signal 
peptide for entry into the secretory pathway, with cleavage between residues 21 
and 22. Consequently these extreme N-terminal transmembrane predictions are 
omitted from figure 4.1a.
As detailed in chapter 1, transmembrane domains consist of a hydrophobic 
region followed by a ‘stop transfer’ signal consisting of charged residues. The 
sequence of the transmembrane region predicted by TMAP, TOPPRED2 and 
TMPRED, between residues 550 and 578, is shown in figure 4.1c i. 16 of the 25 
residues between positions 550 and 574 are hydrophobic, and there are also 
residues that could serve as a ‘stop transfer’ signal located just downstream of 
the predicted transmembrane region. This transmembrane region is typical in 
location and size of those found in proteins such as EBA175, AMA1 and 
PTRAMP, molecules thought to be involved in invasion. However, if a true type I 
membrane protein, the cytosolic tail of PF08_0008 would be slightly longer than 
is typical of these other type I proteins (figure 4.1d).
It is unlikely that the extreme C-terminal hydrophobic region recognised by 
TMHMM2, TOPPRED2 and TMPRED represents a true classical transmembrane 
domain. As can be seen from figure 4.1c ii, the hydrophobic region extends 
almost to the C-terminus. This would mean that the cytosolic domain of the 
protein would be completely lacking, or would consist of a single asparagine 
residue, and this is unlikely to provide a sufficient ‘stop transfer’ signal or to be of 
any functional or structural relevance. As mentioned in chapter 1, it is possible 
that a predicted transmembrane domain at the extreme C-terminus of a protein is 
a mis-assigned GPI-anchor addition sequence, and this is discussed further 
below.
TOPPRED2 and TMPRED both predicted two transmembrane domains. For both 
algorithms, the prediction of a transmembrane domain at the extreme C-terminus 
received a higher score than the prediction that placed a transmembrane domain 
in the residues 555-575 region.
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Figure 4.1: Bioinformatic predictions of transmembrane domains within 
PF08_0008
a) Four web-based algorithms were used to predict the location of 
transmembrane domains, if any, within the amino acid sequence of PF08_0008. 
A schematic view of PF08_0008 is shown for each algortihm, along with the 
location and size of the transmembrane domain(s) they predicted indicated in 
pink. The residues predicted to be part of a transmembrane domain are detailed 
below the name of the algorithm on the right of the figure.
b) A hydrophobicity plot was generated for PF08_0008, based on the Kyte & 
Doolittle (1982) method, using the biological sequence alignment editor BioEdit. 
Mean hydrophobicity for a window size of 13 is shown on the y-axis, and amino 
acid position is shown on the x-axis. The two asterisks mark the two most 
prominent peaks, excluding the peak at the N-terminus that corresponds to the 
predicted signal peptide.
c) i) The amino acid sequence of PF08_0008 from residues 550 to 587 is 
shown. The transmembrane domains predicted by the TMAP, TOPPRED2 
and TMPRED algorithms are contained within this region. Hydrophobic 
residues are indicated in red. Charged residues that follow the hydrophobic 
region, and could act as a ‘stop transfer’ sequence, are underlined.
ii) The amino acid sequence of PF08_0008 from residues 710 to the 
C-terminus (position 738) is show. The transmembrane domains predicted by 
the TMHMM2, TOPPRED2 and TMPRED algorithms are contained within this 
region. Hydrophobic residues are indicated in red.
d) A comparison of the size and location of the transmembrane domains (shown 
in pink) of PTRAMP, AMA1 and EBA175. PF08_0008 is also shown with one of 
the transmembrane domains predicted by TOPPRED2 (residues 555-575).
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4.4 Predictions of GPI-anchoraqe of PF08 0008
Two web-based GPI prediction servers were used to determine the likelihood of 
PF08_0008 being a GPI-anchored protein: the Big-n GPI prediction server 
(Eisenhaber et al., 1999) and DGPI (Kronegg & Buloz, 1999).
The results are summarised in figures 4.2b and 4.2c. No sequences scored 
highly enough for the Big-Tr GPI prediction server to confidently assign 
PF08_0008 as GPI-anchored, although it did identify residue 714 as the best 
possible cleavage (co) site.
DGPI predicted GPI-anchorage of PF08_0008 with 2 potential cleavage (co) sites 
at positions 700 and 715. Position 700 received a score of 0.292, higher than the 
score received by position 715 which was 0.208. These scores represent the 
probability that a protein from a data set of 172 proteins with known GPI-anchor 
addition sites has the same amino acid residues at positions co, co+1 and co+2 as 
those predicted for PF08_0008.
There are four elements that are currently believed to constitute a GPI-anchor 
addition sequence (figure 1.3b) (Eisenhaber et al., 2001). Based on these rules, 
the co site most strongly predicted by DGPI, position 700, is unlikely to be a true 
GPI addition site. Although there are two residues with small side chains (S at 
position co and G at position co+2) within the predicted cleavage site, the 
C-terminal hydrophobic tail begins 26 residues away from the co site (figure 4.2b). 
The C-terminal hydrophobic tail must begin at around position co+9 or co+10. The 
presence of a co site at residue 715 seems more likely, based on the sequence 
requirements. In this case there is an unstructured linker (co-7 to co-2), a cleavage 
site consisting of amino acids with small side chains (co-1 to co+2), a moderately 
polar spacer region (co+3 to co+10) and a hydrophobic region extending to the 
C-terminus (co+11 to C-terminus).
The cleavage site predicted by Big-TT also fits well with the sequence 
requirements (figure 4.2c). There is an unstructured linker (co-6 to co-2), a 
cleavage site consisting of amino acids with small side chains (co-1 to co+2), a 
moderately polar spacer region (co+3 to co+11), and a hydrophobic region 
extending to the C-terminus (co+12 to C-terminus).
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With both of these predictions there are a couple of slight variations from the 
sequence requirements detailed in figure 1.3b. The unstructured linker consists of 
5 or 6 amino acids according to the Big-u or DGPI predictions respectively, 
whereas the described sequence requirements detail an unstructured linker with 
a length of approximately 11 amino acids. Also, the hydrophobic tail has been 
described to begin at positions w+9 or co+10, whereas according to the DGPI 
prediction it would start at position co+11, and with the Big-TT prediction, at co+12.
The two programs used are not designed specifically for use with P. falciparum 
and are trained using animal, plant and fungal protein sequences. Although the 
sequence requirements for GPI addition are generally conserved between 
mammalian and protozoan proteins, they are not interchangeable. For instance it 
has been shown that the GPI addition sequence of the variant surface 
glycoprotein (VSG) of Trypanosoma brucei functions poorly in mammalian cells 
(Moran and Caras, 1994). Non-P/asmod/'ivm-trained algorithms are not ideal for 
use with the current query and may introduce false positive or negative results, 
based on these subtle differences. For example, the known GPI-anchored protein 
MSP1 was not predicted to be GPI-anchored by either the DGPI or Big-TT  
algorithms.
With this in mind, another algorithm has been designed that has been trained 
using known or probable GPI-anchored P. falciparum proteins (Gilson et al., 
2006), GPI-HMM. This algorithm was used to rank all proteins encoded in the 
P. falciparum genome according to their likelihood of being GPI-anchored. In the 
list of the top 30 most strongly predicted GPI-anchored proteins, PF08_0008 
features at number 19. All of the proteins ranked above PF08_0008, apart from 
one, PF0975c, have been shown biochemically to be GPI-anchored, or are 
strongly predicted to be GPI-anchored based on homology with other known GPI- 
anchored proteins. Moreover, none of the proteins on this list has been shown 
not to be GPI-anchored.
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Figure 4.2: Prediction of GPI-anchorage by two algorithms, and GPI signal 
sequence requirements
a) Prediction of the secondary structure of the extreme C-terminus of PF08_0008 
by PSIPRED (McGuffin et al., 2000). It can be seen that the amino acids at 
positions 708 to 715 are predicted to form a random coil and therefore lack any 
secondary structure.
The extreme C-terminus of PF08_0008 was analysed in order to determine if the 
four sequence elements typical of a GPI-anchor addition sequence (described in 
figure 1.3b), are indeed present. The amino acid sequence of the extreme C- 
terminus is shown in b) and c), with hydrophobic residues coloured in red.
b) The thick blue arrow indicates the cleavage site (between residues co and 
co+1) confidently predicted by the DGPI algorithm, and the thin blue arrow 
indicates the second cleavage site predicted less confidently by this algorithm. 
The boxes enclose the four GPI-anchor signal sequence elements of the second 
cleavage site: unstructured linker (blue), cleavage site (pink), moderately polar 
spacer region (yellow), and hydrophobic tail (green).
c) As for b), except the green arrow indicates the cleavage site predicted by the 
Big-u algorithm, although this prediction was below the confidence threshold.
a) Con £: ]33D333333ll 3 3 3 3 33333=333333 31] 3 3 33D333233D{
Pied:
Pred: CCCCHHHHHHHCCCCEEEEECCHHHHHCCCCCCCCHHHHH 
AA; LSOEKTEOIINNNVDIATLSV<3VONTPQ<3PNAKA<SSLINH
S B - Mil* Coa(< lal 111 ( - C*nfl4«nc« et pr«<lntier.
<==> - itrtad Fr«di frtdict*4 «t«o(idary itruetun
------------- • «•!! AAi c«?v«n:«
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4.5 No evidence for GPI-anchorage of PF08 0008 in ‘GPI proteome*
studies
In the same study that resulted in the development of GPI-HMM, parasites were 
metabolically labelled with radioactive glucosamine and a proteomic analysis was 
carried out, in order to identify GPI-anchored proteins by 2-dimensional (2-D) gel 
electrophoresis followed by mass spectrometry. PF08_0008 was not positively 
identified. However, there were a number of spots on the 2-D gels that could not 
be identified by mass spectrometry, and it remains a possibility that PF08__0008 
could be represented in one of those. In addition, it was estimated that the 11 
biochemically confirmed GPI-anchored proteins represent around 94% of the 
GPI-anchored proteome. Other novel GPI-anchored proteins are therefore likely 
to be poorly abundant relative to these 11, and this could hinder their 
identification by conventional means.
In a similar study (Sanders et al., 2005), detergent-resistant membranes (DRMs) 
of mature schizonts were sucrose-gradient purified, since previous work had 
suggested GPI-anchored P. falciparum proteins are enriched in such membrane 
fractions (Black et al., 2003). The proteome of these DRMs was determined and 
found to contain the GPI-anchored proteins MSP1, MSP2, MSP4 and RAMA, as 
well as a number of novel putative GPI-anchored proteins. PF08_0008 was not 
detected in the DRM proteome. Again, this could be a consequence of 
PF08_0008 being poorly abundant relative to other GPI-anchored molecules, 
rather than it being absent from the DRM fractions.
4.6 Orthologues of PF08 0008 in other Plasmodium species
Orthologues of PF08_0008 have been identified in several other Plasmodium 
species: P. yoelii (PY07130), P. berghei (PB000129.01.0), P. chabaudi 
(PC000051.03.0) and P. vivax (PV088910), using the NCBI BLAST tool and 
PlasmoDB. Sequences for PC000051.03.0 and PB000129.01.0 are currently 
incomplete (encoding 387 and 383 amino acids respectively), and the remaining 
parts of these sequences could not be located on other sequenced contigs.
All of these genes are predicted to encode proteins with a signal peptide and no 
identifiable functional domains. The first 383 amino acids from the P. yoelii, 
P. chabaudi and P. berghei sequences were initially used in a ClustalW multiple
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alignment (Thompson et al., 1994) to calculate similarity between these 
sequences. The results are shown in figure 4.3a i and it can be seen that there is 
likely to be a very high level of conservation between these species, based on the 
results for the available sequence.
The complete sequence of P. yoelii was therefore used as a representative 
rodent malaria parasite for a ClustalW (Thompson et al., 1994) multiple alignment 
with the entire P. falciparum and P. vivax sequences (figure 4.3b). The level of 
identity between the P. falciparum protein sequence and the sequences of its 
orthologues was found to be around 40% (figure 4.3a ii).
This existence of such orthologues is suggestive of a conserved role for this 
protein in Plasmodium species. Interestingly, 8 out of 9 of the cysteine residues in 
the P. falciparum protein sequence, which may be important structurally for the 
formation of disulphide bonds, are conserved in both PY07130 and PV088910.
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Figure 4.3: Alignment of PF08_0008 with orthologues from other 
Piasmodium species
a) i) ClustalW multiple alignments were used to calculate sequence identity 
between the three PF08_0008 orthologues in rodent malaria species.
ii) ClustalW multiple alignments were used to calculate sequence identity 
between PF08_0008, the P. vivax orthologue PV088910 and the P. yoelii 
orthologue PY07130.
b) A ClustalW multiple alignment of the PF08_0008, PV088910, and PY07130 
protein sequences. PF08_0008 and PV088910 each contain nine cysteine 
residues and PY07130 contains 10. Eight of these are positionally conserved 
between all three species and are indicated with a yellow star. The remaining 
non-conserved cysteine residues are indicated with red crosses. Identical 
residues are coloured in pink, similar residues are coloured in blue.
c) Two ClustalW multiple alignments were carried out on regions of PF08_0008 
and its orthologues that do not contain any low complexity regions. The 
alignments were used to calculate the sequence identity between the three 
sequences.
i) Residues 65-338 of the PF08_0008 sequence were aligned with the 
corresponding sequence from the P. vivax and P. yoelii orthologues, as 
aligned in b)
ii) Residues 500-653 of the PF08_0008 sequence were aligned with the 
corresponding sequence from the P. vivax and P. yoelii orthologues, as 
aligned in b).
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4.7 PF08 0008 contains two asparagine-rich regions of low complexity
The alignment of PF08_0008 with PV088910 and PY07130 highlights an 
interesting feature of PF08_0008 - it contains two low complexity regions (LCRs), 
which are predominantly made up of asparagine residues. The first region 
encompasses amino acid residues 38-64 at the N-terminal end of the sequence. 
The second LCR is much larger and covers residues 356-485 towards the middle 
of the predicted protein sequence. Similarly, the Plasmodium vivax sequence 
contains a long stretch of alanine, asparagine and leucine residues, towards its 
C-terminus, and these LCRs together represent the notable differences between 
the sequences.
The presence of the LCRs in the P. falciparum and P. vivax sequences is likely to 
have affected the level of identity between the sequences calculated previously. 
Two more ClustalW multiple alignments were carried out on regions of the 
P. falciparum and P. vivax sequences lacking any LCRs. Two regions of the 
P. falciparum sequence (residues 65-338 and 500-653) were aligned with the 
corresponding regions of the P. vivax and P. yoelii sequences, as aligned in 
figure 4.3b. It can be seen from figure 4.3c that the level of sequence identity 
between P. falciparum and its orthologues in these two regions is around 55- 
60%.
P. falciparum proteins are usually larger than their homologues from other 
species (Florens et al., 2002, Gardner et al., 2002) and this is due to the insertion 
of amino acid sequences that are often enriched in a particular residue. These 
regions of low complexity are thought to form non-globular structures that extend 
from ordered protein domains. They are thought to have arisen as a result of the 
high A/T content of the Plasmodium genome, combined with the effects of this 
bias on replication slippage and genetic recombination (DePristo et al., 2006). 
The function of these repeats, which are present in all functional classes of 
Plamodium proteins, is unknown, although their presence in the var gene family 
is thought to facilitate intra-exonic recombination and hence antigenic diversity 
(DePristo et al., 2006).
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4.8 PF08 0008 contains no predicted domains
A BLAST search using the PF08_0008 sequence does not yield any hits from 
characterised proteins of any known function, therefore these results cannot be 
used to imply any functional role for PF08_0008 itself. Other databases can be 
used to identify functionally important motifs within a query sequence that may be 
present in other proteins, even when the protein is distantly related to any other 
proteins of known function.
The Simple Modular Architecture Research Tool (SMART) database is designed 
to identify evolutionarily conserved protein domains within query sequences 
(Schultz et al., 1998). SMART contains information on over 500 domain families 
found in proteins with diverse cellular functions. When the PF08_0008 amino acid 
sequence is used to search the SMART database, no protein domain features 
are identified, except for the predicted signal peptide, asparagine-rich regions 
and C-terminal transmembrane domain, all of which have been identified through 
other methods.
ProSite is another searchable database that can be used to assign query 
sequences to protein families or to identify protein domains within the sequence. 
As was the case with SMART, no functional domains were identified in 
PF08_0008, nor could it be assigned to any protein family.
Notably, there does not appear to be a homologue of PF08_0008 in the related 
apicomplexan parasite Toxoplasma gondii, suggesting that it may be performing 
a function specific to Plasmodium.
4.9 Yeast 2-hvbrid interactions
In 2005 a study was published in which a high-throughput version of the yeast 
two-hybrid assay was used to identify P. falciparum protein-protein interactions 
(LaCount et al., 2005). Two potential interactions involving PF08_0008 were 
identified. The interacting proteins were MSP7 and the hypothetical protein 
PF14_0495. In both cases, PF08_0008 was the prey.
The dataset of protein-protein interactions generated in this study was refined to 
remove false positives, for example interactions involving ‘promiscuous’ protein
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fragments with many partners. However, false positives can arise for many 
different reasons, for example, plasmid mutations or non-specific interactions 
resulting from protein over-expression. It is therefore extremely likely that false 
positives constitute a significant proportion of the remaining dataset. Although 
PF14_0495 and MSP7 have similar expression profiles to PF08_0008 and are 
thus likely to be present at the same time within the parasite, suggestions of any 
interaction would need to be confirmed through experimental means such as co- 
immunoprecipitation.
4.10 Conclusions
4.10.1 Membrane anchorage of PF08 0008
The information generated from the various algorithms discussed above acts 
merely as a guide for future work - the nature of any membrane anchorage needs 
to be determined experimentally before any conclusions can be drawn.
However, the data discussed above suggests that PF08_0008 is likely to be GPI- 
anchored:
• Three of the four transmembrane domain prediction algorithms predicted 
a transmembrane domain at the extreme C-terminus.
• This was the sole prediction for TMHMM2. For the two algorithms that 
also predicted a transmembrane domain in the region of residues 555- 
575, the prediction at the C-terminus was stronger.
Based on the results for the four transmembrane prediction algorithms, it appears 
that the prediction at the extreme C-terminus is the strongest. However, the 
C-terminal hydrophobic region is more likely to be a GPI signal sequence than a 
true transmembrane domain, and this region does contain the typical GPI signal 
sequence elements. Importantly, the GPI-HMM algorithm, trained on 
P. falciparum GPI signal sequences, predicted PF08_0008 was likely to be GPI- 
anchored, although no evidence has been found in any proteomic or DRM 
studies.
91
Chapter 4: Bioinformatic characterisation of PF08_0008
4.10.2 Orthologues of PF08 0008
There are orthologues of PF08_0008 in P. vivax, as well as in the rodent malaria 
parasites P. yoelii, P. berghei, and P. chabaudi. All of the cysteine residues of the 
P. falciparum sequence, excluding one in the predicted signal peptide, are 
conserved in the other Plasmodium species examined, suggesting the structure 
of PF08_0008 may be conserved. LCRs are found in the P. falciparum and 
P. vivax sequences, and it could be postulated that in both species these repeats 
are situated between structured or functional domains. Sequence identity 
between the different orthologues was found to be in the region of 55-60% in 
regions lacking LCRs. However, BLAST and conserved protein domain searches 
have failed to provide any information as to any possible function of this gene.
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5. Raising antibodies against N- and C-terminal regions of PF08 0008
5.1 Introduction
In order to study PF08_0008 further, polyclonal antibodies were raised in mice 
and rabbits against different regions of the protein, with a view to allowing the 
characterisation of PF08_0008 through antibody-based techniques such as 
Western blot, immunofluorescence and immunoprecipitation.
Two regions of the PF08_0008 protein were chosen for recombinant expression, 
one from the N-terminus and one from the C-terminus. In the event that 
PF08_0008 is proteolytically processed, antibodies raised against separate 
regions of the protein would allow this to be studied more easily. The relative size 
and location of these regions within the PF08_0008 sequence, in relation to the 
predicted signal peptide and GPI-anchoring sequences are shown in figure 5.1.
5.2 Ligation-independent cloning (LIC)
Primers were designed to amplify two regions of the PF08J0008 gene, 
corresponding to N- and C-terminal regions of the translated protein, 
incorporating ligation-independent cloning (LlC)-compatible overhangs into the 
PCR product. The expected sizes of the PCR products were 331 bp and 445 bp 
for the N- and C-terminal inserts respectively, including overhangs. PCR products 
were analysed by agarose gel electrophoresis (figure 5.1b).
The 331 bp N-terminal product was annealed to the pET 30 LIC vector, and the 
445 bp C-terminal product to the pET 32 LIC vector. The pET 30 vector allows 
expression of recombinant protein fused with N-terminal His-tag and S-tag 
sequences for identification and purification purposes. The pET 32 vector also 
allows for expression of recombinant protein fused N-terminally with these two 
tags, in addition to a 109 amino acid thioredoxin protein tag to enhance solubility. 
E. coli One Shot TOP10 cells were transformed with these vectors, and plasmid 
DNA was obtained from a number of clones. Restriction digests confirmed the 
presence of the correctly-sized insert in the plasmid DNA (figure 5.1c).
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Figure 5.1: Cloning two regions of PF08_0008 into the expression vectors 
pET 30 and pET 32, by ligation-independent cloning (LIC)
a) Two regions of PF08_0008 were chosen to be expressed as recombinant 
proteins, in order to generate antibodies. These regions are shown in green. The 
putative GPI-anchor signal sequence is shown in pink, and the N-terminal signal 
sequence in blue. The amino acid residues corresponding to the start and end of 
the N- and C-terminal regions chosen for recombinant expression are numbered, 
along with the extreme N- and C-termini of PF08_0008.
b) Specific primers were used to amplify two regions of PF08J0008, encoding the 
N- and C-terminal regions of the protein to be recombinantly expressed. The PCR 
products were analysed by agarose gel electrophoresis. Molecular sizes are 
given in bp.
i) The 331 bp fragment, encoding the N-terminal region
ii) The 445 bp fragment, encoding the C-terminal region
c) PCR products from b) were annealed to pET 30 (331 bp fragment) and pET 32 
(445 bp fragment) vectors. E. coli One Shot TOP10 cells were transformed 
separately with the two plasmids, and DNA was obtained from resultant clones. 
Plasmid DNA was digested with BamH\ and Bg/ll. These enzymes cut either side 
of the LIC site and should release the cloned fragment. Digested DNA was 
analysed by agarose gel electrophoresis. Molecular sizes are given in bp.
i) N-terminal region/pET 30 vector: Digested plasmid DNA from three 
clones numbered 1-3 is shown. Only clone 2 possesses the vector 
containing the correctly-sized insert (arrowed).
ii) C-terminal region/pET 32 vector: Digested plasmid DNA from three 
clones numbered 1-3 is shown. All three clones possess the vector 
containing the correctly-sized insert (arrowed).
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5.3 Testing the solubility of recombinant protein
Plasmid DNA containing the correctly sized insert was gel-purified and used to 
transform E. coli BL21 (DE3) cells. Initially, small scale 1 ml cultures were grown 
to determine the solubility of the recombinant protein. The predicted molecular 
mass of recombinant protein, including the relevant tags, was 16 kDa for the 
N-terminal fragment and 33 kDa for the C-terminal fragment.
Soluble and insoluble protein fractions were separated by reducing SDS-PAGE 
and visualised by Coomassie blue staining (figure 5.2). The major protein band 
present in figure 5.2a i runs at approximately 40 kDa, and is present in the 
insoluble protein fraction of both the induced and un-induced samples. The major 
band in figure 5.2a ii runs at just under 18 kDa and again is present in the 
insoluble fraction of both induced and un-induced samples. These 40 kDa and 
18 kDa bands are likely to correspond to the C-terminal and N-terminal 
recombinant protein fragments respectively.
The presence of recombinant protein in the un-induced pellet fraction suggests 
that ‘leaky expression’ of the recombinant proteins is occurring. In the presence 
of IPTG, BL21 (DE3) cells express the lacilV5 promoter-controlled T7 RNA 
polymerase. The sequence encoding the protein of interest is cloned into the 
pET 30/32 vectors so that transcription is driven by the T7 RNA polymerase, and 
thus should only occur in the presence of IPTG. Transcription of the T7 
polymerase gene in the absence of IPTG, and therefore transcription of the 
cloned gene, is likely to account for the presence of target protein in the un- 
induced samples.
In order to confirm that the prominent bands visible by Coomassie staining were 
in fact the His-tagged proteins of interest, a Western blot was carried out using 
the same protein samples and an anti-His primary antibody. Figure 5.2b shows 
that the prominent bands from figure 5.2a do indeed represent His-tagged 
proteins. It is also apparent that some breakdown of the C-terminal fragment has 
occurred.
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Figure 5.2: Expression of recombinant protein
a) Coomassie-stained SDS-PAGE gels showing analysis of soluble and insoluble 
protein fractions from BL21 (DE3) cells, before and after induction with IPTG. 
Molecular mass is shown in kDa. SNI = soluble fraction, before induction. 
PNI = insoluble fraction, before induction. SI = soluble fraction, following IPTG 
induction. PI = insoluble fraction following IPTG induction. Bands representing the 
target recombinant protein of interest are arrowed. Amino acid sequences are shown.
i) Analysis of protein fractions from cells transformed with the pET 30 vector 
encoding the N-terminal fragment of PF08_0008 (predicted molecular mass 
16 kDa)
ii) Analysis of protein fractions from cells transformed with the pET 32 vector 
encoding the C-terminal fragment of PF08_0008 (predicted molecular mass 
33 kDa).
b) The same protein fractions as analysed in a) were used in Western blot analysis, 
using an anti-His primary antibody. The His-tagged recombinant proteins are 
detected in the insoluble protein fraction of both induced and un-induced cultures. It 
can be seen that there has been some C-terminal breakdown of the recombinant 
fragment expressed in pET 32.
a) i) ii)
kDa
2 8 -
14 —
b)
16 CDIQKIAEEMMENLLNENDMYTNIMLSLQNRLS 
DDYLCSEPKYENICIHEKDKISLSFPCSNPKYE 
KLIHKFTFKKLCNSKAAFNNTLLKSFIEEDEEQ166
NTD
kDa 
49 —
3 8 “
578 AKAYCKKALINDQLVPTNDTNILSEENEV 
NNFSTKYVLIYEKMKLQELKEMEESKLKM 
KYSKTNLSALQVTNPQNNKDKNDASNKNN 
NPNNSSTPLIAWTDLSGEKTEDIINNNV 
DIATLSVGVQNTFQGPNAKA 714
C TD
kDa 
49 —
1 8—
97
Chapter 5: Raising antibodies against N- and C-terminal regions of PF08_008
5.4 Purification of recombinant protein
In order to obtain sufficient quantities of N- and C-terminal protein fragments for 
immunisation of animals, large scale cultures of BL21 (DE3) cells were grown. 
Recombinant protein was solubilised in a urea-containing buffer and passed 
down a pre-equilibrated nickel-nitrilotriacetic acid (Ni-NTA) resin column. The six 
consecutive histidine residues of the recombinant protein are able to specifically 
bind the chromatography matrix and the protein is immobilised. Washes with 
buffers containing low concentrations of imidazole, which can also bind to the 
matrix, were then carried out to disrupt the binding of dispersed histidine residues 
in non-tagged proteins. Recombinant protein was then eluted with 250 mM 
imidazole as the His-tagged protein is competed off the matrix. Samples of 
protein taken at each stage of the purification process were separated by SDS- 
PAGE and visualised by Coomassie blue staining (figure 5.3). It can be seen that 
both N- and C-terminal recombinant proteins were readily purified using this 
method.
Following extensive dialysis against PBS, the protein became insoluble, meaning 
that its concentration could not be established through conventional 
spectrophotometric means. Instead, the concentration was determined using 
SDS-PAGE. Proteins standards of known concentration were loaded on reducing 
SDS-PAGE gels alongside samples of purified recombinant protein (fig 5.4a). 
Gels were stained with Coomassie blue, de-stained, and the relative intensities of 
the bands corresponding to the protein standards were determined using ImageJ 
software. This allowed an estimation of the concentration of the recombinant 
protein preparations.
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Figure 5.3: Purification of recombinant protein
The insoluble protein fractions of BL21 (DE3) cultures expressing the 
recombinant N- and C-terminal domains of PF08_0008 were solubilised in a 
urea-containing buffer and passed down a pre-equilibrated nickel-nitrilotriacetic 
acid (Ni-NTA) resin column. The flow-through of unbound protein was collected in 
each case, and three wash steps were carried out with buffers containing 
increasing concentrations of imidazole. Recombinant proteins were eluted with 
buffer containing 250 mM imidazole. Samples of protein that passed through the 
column at each step were analysed by SDS-PAGE and Coomassie blue staining. 
Molecular mass is indicated in kDa.
FT = initial flow-through of unbound protein. 10 mM = wash step with buffer 
containing 10 mM imidazole. 20 mM = wash step with buffer containing 20 mM 
imidazole. 50 mM = wash step with buffer containing 50 mM imidazole. 250 mM = 
elution of recombinant protein with buffer containing 250 mM imidazole.
a) Purification of C-terminal domain, expressed using pET 32 vector.
b) Purification of N-terminal domain, expressed using pET 30 vector.
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Figure 5.4: Quantification of purified recombinant protein
The particulate nature of both recombinant proteins in PBS required protein 
concentration to be estimated by SDS-PAGE followed by Coomassie staining. 
Samples of recombinant protein were loaded alongside a range of protein 
standards of known protein concentration. Equal volumes of recombinant protein 
and protein standard were loaded.
a) Equal volumes of recombinant CTD protein were loaded alongside protein 
standards with known concentrations of 1000 pg ml'1, 800 pg ml"1, 600 pg ml'1, 
and 400 pg ml'1. Densitometry was performed on the resultant bands using the 
ImageJ program. A standard curve of band density against protein concentration 
was drawn using the data obtained for the protein standards (not shown). This 
allowed the calculation of the concentration of the protein sample, which in this 
instance was 609 pg ml'1.
b) As a), but with equal volumes of recombinant NTD protein loaded alongside 
protein standards with known concentrations of 800 pg ml'1, 600 pg ml'1, 
400 pg ml'1 and 200 pg ml'1. The concentration of recombinant protein in this 
instance was calculated as 286 pg ml'1.
c) Western blot analysis of purified recombinant N- and C-terminal domain 
proteins. The blot was probed with an anti-His antibody.
kDa 
62 —
kDa
62 -
4 9 -
49  —  
38 — 3 8 -
28 -
18 -
kDa
4 9 -
38 -
18 -
14 -
100
Chapter 5: Raising antibodies against N- and C-terminal regions of PF08_008
5.5 Production of polyclonal antibodies in mice and rabbits
As can be seen from figure 5.4a, the preparations of recombinant protein were 
very pure. Mice and rabbits were therefore immunised with the recombinant 
proteins without the need for further purification.
Sera from each of the 5 mice immunised per antigen were kept separate. In all of 
the experiments in which mouse anti-CTD antibodies were required, unprocessed 
mouse serum was used.
Immunoglobulin G (IgG) was purified from the serum of one mouse immunised 
with recombinant N-terminal protein, using a 1 ml HiTrap Protein G column. 
Figure 5.5a shows that the IgG eluted in fractions 3-7. These fractions were 
pooled, concentrated and buffer exchanged against PBS. This IgG preparation 
was used in all experiments where mouse anti-NTD antibodies were required.
Rabbit antibodies were received from Harlan as IgG and so no further purification 
was necessary. Rabbit pre-bleed sera were not purified by Harlan and so a 
HiTrap Protein G purification was carried out on one rabbit pre-bleed serum 
sample (see figure 5.5b). Fractions 5-10 were pooled and buffer exchanged 
against PBS.
Affinity purification of antisera would have been desirable, but this was not 
possible since most common antigen immobilisation techniques require soluble 
recombinant protein. Consequently, all of the mouse antisera and rabbit IgG 
generated contain a proportion of His-tag-specific antibodies, and therefore react 
with either recombinant protein by Western blot. The specificity of the antibodies 
raised could therefore not be confirmed using this approach.
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Figure 5.5: Purification of IgG from mouse antiserum and rabbit pre- 
immune serum
1ml Protein G HiTrap columns were used to purify IgG from mouse antiserum 
raised against the N-terminal domain recombinant protein, and from rabbit pre- 
immune serum obtained from Harlan. IgG was eluted with 0.1 M glycine pH 2.7 
into 10 0.5 ml fractions. Samples of all 10 fractions were analysed by SDS-PAGE 
followed by Coomassie staining.
SDS-PAGE analysis of the 10 elution fractions obtained following protein G 
purification of:
a) mouse antiserum, raised against the N-terminal domain recombinant protein
b) rabbit pre-immune serum.
a )  b )
1 2 3 4 5 6 7 8 9  10 1 2 3 4  5 6 7 8 9  10
4 9 -  ,  -
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6. PF08 0008 is proteolvticallv processed within P. falciparum  
schizonts and shed into culture supernatant
6.1 Introduction
A common feature of P. falciparum and T. gondii proteins involved in invasion is 
their proteolytic processing. For example, the TgMIC2/TgM2AP complex in 
T. gondii and the Plasmodium proteins AMA1, MSP1, and MTRAP are all 
proteolytically processed. This can occur during transport to their sub-cellular 
location, following their secretion onto the parasite surface, or both, and such 
processing events are believed to be critical in the functioning of these proteins 
(reviewed in (Dowse and Soldati, 2004)).
It was decided to investigate whether PF08_0008 is subject to any proteolytic 
cleavages.
6.2 Processed forms of PF08 0008 are present in both schizonts and 
merozoites
Samples of total parasite protein from mature schizonts and merozoites were 
analysed by Western blot, using the mouse anti-CTD antibody, and the results 
can be seen in figure 6.1a. This antibody detects 3 different protein species, with 
apparent molecular masses of 72 kDa, 49 kDa and 42 kDa. The same band 
pattern is observed whether schizont or merozoite material is analysed. Both the 
rabbit and mouse anti-NTD antibodies have proven to be of limited use in 
Western blot analyses when used on total parasite protein material. The reactivity 
of the antibodies with PF08_0008 relative to background parasite proteins is low, 
and this is presumably due to the presence of low levels of PF08_0008-specific 
antibodies within the serum.
In a separate experiment schizont material was treated with a high pH carbonate 
buffer, in order to enable separation of soluble or peripheral membrane proteins 
from those proteins with a membrane anchor. A Western blot carried out on the 
different fractions obtained in this extraction using the mouse anti-CTD antibody 
showed that the 72 kDa and 49 kDa forms of PF08_0008 are membrane- 
anchored (figure 6.1b). It is also evident that in this particular preparation of
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parasite material, PF08_0008 is present almost exclusively in the 49 kDa form, 
with very little 72 kDa form and no visible 42 kDa form.
The 72 kDa protein that is detected by the anti-CTD antibody in schizonts and 
merozoites is presumably full-length PF08_0008, since the predicted molecular 
mass of the protein, minus the signal peptide, is 83 kDa (http://expasy.org/cgi- 
bin/pi_tool). The predicted molecular mass of the protein minus the signal 
peptide, and also the putative GPI signal sequence, is 80 kDa. This discrepancy 
between the observed and predicted molecular mass is likely to be due to the fact 
that molecular mass calculations were performed using molecular mass 
standards of 62 kDa and 188 kDa, with no intermediate, and therefore may not 
be accurate for values in this range.
The 49 kDa and 42 kDa bands, denoted p49 and p42, presumably represent 
products of two processing events. When the size of the processing products, the 
location and length of the region against which the C-terminal antibodies were 
raised (figure 6.1c), and the fact that full-length PF08_0008 and p49 appear to be 
membrane anchored are taken into account, it seems probable that any 
proteolytic cleavages occurring are in the protein ectodomain, N-terminal of the 
region expressed to raise C-terminal antibodies.
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Figure 6.1: Western blot analysis of PF08_0008
a)
i) Analysis of the reactivity of anti-CTD antibodies with P. falciparum 
schizont and merozoite material separated under reducing conditions. 
Three polypeptides were detected in each sample.
ii) The distances travelled along the gel by the protein standards were 
measured and used to plot a standard curve of distance against 
logio(molecular mass). Data points are connected in black, and the 
trendline displayed in red. This enabled the calculation of the molecular 
mass of the three polypeptides, using their migration distances and the 
equation displayed. The R2 value is also indicated on the graph. The table 
shows the data used to produce the standard curve. The values marked 
with an asterisk represent data for the three polypeptides.
b) Analysis of the reactivity of anti-CTD, anti-PTRAMP and anti-MSP3 antibodies 
with high pH carbonate buffer-treated P. falciparum schizont material. Total 
parasite material (T) and fractions of parasite material soluble (CS) or insoluble 
(CP) in 100 mM Na2C03 buffer (pH 11.0) were separated under reducing 
conditions. The 72 kDa and 49 kDa polypeptides of PF08_0008 are detected in 
total parasite and carbonate-insoluble material. The type I transmembrane protein 
PTRAMP is detected in the total and carbonate-insoluble material, and the 
soluble merozoite surface protein MSP3 in the total and carbonate-soluble 
material, both as expected.
c) Schematic representation of the size, and location within PF08_0008, of 
recombinant protein fragments expressed and used to generate antibodies 
against the N- and C-terminal regions. Location of the signal peptide (blue) and 
putative GPI-anchorage sequence (pink) are also shown.
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Schematic representations of cleavages which result in the generation of p49 and 
p42 are shown in figure 6.2. In order for the C-terminal p49 fragment to be 
generated (figure 6.2a), an N-terminal by-product of around 32 kDa would also be 
generated, assuming a molecular mass of 80 kDa. However, antibodies raised 
against the N-terminal region of PF08_0008 have not been used successfully in 
Western blots on total parasite material and so the existence of a 32 kDa 
fragment could not be verified using this approach alone.
A membrane-anchored p42 product (figure 6.2b) could arise through further 
processing of p49 at its N-terminal end. Alternatively, the shedding of p49 from 
the surface of the parasite, as a result of a cleavage close to its membrane 
anchor, could also result in the generation of soluble p42. The absence of p42 in 
the parasite preparations used for the extraction of membrane proteins (figure 
6.1b) has made it difficult to confidently predict which cleavage event occurs.
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Figure 6.2: Schematic representations of proteolytic cleavages that could 
result in the generation of p49 and p42
a) Full-length PF08_0008 is shown schematically on the right of the figure, 
membrane-anchored at its C-terminus, enclosed in a red box. The top band 
observed in the Western blot analysis (left) corresponds to this full length protein. 
This is cleaved to give the C-terminal p49 fragment, enclosed in blue, which 
corresponds to the middle band on the Western analysis. An N-terminal product 
is also generated, but is not detected by anti-CTD antibodies.
b) p42 could be generated by either of two cleavage events. p49 could be 
cleaved near to its membrane anchor, resulting in the ‘shedding’ of p42 from the 
merozoite surface. Alternatively, further processing of p49 at its N-terminus could 
result in the generation of a membrane-bound p42.
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6.3 PF08 0008 is shed into culture supernatant
Some parasite molecules that are important in the invasion process such as 
AMA1, MSP1 and EBA175 are quantitatively shed from the surface of the 
merozoite, through two distinct mechanisms involving different classes of 
enzyme, as the parasite invades (reviewed in (O'Donnell and Blackman, 2005)). 
Such ‘shedding’ of molecules from the surface of merozoites also happens 
spontaneously in the absence of erythrocytes. Moreover, antibodies raised 
against the shed portion of proteins show reactivity by Western blot with 
supernatant from cultures in which schizonts are purified and then allowed to 
rupture in the absence of erythrocytes (Blackman et al., 1991, Green et al., 
2006a, Howell et al., 2001, O'Donnell et al., 2006). A residual ‘stub’ of protein is 
also generated during shedding, consisting of the extreme C-terminus of the 
protein that remains anchored to the merozoite membrane (Blackman et al., 
1990, Howell et al., 2001).
In order to determine if PF08_0008 is shed from the surface of merozoites, 
Western blotting was carried out under reducing conditions on culture 
supernatant. The results are shown in figure 6.3a. It can be seen that both the 
anti-CTD and anti-NTD antibodies are reactive with culture supernatant. This is in 
contrast to what is found when Western blots are carried out on total parasite 
material, where only the anti-CTD antibodies demonstrate a strong and specific 
reactivity. This is likely to be due to the fact that the culture supernatants contain 
a less complex mix of parasite proteins compared to total parasite material, which 
is less likely to cause a background level of non-specific reactivity. 1E1 is a 
monoclonal antibody raised against MSP1i9, the extreme C-terminal stub of 
MSP1 that remains attached to the merozoite surface following its shedding. 1E1 
does not react with culture supernatants, showing that there is no contamination 
with cellular material.
The anti-CTD antibody recognises a doublet of proteins running at approximately 
43 kDa. This is consistent with one of the models discussed above, in which the 
p49 fragment is cleaved near to its membrane anchor. However, the presence of 
a doublet suggests that such a cleavage takes place at two alternative sites. It is 
entirely possible that molecules that are shed from merozoites into culture 
supernatant, either spontaneously or upon productive invasion, are present in the 
purified schizont and merozoite preparations used for Western blot analysis.
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Therefore, given their near-identical apparent size, it is likely that the 43 kDa 
doublet detected by the anti-CTD antibodies in culture supernatant is the same 
as the p42 fragment detected in total schizont and merozoite material, as shown 
in figure 6.1.
The anti-NTD antibody recognises a polypeptide with an apparent molecular 
mass of 37 kDa in culture supernatant. Since it is expected that an N-terminal 
fragment of approximately 32 kDa would be produced simultaneously with p49, it 
is possible that the 37 kDa fragment detected in culture supernatant is in fact this 
N-terminal product. This N-terminal fragment could be shed independently of the 
p42 shedding, or simultaneously, perhaps as part of a complex.
The detection of C-terminal fragments of PF08_0008 in culture supernatant also 
has implications regarding the membrane anchorage of this protein (figure 6.3b). 
The region of PF08_0008 between, but not including, the putative 
transmembrane and GPI-anchoring sequences was expressed recombinantly 
and used to generate the anti-CTD antibodies. It is clear from Western analysis 
detailed above that the anti-CTD antibodies detect fragments of PF08_0008 in 
culture supernatant. If the protein was anchored via a transmembrane domain, 
these antibodies would not detect any shed fragments, since their specificity lies 
C-terminal of the putative transmembrane domain. Similarly, antibodies raised 
against the C-terminal end of the AMA1 cytoplasmic region do not react with 
culture supernatant, whereas antibodies raised against the AMA1 ectodomain are 
able to detect the various shed fragments (Howell et al., 2005). However, 
anchorage of PF08_0008 via a GPI-anchor at the extreme C-terminus could allow 
shed fragments containing the antigenic region to be released into culture 
supernatant.
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Figure 6.3: Western blot analysis of P. falciparum culture supernatant
a)
i) Samples of supernatant were separated by SDS-PAGE under reducing 
conditions, transferred to nitrocellulose and probed with antibodies raised 
against the N- and C-terminal regions of PF08_0008, as well as the anti- 
MSP1 19 monoclonal antibody 1E1. Anti-CTD antibodies detect a doublet 
of polypeptides and anti-NTD antibodies detect a single polypeptide. No 
reactivity is exhibited by 1E1, a monoclonal antibody raised against the 
extreme C-terminal stub of MSP1 (MSP119) that remains attached to the 
merozoite surface following shedding of MSP1.
ii) The distances travelled along the gel by the protein standards were 
measured and used to plot a standard curve of distance against 
logio(molecular mass). Data points are connected in black, and the 
trendline displayed in red. This enabled the calculation of the molecular 
mass of the two polypeptides shown in i), using their migration distances 
and the equation displayed. The R2 value is also indicated on the graph. 
The table shows the data used to produce the standard curve. The values 
marked with an asterisk represent data for the two polypeptides.
b) Schematic showing the location of the region of anti-CTD antibody specificity 
(green) on PF08_0008 in both the transmembrane and GPI-anchored models of 
protein anchorage. Hydrophobic sequences acting as potential transmembrane 
or GPI addition sequences are shown in pink. The parasite plasma membrane is 
indicated by a vertical line.
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6.4 Anti-CTD antibodies immunoprecipitate multiple protein species
from NP40- and SDS-solubilised 35S-labelled parasites
Anti-CTD and anti-NTD antibodies were used in immunoprecipitation experiments 
carried out on extracts of 35S-labelled mature schizonts (42 hours post-invasion 
(hpi)). Two different solubilisation methods were used. The first involved lysing 
parasite material in a buffer containing the non-ionic detergent NP40. This 
treatment allows the solubilisation and immunoprecipitation of protein complexes 
that are covalently or non-covalently associated. The second method utilised an 
SDS-containing lysis buffer, which disrupts any non-covalent interactions in a 
protein complex. In all cases, the immunoprecipitated proteins were separated on 
reducing SDS-PAGE gels. Figure 6.4a shows the result of an 
immunoprecipitation carried out using NP40-lysed parasite material. The anti- 
CTD antibody immunoprecipitates four separate protein species running at sizes 
of approximately 72 kDa, 49 kDa, 42 kDa and 37 kDa.
The immunoprecipitation band pattern obtained with the anti-CTD antibody is 
strikingly similar to the pattern obtained when this antibody is used in a Western 
blot (figure 6 .1), with one notable exception - the presence of the additional 
37 kDa band. Therefore it can be assumed that the 72 kDa and 49 kDa bands 
obtained by immunoprecipitation represent the full-length protein and p49 
fragments detected by Western blot. As is the case with Western blots, 
immunoprecipitations carried out on total schizont material could also 
theoretically detect proteins that have been shed from the merozoite surface, 
because it is likely such schizont material will contain free merozoites. Therefore 
the 42 kDa band present on the immunoprecipitation can again be assumed to be 
the shed p42 fragments.
The presence of the 37 kDa band on the anti-CTD immunoprecipitation suggests 
that either some or all of the PF08_0008 fragments (full-length, p49, p42) exist in 
a complex with an unrelated 37 kDa protein. Alternatively, this 37 kDa protein 
could represent the N-terminal product that arises following full-length 
PF08_0008 processing to p49.
Figure 6.4b shows that when an immunoprecipitation is carried out on NP40- 
lysed parasite material using the anti-NTD antibodies, a very similar pattern of 
bands is produced on the autoradiograph as with the anti-CTD antibody. The only
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inconsistency surrounds the presence or absence of the p42 product. The quality 
of the autoradiograph makes it difficult to determine whether a band is present or 
not and unfortunately the anti-NTD antibodies have proven to be of limited use in 
further immunoprecipitation experiments. Relative to the results obtained with the 
anti-CTD antibodies, very faint bands are produced on autoradiographs, making it 
hard to draw objective conclusions.
When an immunoprecipitation with the anti-CTD antibody is carried out following 
the disruption of non-covalently associated protein complexes with an SDS- 
containing lysis buffer, the same protein species are immunoprecipitated as when 
NP40-buffer is used (figure 6.5). Full-length protein, p49, p42 and the 37 kDa 
fragments are visible in both the SDS and NP40 lanes. The bands in the SDS 
lane appear less intense than in the NP40 lane, in particular the band 
corresponding to full-length PF08_0008, but they are clearly all still present. This 
result suggests that the 37 kDa protein species, whether it is a fragment of 
PF08_0008 or not, is linked to either the full length PF08_0008, its C-terminal 
processing fragments, or both, by one or more disulphide bonds.
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Figure 6.4: Immunoprecipitation of PF08_0008 from NP40-lysed schizonts
Immunoprecipitation of 35S-labelled proteins from NP40-lysed mature schizont 
material with PF08_0008 mouse anti-CTD (a) and anti-NTD (b) antibodies. No 
proteins were immunoprecipitated with normal mouse serum (not shown).
Anti-CTD and anti-NTD antibodies both immunoprecipitate full-length 
PF08_0008, the p49 polypeptide and the 37 kDa fragment. The anti-CTD 
antibodies also immunoprecipitate p42, although the quality of the autoradiograph 
makes it difficult to determine if p42 is also immunoprecipitated by the anti-NTD 
antibodies.
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Figure 6.5: Immunoprecipitation of PF08_0008 from SDS-treated schizonts
Immunoprecipitation with anti-CTD antibodies of 35S-labelled proteins from 
mature schizonts, lysed with NP40 lysis buffer and an SDS-containing lysis 
buffer. All polypeptides precipitated from NP40-lysed parasite material can also 
be immunoprecipitated from SDS-lysed material (polypeptides arrowed and 
labelled full length, p49, p42 and 37 kDa fragment).
Myosin tail interacting protein (MTIP) is present in a complex with myosin A 
(Green et al., 2006b), although this complex can be disrupted with SDS. Anti- 
MTIP antibodies were used as a positive control for non-covalent complex 
disruption by SDS. Myosin A (arrowed), with an apparent molecular mass of ~92 
kDa, can be immunoprecipitated from NP40- but not SDS-lysed parasite material 
with anti-MTIP antibodies. MTIP (arrowed) can be immunoprecipitated from both 
NP40- and SDS-lysed parasite material.
Proteins immunoprecipitated from NP40-lysed parasite material with rabbit (NRS) 
and mouse (NMS) pre-immune sera were also included as negative controls.
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6.5 PF08 0008 processing products remain covalently associated
An immunoprecipitation was carried out on 35S-labelled NP40-lysed parasite 
material using the anti-CTD antibody. The precipitated proteins were separated, 
in duplicate, by reducing SDS-PAGE. One set of samples was transferred to 
nitrocellulose and probed with the anti-NTD antibody by Western blot. The other 
sample was exposed to film as normal. This was in order to investigate the 
possibility that the 37 kDa protein species immunoprecipitated with the anti-CTD 
antibody is actually the N-terminal fragment that is generated following proteolytic 
cleavage of full-length protein.
Figure 6 .6a shows that when used to probe proteins immunoprecipitated by the 
C-terminal antibody, the N-terminal antibody detects a band at approximately 40 
kDa. This suggests that the 37 kDa band observed on autoradiographs following 
immunoprecipitation with the anti-CTD antibody is indeed the N-terminal portion 
of PF08_0008, hereby denoted p37. If no reactivity had been seen with the anti- 
NTD antibody on the blotted immunoprecipitation products, it would be 
suggestive of an interaction with an unrelated protein. If the result shown in figure
6.5 is taken into account, it can be deduced that the p49-p37 complex is held 
together by disulphide bonds.
If a p49-p37 covalently associated complex does exist, it would be expected that 
immunoprecipitations carried out with the anti-NTD antibody would give the same 
results as those obtained with the anti-CTD antibody (6.4b). This appears to be 
the case, but cannot be confirmed due to the problems associated with the anti- 
NTD antibodies.
Disulphide bonds in proteins are formed between the thiol groups of cysteine 
residues. When the distribution of cysteine residues in the PF08_0008 amino 
acid sequence is analysed, it can be seen that 7 of the 8 conserved cysteine 
residues are present in the N-terminal region of the protein, and there is a single 
residue in the C-terminal region. Therefore amino acid sequence information 
suggests it is possible that the N-terminal p37 and the C-terminal p49 fragments 
exist in a disulphide-linked complex.
Further support of a p49-p37 complex comes from performing Western blots on 
total schizont material under non-reducing conditions. A disulphide linkage
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between the two fragments would be preserved under these conditions, and so it 
would be expected that the complex would have an apparent molecular mass 
similar to that of the full length PF08_0008, assuming no significant part of the 
sequence is lost during cleavage. Figure 6 .6c shows that this is indeed the case. 
On a Western blot carried out under non-reducing conditions, the anti-CTD 
antibodies detect two protein species with very similar apparent sizes, in the 
region of 72 kDa. These are likely to represent full length PF08_0008, and the 
p49-p37 complex. The difference between the size of the two polypeptides could 
be due to the loss of part of the PF08_0008 sequence at the point of cleavage.
In order to confirm that the p42 and p37 fragments detected in culture 
supernatant are shed as a complex, Western blot analysis was carried out on 
culture supernatant under non-reducing conditions (figure 6 .6d). If p42 and p37 
are indeed shed as a complex, it would be expected that under non-reducing 
conditions, the anti-CTD and anti-NTD antibodies would detect protein species 
with a greater molecular mass than under reducing conditions, a mass that is 
slightly less than that of the full-length protein. It can be seen that this is indeed 
the case, with each antibody detecting at least two protein species. The multiple 
bands are likely to be due to the alternative shedding cleavages which are 
responsible for the generation of the doublet of p42 fragments that are seen 
under reducing conditions.
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Figure 6.6: Western blot analysis of immunoprecipitated proteins
a) Proteins immunoprecipitated from 35S-labelled NP40-lysed schizonts with anti- 
CTD antibodies were separated by SDS-PAGE, transferred to nitrocellulose and 
probed with anti-NTD antibodies. Molecular masses are shown in kDa.
b) Autoradiograph showing proteins immunoprecipitated from the same 
preparation of schizonts used in a), using anti-CTD antibodies (anti-CTD (35S)) or 
mouse pre-immune serum (NMS (35S)). Molecular masses are shown in kDa.
Both a) and b) are on the same scale.
No proteins were immunoprecipitated by the mouse pre-immune serum, 
suggesting that all bands immunoprecipitated by the anti-CTD antibodies are 
specific PF08_0008 polypeptides or binding partners. Anti-NTD antibodies react 
by Western blot with both the full length PF08_0008 and the 37 kDa polypeptide 
that are immunoprecipitated by the anti-CTD antibodies (both polypeptides 
arrowed and labelled), suggesting that the 37 kDa fragment is indeed the 
N-terminal product of full length PF08_0008 processing. Mouse anti-NTD 
antibodies also react by Western blot with the heavy and light chains of the anti- 
CTD IgG antibodies present in the sample (marked with asterisks). The anti-NTD 
antibodies do not react with the 42 kDa polypeptide immunoprecipitated by the 
anti-CTD antibodies, and presumably not the 49 kDa polypeptide, although the 
latter is hard to confirm due to reactivity with immunoglobulin heavy chain.
c) Western blot of total schizont material separated by SDS-PAGE under 
reducing and non-reducing conditions. Blots were probed with mouse anti-CTD 
antibodies. Molecular masses are shown in kDa.
d) Western blot of culture supernatant separated by SDS-PAGE under reducing 
(labelled R) and non-reducing (labelled NR) conditions, and probed with mouse 
anti-CTD and anti-NTD antibodies. Molecular masses are shown in kDa.
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6.6 Processing of PF08 0008 is sensitive to brefeldin A
Brefeldin A (BFA) is a fungal metabolite that is known to inhibit the transport of 
proteins from the endoplasmic reticulum to the Golgi in P. falciparum (Elmendorf 
and Haidar, 1993). To investigate the timing of PF08_0008 processing, parasites 
were radiolabelled in the presence of BFA or a solvent control (methanol), and 
immunoprecipitations were carried out with anti-CTD antibodies as before. The 
results are shown in figure 6.7.
In the presence of methanol, the usual band pattern is observed. This pattern is 
also observed in the presence of BFA. However, there are marked differences in 
band intensities between the 2 samples. There appears to be an accumulation of 
the full length protein in the presence of BFA, relative to the methanol control. 
There is also much less p37 visible in the presence of BFA, and virtually no p42 
products are evident. Any changes in the intensity of p49 cannot be readily 
determined as the result is obscured by co-migrating IgG heavy chain.
Treatment of parasites with BFA will result in an accumulation of protein between 
the endoplasmic reticulum and the Golgi. This result indicates that processing of 
full length PF08_0008 occurs following transport to the Golgi. The p37 processed 
form of the protein is not completely absent from protein samples labelled in the 
presence of BFA. This is likely to be due to an incomplete block of protein 
transport. However, a non-uniform labelling of the protein with 35S-methioine and 
35S-cysteine could also be a factor. Parasites are metabolically labelled with 
Pro-mix, a mix of 70% 35S-methionine and 30% 35S-cysteine. Since 89% of the 
methionine residues and 69% of the cysteine residues lie in the N-terminal-most 
50% of the protein, the N-terminal region will be more heavily 35S-labelled than 
the C-terminal most 50%.
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Figure 6.7: Immunoprecipitation of PF08_0008 from brefeldin A-treated 
parasites
Autoradiograph showing proteins immunoprecipitated from brefeldin- (+BFA) or 
methanol- (-BFA) treated schizont material. Anti-CTD antibodies and mouse pre- 
immune serum (NMS) were used.
The level of processing of PF08_0008 is reduced in the presence of BFA. Full- 
length PF08_0008 is more abundant in the treated samples than in un-treated 
samples. The converse is true for the p42 and p37 fragments. It is difficult to 
determine any difference in the level of p49 in both samples due to co-migrating 
IgG heavy chain.
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6.7 PF08 0008 is processed rapidly following translation
In order to investigate the processing of PF08_0008 further, a pulse-chase 
experiment was carried out. Tightly synchronised mature schizonts (42 hpi) were 
metabolically pulse-radiolabelled for 10 minutes with 35S-methionine/cysteine. 
Non-radiolabelled medium was substituted and parasites were harvested at 
intervals following the initial labelling. Only proteins translated within this 10 
minute window will become radiolabelled, and their fate can be followed 
throughout the experiment.
The results are shown in figure 6 .8. It can be seen that even at t=0, p49 and p37 
are already visible. This shows that the processing of full-length protein to give 
p49-p37 takes place very rapidly, and within 10 minutes of translation. Overtime, 
there is a loss of the full-length PF08_0008. When full-length protein is no longer 
present, p49 is detectable, suggesting a transition to this form. Towards the end 
of the chase there is a loss of p49, although p42 is present, which is consistent 
with a transition from the p49-p37 complex to the shed p42-p37 complex. 
However, the p49 and p42 fragments are both detectable in the t=10, t=30 and 
t=60 time points. This suggests that not all p49-p37 complexes are shed at the 
same time. The p37 band does not change in intensity throughout the chase, 
presumably because it is not subjected to further processing following the 
formation of the p49-p37 complex.
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Figure 6.8: Immunoprecipitation of PF08_0008 from pulse-radiolabelled 
parasites
Mature schizonts were pulse-radiolabelled with 35S-methionine/cysteine for 10 
minutes and parasites were harvested at 10, 30, 60 and 120 minutes after the 
end of the 10 minute pulse. A sample of parasites was also taken at the end of 
the 10 minute pulse. An autoradiograph showing the proteins immunoprecipitated 
with anti-CTD antibodies at each of these time points is shown.
At t=0, p49 and p37 are already present, suggesting rapid processing of full- 
length PF08_0008 to p49-p37 occurs, within 10 minutes of translation. Full-length 
PF08_0008 has disappeared by t=60. Towards the end of the chase there is a 
loss of p49, although p42 is present which suggests a transition from the p49-p37 
complex to the shed p42-p37 complex. p49 and p42 fragments are both 
detectable in the t=10, t=30 and t=60 time points, suggesting that not all p49-p37 
complexes are shed simultaneously. The p37 band does not change in intensity 
throughout the chase, presumably because it is not subjected to further 
processing following the formation of the p49-p37 complex.
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6.8 PF08 0008 is GPI-anchored
In order to determine if PF08_0008 is GPI-anchored as expected, parasites were 
metabolically labelled with radioactive GPI-anchor precursors. Parasites were 
labelled with 3H-glucosamine and 3H-mannose and proteins were 
immunoprecipitated using the PF08_0008 anti-CTD antibodies (figure 6.9). It can 
be seen from the autoradiograph that 3H-labelled full-length PF08_0008 can be 
immunoprecipitated with the anti-CTD antibodies, confirming that PF08_0008 is 
indeed GPI-anchored. The apparent absence of the p50 processing product may 
be due to its low abundance in the particular preparation used. This result is 
unlikely to indicate that p50 is no longer GPI-anchored, since figure 6.1b has 
shown it to be membrane-associated.
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Figure 6.9: Immunoprecipitation of PF08_0008 from parasites metabolically 
labelled with the radioactive GPI precursors 3H-glucosamine and 
3H-mannose
a) Anti-PF08_0008 antibodies were used to immunoprecipitate full-length 
PF08_0008 (arrowed) from labelled parasites. The monoclonal antibody 1E1 was 
used to immunoprecipitate full-length MSP1 protein (~200 kDa) from labelled 
parasites. The proteins immunoprecipitated with these two antibodies were 
separated on different gels and film was subjected to different exposure times. No 
proteins were immunoprecipitated with normal mouse serum (NMS).
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6.9 Shedding of PF08 0008 is largely calcium-independent
The p42 and p37 fragments of PF08_0008 which can be detected in culture 
supernatant are likely to be shed by a parasite-derived protease, as is the case 
with other parasite molecules such as AMA1, PTRAMP, MSP1 and EBA175. In 
order to investigate the nature of this protease, a merozoite processing assay 
was carried out. Merozoites were purified in the presence of the calcium-chelating 
agent EGTA and resuspended in a calcium-containing buffer in order to allow 
processing to occur. The shedding of MSP133 into supernatant was compared 
with the shedding of the p42-p37 complex of PF08_0008 (see figure 6.10). It can 
be seen that the incubation of merozoites at 37°C resulted in an increase in the 
level of shed MSP133 and p42-p37, relative to the sample that was not incubated 
at 37°C. Shedding of MSP133 was diminished by the presence of 10 mM EGTA, 
as has been reported previously. The level of PF08_0008 shedding was reduced 
slightly by the presence of 10 mM EGTA. Densitometry carried out on the 
resulting bands showed that there was an approximately 77% reduction in 
MSP133 shedding relative to the control sample, but only a 24% reduction in p42 
shedding.
The reduction in PF08_0008 shedding in the presence of EGTA is not 
inconsistent with the protease responsible being PfSUB2, the calcium-dependent 
protease responsible for the shedding of AMA1, MSP1 and PTRAMP. However, 
since there was only a 24% reduction in shedding of PF08_0008 compared to a 
77% reduction in shedding of MSP133, it is likely that the p42-p37 complex is 
shed by a different protease that is not as calcium-dependent. The rhomboid 
proteases ROM1 and ROM4 have been shown to be responsible for the 
shedding of a range of adhesins from the surface of the merozoite in a calcium- 
independent manner (Baker et al., 2006). However, rhomboids are known to 
cleave their substrate protein within a transmembrane domain, and PF08_0008 is 
a GPI-anchored protein. The current evidence suggests that an alternative, 
probably as yet undefined, parasite protease is responsible for shedding of 
PF08_0008 into culture supernatant.
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Figure 6.10: Western blot analysis of the shedding of PF08_0008 from the 
surface of purified free merozoites
Merozoites prepared in the presence of EGTA were resuspended in a 
calcium-containing processing buffer (PB). Parasites were incubated at 37°C in 
the presence or absence of 10 mM EGTA. Supernatants from merozoites were 
separated by SDS-PAGE under reducing conditions and probed with anti-MSP133 
monoclonal antibody X509 or the anti-CTD antibody. Supernatant from 
merozoites that had not been subject to the 37°C incubation following 
re-suspension in processing buffer was also probed, to give an indication of the 
background level of shed protein fragments present prior to the incubation (at 
t=0).
It can be see that there was an increase in the amount of shedding of p42 and 
MSPI33 following the incubation in processing buffer, relative to the t=0 control. 
Addition of EGTA to 10 mM reduced the shedding of MSP133 by 77%. However 
there was only a 24% reduction in the amount of shed PF08_0008 present. Both 
values were obtained by performing densitometry on the resultant bands using 
the ImageJ software. A graph displaying band intensities as percentages relative 
to the processing buffer controls is shown to the right of the figure.
MSP1
□  T-0
□  PB
□  EGTA
MSP1
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6.10 Conclusions
The results that have been presented in this chapter support the following model 
of proteolytic processing of PF08_0008 (figure 6.11).
PF08_0008 is a GPI-anchored protein, with a predicted molecular mass of 
80 kDa. Full length PF08_0008 is proteolytically cleaved, within minutes of 
translation, to yield two products, a 49 kDa membrane-anchored C-terminal 
fragment and a 37 kDa N-terminal fragment. Since these fragments are detected 
in schizonts as well as in free merozoite preparations, this processing must occur 
prior to schizont rupture. These two fragments remain covalently associated. The 
p49-p37 complex is shed from merozoites as a result of proteolytic cleavage at 
two distinct sites near to the membrane anchor. This releases the p42-p37 
complex into culture supernatant. The proteases responsible for the primary 
processing, and also the shedding of PF08_0008, are yet to be identified.
It is likely that either one or both of the p49 and p37 polypeptides run aberrantly 
on SDS-PAGE gels, since the combined molecular mass of these polypeptides is 
greater than the predicted molecular mass of the entire protein. This makes it 
difficult to predict where in the protein the cleavage of full-length PF08_0008 to 
p49-p37 occurs, and also where the cleavages responsible for the shedding 
occur.
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Figure 6.11: Schematic representation of the processing and shedding of 
PF08_0008
Primary processing of full length protein (a) gives rise to the p49 and p37 
fragments. These fragments are held together in a disulphide-bonded complex 
and are released into culture supernatant following alternative cleavage events 
near to the membrane anchor (b), leaving behind a residual ‘stub’.
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7. PF08 0008 is located in the micronemes of mature schizonts and is 
secreted onto the surface of free merozoites
7.1 Introduction
When attempting the characterisation of a novel P. falciparum protein such as 
PF08_0008, it is useful to determine the sub-cellular location of the protein in 
parasites, as this could give clues as to its functional role. For instance, 
molecules such as MSP1 and its associated proteins that are present on the 
surface of mature blood-stage parasites are thought to be important in 
maintaining initial, low-affinity interactions between parasites and erythrocytes. In 
contrast, since the contents of the apical organelles are known to be secreted at 
the point of invasion, molecules locating to the micronemes, rhoptries and dense 
granules, are often important in the different stages of the invasion process.
7.2 Anti-PF08 0008 antibodies suggest an apical location within mature 
parasites
Smears of late schizont-stage parasites were examined in indirect 
immunofluorescence assays (IFA). Initially, mouse and rabbit antibodies raised 
against the N- and C-terminal regions of PF08_0008 were used in single-labelling 
experiments. Figure 7.1a shows that staining schizonts with mouse anti-NTD and 
anti-CTD antibodies results in a strong punctate patterning that appears to be 
identical for both antibodies. The fluorescence is focused at a single point away 
from the nucleus, with a corresponding number of foci and nuclei. This pattern of 
staining is consistent with a location within the apical organelles. No reactivity is 
found when schizonts are stained with mouse pre-immune serum (7.1c i).
Figure 7.1b shows that the same results obtained with the mouse antibodies are 
obtained when the rabbit antibodies are used. The staining with rabbit antibodies 
seems more dispersed, in contrast to the tight foci obtained with the mouse 
antibodies. However the overall pattern obtained is similar. This justifies the use 
of either rabbit or mouse antibodies in future experiments.
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7.3 PF08 0008 is located within the micronemes of mature P. falciparum 
schizonts
In order to further investigate the location of PF08_0008, dual labelling 
experiments were carried out using the anti-NTD and anti-CTD antibodies in 
combination with antibodies raised against other P. falciparum proteins with 
different, defined, sub-cellular locations.
Clag9 encodes a protein that is part of the high-molecular-mass rhoptry protein 
complex (RhopH) present in the rhoptry bodies of developing merozoites (Ling et 
al., 2004). RhopH2 is another member of the RhopH complex, and antibodies 
against both RhopH2 and clag9 were used in dual-labelling experiments.
It can be seen in figure 7.2a that the staining of the C-terminus of PF08_0008 
does not colocalise with the staining of either clag9 or RhopH2. Although both 
patterns are suggestive of an apical location, the red and green staining patterns 
remain distinct when the two images are overlaid in the final panels. This 
suggests that PF08_0008, although apically-restricted, is not located in the 
rhoptries.
Antibodies against two known microneme proteins were also used in dual 
labelling experiments: AMA1, which is initially present in the micronemes of 
developing merozoites before being released onto the surface following schizont 
rupture, and EBA175 which is known to bind the erythrocyte receptor glycophorin 
A at the tight junction.
Figure 7.2b shows that anti-PF08_0008 staining colocalises with anti-EBA175 
and anti-AMA1 staining in mature schizonts. This is demonstrated by the yellow 
colour observed when the red and green staining is merged in the far right hand 
panels. Antibodies against both the N- and C-terminal regions of PF08_0008 give 
the same result.
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Figure 7.2: Immunofluorescence assay images showing segmented 
schizonts dual labelled with anti-PF08_0008 antibodies and antibodies 
raised against the rhoptry markers RhopH2 and clag9, and the microneme 
markers EBA175 and AMA1
a) Formaldehyde-fixed P. falciparum 3D7 schizonts were probed with mouse anti- 
CTD antibodies and rabbit anti-clag9 antibodies (i) or rabbit anti-RhopH2 
antibodies (ii). Rabbit antibodies were detected with an anti-rabbit Texas Red 
conjugate (red) and mouse anti-CTD antibodies with an anti-mouse FITC 
conjugate (green). Parasite nuclei were stained with DAPI (blue). Scale bars are 
all 5 pm. Strong apical FITC and Texas Red signals are exhibited by parasites, 
although they are distinct and do not overlap.
b) Formaldehyde-fixed P. falciparum 3D7 schizonts were probed with mouse anti- 
CTD or anti-NTD antibodies, and either rabbit anti-EBA175 antibodies (i) or 
biotinylated anti-AMA1 monoclonal antibody 4G2 (ii). Mouse antibodies were 
detected with anti-mouse Texas Red (red) or FITC (green) conjugates. Rabbit 
antibodies were detected with anti-rabbit FITC (green) or Texas Red (red) 
conjugates. Biotinylated 4G2 was detected with a FITC-streptavidin conjugate 
(green). Parasite nuclei were stained with DAPI (blue). Scale bars are 2 pm. 
Strong apical FITC and Texas Red signals are exhibited by parasites, and these 
overlap to form a yellow colour as visible in the far right hand panels.
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7.4 PF08 0008 is present on the surface of some free merozoites
Some molecules are known to relocate from the apical organelles of segmenting 
schizonts to the surface of free merozoites, and are subsequently shed at the 
point of invasion. For example AMA1, which is shed by PfSUB2 (Harris et al., 
2005), and the adhesin EBA175, shed by PfROM4 (O'Donnell et al., 2006). In 
contrast, other apically-restricted molecules do not relocate onto the surface of 
merozoites, for example RhopH2.
In order to investigate the fate of PF08_0008 following schizont rupture, naturally 
released merozoites were examined by indirect immunofluorescence in the same 
way £s mature schizonts.
It was evident that PF08_0008 had different distributions in different merozoites, 
and these are summarised in figure 7.3. In some instances PF08_0008 appeared 
to be micronemal, as is the case with mature schizonts. Figure 7.3a shows that 
anti-CTD antibodies give a staining pattern identical to that of anti-AMA1 
antibodies, but distinct from the anti-RhopH2 monoclonal antibody 61.3.
Figure 7.3b shows two different distributions of PF08_0008 on free merozoites. In 
figure 7.3b i, it can be seen that PF08_0008 appears to have a circumferential 
distribution, similar to that of AMA1. Figure 7.3b ii shows examples of merozoites 
where PF08_0008 appears to be distributed in a ‘cap’-like manner over one pole 
of the parasite, presumably the apex.
The three different distributions of PF08__0008 described above were not equally 
represented in the merozoite populations analysed by IFA (see table 7.1).
Table 7.1. T h e  percentage o f free m erozoites exhibiting one of th ree  observed  P F 0 8 _ 0 0 0 8  
distributions is shown as the m ean ± one standard deviation for three experim ents .
Location Percent of merozoites
Apical 54±4
Cap 37±7
Surface 11 ±2
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Figure 7.3: Immunofluorescence assay images showing free merozoites 
dual labelled with anti-PF08_0008 antibodies and antibodies raised against 
the merozoite microneme and surface marker AMA1, and rhoptry marker 
RhopH2
Formaldehyde-fixed P. falciparum free merozoites were probed with rabbit anti- 
CTD antibodies, and either mouse polyclonal anti-AMA1 antibodies (a i and b) or 
mouse monoclonal anti-RhopH2 antibody 61.3 (a ii). Scale bar of a i is 5 pm, rest 
are 2 pm. Mouse antibodies were detected with an anti-mouse Alexa Fluor 594 
conjugate (red), and rabbit antibodies with an anti-rabbit Alexa Fluor 488 
conjugate (green). Parasite nuclei were stained with DAPI (blue).
In 7.3a, there is a clear apical localisation of AMA1, RhopH2 and PF08_0008. 
AMA1 and PF08_0008 are co-localised in the micronemes of free merozoites. 
7.3b i shows a circumferential localisation of both PF08_0008 and AMA1 on the 
surface of free merozoites. 7.3b ii shows a ‘cap’-like distribution of PF08_0008 on 
the surface of free merozoites (arrowed), in contrast to the circumferential 
distribution of AMA1.
a) i)
MergeAMA1
MergeRhopH2
b) i)
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7.5 Anti-CTD. but not anti-NTD antibodies react with rinq-staqe parasites
The residual stubs of AMA1 and MSP1, which are generated following the 
shedding of these molecules from the merozoite surface, are carried into 
erythrocytes with the invading merozoite, and can be detected by IFA on ring- 
stage parasites (Blackman et al., 1996; Howell et al., 2005).
IFAs carried out on newly-invaded (£4 hours post invasion) ring-stage parasites 
with anti-PF08_0008 antibodies show that the C-terminal part of the protein can 
be detected in ring-stage parasites whereas the N-terminal part cannot (figure 
7.4). Dual labelling IFA shows that the signal produced by the anti-CTD 
antibodies co-localises with that produced by the monoclonal antibody 1E1, 
raised against the stub of MSP1, MSP1i9 (figure 7.6a). In contrast, no signal is 
produced by the anti-NTD antibodies in IFA on ring-stage parasites (figure 7.4b).
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Figure 7.4: Immunofluorescence assay images showing newly invaded ring- 
stage parasites dual labelled with anti-PF08_0008 antibodies and a 
monoclonal antibody 1E1, raised against MSP119
Formaldehyde-fixed P. falciparum newly-invaded ring-stage parasites were 
probed with the mouse monoclonal anti-MSP1i9 antibody 1E1, and either rabbit 
anti-CTD (a) or anti-NTD (b) antibodies. Mouse antibodies were detected with an 
anti-mouse Alexa Fluor 594 conjugate (red) and rabbit antibodies with an anti- 
rabbit Alexa Fluor 488 conjugate (green). Parasite nuclei were stained with DAPI 
(blue). There was no reactivity exhibited by mouse pre-immune serum with ring- 
stage parasites (not shown). Scale bars are 2 pm.
This figure shows that there is clearly reactivity of anti-CTD antibodies (a), but not 
anti-NTD antibodies (b), with ring-stage parasites. Anti-CTD and anti-MSP119 
signals appear to co-localise (a), suggesting that ‘stub’ part of PF08_0008 that is 
produced upon shedding of the p42-p37 complex is carried into the host cell and 
remains associated with the plasma membrane of the ring-stage parasite, (c) 
shows that the specificity of the anti-CTD antibodies (green) for PF08_0008 
extends up to the GPI-anchor addition sequence (pink) and that these antibodies 
would also be reactive with the stub region.
b)
-t N*
DAPI m s p 1i9 CTD Merge _
DAPI m s p 1i9 NTD Merge
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7.6 Conclusions
The results presented above indicate that PF08_0008 is an apically-restricted 
protein, and is likely to be resident in the micronemes of developing schizonts. 
This is supported by images demonstrating both the co-localisation of 
PF08_0008 with two different micronemal markers, AMA1 and EBA175, and the 
distinction between anti-PF08_0008 labelling and the labelling of rhoptry markers.
It is evident that the antibodies raised against both the N- and C-termini of 
PF08_0008 show the same pattern of reactivity within schizonts and merozoites. 
This is not surprising since work detailed in the previous chapter has shown that 
following a processing event, the N- and C-terminal regions of the protein remain 
associated through a disulphide bond. This processing event occurs before 
schizont rupture, and perhaps during transport of PF08_0008 to the micronemes.
Fragments of PF08_0008 are also detectable in culture supernatant, by both the 
NTD and CTD antibodies. As is the case with MSP1 and AMA1, shedding of 
PF08_0008 into culture supernatant could generate a residual ‘stub’ of protein, 
which remains anchored to the merozoite surface and is carried into the next 
erythrocyte upon invasion. The IFA data presented here suggests that this is 
indeed what happens. The specificity of the anti-CTD antibodies for the entire 
region of PF08_0008 between the putative transmembrane and GPI-anchor 
sequences means that any ‘stub’ generated during shedding is also likely to be 
detected by a subset of these antibodies. This explains the reactivity of the 
antibodies with ring-stage parasites. In contrast, the N-terminal antibodies do not 
react with ring-stage parasites, since all of PF08_0008 except the ‘stub’ would be 
released into culture supernatant.
Approximately half of the free merozoites examined exhibited an apical 
distribution of PF08_0008, as is seen in mature schizonts, although smaller 
proportions demonstrated a ‘cap’-like or circumferential distribution. This is not 
unexpected since the secretion of molecules such as AMA1, EBA175 and SUB2 
from the micronemes onto the parasite surface is known to occur in the absence 
of productive invasion. These data suggest that PF08_0008 is also redistributed 
from the micronemes of schizonts to the surface of free merozoites. The ‘cap’-like 
distributions could represent an intermediate state, where PF08_0008 has been 
released onto the surface but has not yet become circumferentially distributed.
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The proportion of parasites demonstrating a circumferential or ‘cap’-like 
distribution of PF08_0008 is likely to be directly linked to the proportion of 
merozoites that are undergoing or have undergone spontaneous microneme 
secretion in the samples analysed.
It would be of interest to determine how PF08_0008 becomes distributed over the 
surface of free merozoites. One possibility is that it merely diffuses throughout the 
plasma membrane following secretion at the apex. Alternatively, PF08_0008 
could be linked indirectly, via interactions with other proteins, to the actin-myosin 
motor of the parasite. This appears to be the case with PfSUB2, as its 
redistribution towards the rear of the parasite does not occur in the presence of 
latrunculin A, which causes net actin depolymerisation within the cell (Harris et 
al., 2005).
PF08_0008 joins the list of previously identified microneme proteins that includes 
AMA1, EBA140, EBA175, EBA181, MTRAP, ROM4, ROM1, SUB2, PTRAMP, 
and ASP, with all but the last two having defined roles in the process of invasion. 
Of these microneme proteins, AMA1, EBA175, SUB2, PTRAMP and ROM4 have 
also been shown to relocate from the micronemes onto the surface of free 
merozoites. The evidence presented here is therefore highly suggestive of 
PF08_0008 having a role in the process of invasion.
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8. PF08 0008 binds erythrocytes but anti-PF08 0008 antibodies do not
inhibit erythrocyte invasion
Relatively few P. falciparum proteins have been shown to have a well-defined 
erythrocyte-binding capability. MSP1 is a putative ligand for the erythrocyte 
protein band 3 (Goel et al., 2003), EBA175 is known to bind glycophorin A on the 
erythrocyte surface (Sim et al., 1994), EBA140 binds glycophorin C (Maier et al., 
2003), and both EBA181 and PfRH1 bind undefined receptors (Gilberger et al., 
2003b, Rayner et al., 2001). The presence of PF08_0008 in culture supernatant 
hints at a potential role for this protein as an adhesin, so this was investigated 
further.
8.1 The p42- p 37 complex of PF08 0008 is able to specifically bind 
erythrocytes
In order to investigate the ability of PF08_0008 to bind to erythrocytes, 
supernatant from cultures in which schizonts had undergone rupture was 
prepared. Samples of culture supernatant were then incubated at 37°C in the 
presence or absence of washed, type 0+ erythrocytes. Figure 8.1a shows that 
PF08_0008 is present in culture supernatant incubated in the absence of 
erythrocytes, but not in supernatant incubated in the presence of erythrocytes. 
The defined erythrocyte adhesin EBA175 is also depleted from culture 
supernatant following incubation with erythrocytes, whereas the merozoite 
surface protein MSP3 is not.
Although this result is highly suggestive of PF08_0008 having an erythrocyte- 
binding ability, it was necessary to establish that the depletion of PF08JD008 
from culture supernatant was due to a specific interaction between this protein 
and erythrocytes. Following incubation of culture supernatant with erythrocytes, 
the cells were washed and any proteins bound to the surface were eluted with 
0.5 M NaCI. A Western blot carried out on the eluted proteins showed that 
PF08_0008 does indeed bind specifically to the erythrocyte surface (figure 8.1b).
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Figure 8.1: PF08_0008 binds specifically to the surface of erythrocytes
a) P. falciparum culture supernatant was incubated in the presence or absence of 
washed, group 0+ erythrocytes at 37°C. Cellular material was removed and 
supernatants were separated by SDS-PAGE under reducing conditions, before 
being transferred to nitrocellulose and probed with antibodies raised against 
EBA175 (i), MSP3 (ii) and the C-terminal domain of PF08_0008 (iii). Molecular 
mass is shown in kDa.
It can be seen that the erythrocyte binding protein EBA175 is present in samples 
of culture supernatant incubated in the absence of erythrocytes (labelled 
‘untreated S/N’) and is almost completely absent from supernatant incubated in 
the presence of erythrocytes (labelled ‘depleted S/N’), whereas MSP3 is present 
in both samples. As is the case for EBA175, the C-terminal fragments of 
PF08_0008 that are released into culture supernatant are depleted following 
incubation of supernatant with erythrocytes.
b) In order to confirm that the depletion of PF08_0008 from culture supernatant is 
the result of a specific interaction with erythrocytes, proteins bound to the 
erythrocyte surface were eluted with 0.5 M NaCI. Eluted proteins were separated 
by SDS-PAGE under reducing conditions, transferred to nitrocellulose then 
probed with the anti-CTD antibodies. Molecular mass is shown in kDa.
PF08_0008 can be eluted from the surface of erythrocytes following their 
incubation with P. falciparum culture supernatant, suggesting a specific 
interaction between this protein and an erythrocyte ligand.
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8.2 Anti-PF08 0008 antibodies do not inhibit erythrocyte invasion
Antibodies raised against EBA175, EBA181 and MSP1, which are all erythrocyte 
binding proteins, are able to inhibit the invasion of erythrocytes by parasites. In 
order to address the possibility that the anti-NTD and anti-CTD antibodies inhibit 
parasite invasion of erythrocytes, invasion inhibition experiments were carried 
out. Antibodies were added to late blood-stage cultures at concentrations of 
1 mg ml'1, 0.5 mg ml'1 and 0.25 mg ml'1. Cells were harvested approximately 42 
hours later and the parasitemia determined by flow cytometry (figure 8.2).
It can be seen that relative to the PBS control, the rabbit pre-immune serum 
reduced invasion by only 5% whereas incubation with EGTA reduced parasitemia 
by approximately 90%. Neither the anti-CTD nor anti-NTD antibodies inhibited 
invasion at any of the concentrations tested, relative to the control. Essentially 
identical results were obtained from two identical but independent experiments.
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Figure 8.2: Anti-PF08_0008 antibodies do not inhibit erythrocyte invasion
Invasion inhibition assays were carried out using the anti-NTD and anti-CTD 
antibodies. PBS and rabbit pre-immune serum (labelled PI) were included as 
negative controls, and 12.5 mM EGTA as a positive control. Rabbit antibodies in 
PBS were tested at concentrations of 1 mg ml'1 (labelled 1.0), 0.5 mg ml'1 
(labelled 0.5) and 0.25 mg ml'1 (labelled 0.25), supplemented with pre-immune 
IgG as appropriate to give a final IgG concentration of 1 mg ml'1 per well.
Parasite cultures were incubated with the test or control solutions, in triplicate, for 
approximately 42 hours to allow invasion to occur. Cells were stained with 
ethidium bromide and the parasitemia of each well was determined by flow 
cytometry. Parasitemia shown is the mean of three wells, relative to the 
parasitemia resulting from incubation with PBS alone. Error bars indicate one 
standard deviation above and below the mean. Essentially identical results were 
obtained in two identical but independent experiments.
CTD1.0 CTO 0.5 CTO 0.25 NTD 1.0 NTD 0.5 NTD 0.25
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8.3 Conclusions
PF08_0008 appears to be an erythrocyte-binding protein - the p42 fragments are 
depleted from culture supernatant following incubation with erythrocytes, and can 
be eluted from the erythrocyte surface. However, antibodies raised against the 
N- and C-terminal regions of PF08_0008 do not inhibit erythrocyte invasion by 
parasites.
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9 Epitope taaaina o f endogenous PF08 0008 with a C-terminal triple
haemagglutinin tag
It was decided to modify the endogenous copy of PF08J0008 to include a 
C-terminal epitope tag, by targeted homologous recombination. The epitope tag 
of choice was the triple haemagglutinin (HA) tag. The availability of the anti-HA 
monoclonal antibody 3F10 could in theory allow the purification of tagged 
PF08_0008 from parasites, with a view to ultimately obtaining information on the 
cleavage sites responsible for primary processing and shedding. The decision to 
adopt this strategy was made at a time when the bioinformatic evidence available 
on PF08_0008 was suggestive of a transmembrane- rather than GPI-anchorage.
9.1 Vector construction
The vector used for transfection is a modified version of the pHH1 vector (Reed 
et al., 2000), which allows integration of the plasmid into the locus of choice via a 
single-crossover homologous recombination event (figure 9.2). The vector 
contains the human dihydrofolate reductase (dhfr) gene, for use as a selectable 
marker.
The 3’-most 829 bp of PF08J0008 coding sequence was amplified from parasite 
genomic DNA, incorporating BglW and Xho\ restriction sites at the 5’ and 3’ ends 
of the product respectively (figure 9.1a). Importantly, primers were designed to 
omit the last three nucleotides of coding sequence, encoding the stop codon. The 
PCR product was ligated into the pHH1-T996HA3 vector (a gift from Pippa Harris) 
(Harris et al., 2005), which was obtained in a BglW- and X/?ol-digested form, to 
make pHH1-PF08_0008HA3, with a continuous reading frame formed from the 
PF08J0008 coding region into the triple HA tag coding sequence.
E. coli TOP10 cells were transformed with pHH1-PF08_0008HA3 and a PCR 
screen was carried out on a number of resulting colonies (figure 9.1b), using the 
same primers as above. Plasmid DNA was obtained from a number of colonies 
that appeared to contain pHH1-PF08_0008HA3 and a restriction digest was 
carried out to confirm that this was indeed the case (figure 9.1c). The plasmid 
DNA from a number of clones was also sequenced to ensure no mistakes had 
been introduced during PCR amplification of the PF08J0008 coding region.
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Figure 9.1: Cloning the 3’-most 829 bp of the PF08JD008 coding sequence 
into pHH1-T996HA3
a) Primers were designed to amplify the 3’-most 829 bp of the PF08_0008 coding 
sequence, excluding the final three nucleotides that encode the stop codon. Xho\ 
and BglW sites were incorporated into the 5’ and 3’ ends of the PCR product 
respectively. A product of 848 bp was expected. Analysis of PCR products was 
carried out by agarose gel electrophoresis. Molecular sizes are given in bp.
b) A PCR screen was carried out on E. coli colonies obtained following 
transformation with pHH1-PF08_0008HA3. Products were analysed by agarose 
gel electrophoresis. Molecular sizes are given in bp. Of the three colonies shown 
(numbered 1-3), colonies 1 and 2 appear to contain the vector with the insert.
c) Restriction digests were carried out on plasmid DNA obtained from the two 
colonies that gave a positive PCR screen result in b. DNA was digested with Xho\ 
and BglW in order to release an 841 bp fragment from the vector (arrowed). The 
size of the remaining plasmid backbone is 5867 bp. Products were analysed by 
agarose gel electrophoresis. Molecular sizes are given in bp.
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Figure 9.2: The vector pHH1-PF08_0008HA3
a) The vector used to transfect parasites, pHH1-PF08_0008HA3, consists of the 
3’-most 829 bp of the PF08J0008 coding sequence, excluding the terminal stop 
codon (yellow), fused in-frame to the coding sequence of the triple 
haemagglutinin tag (red). The correct transcription termination and 
polyadenlyation of this gene is regulated by the presence of the P. berghei 
dihydrofolate reductase 3’ untranslated region (UTR) (grey). The human 
dihydrofolate reductase (hDHFR) cassette (blue) is under the transcriptional 
control of the 5’ untranslated region of the P. falciparum calmodulin gene (green) 
and the 3’ untranslated region of the hrp2 gene (purple). The Xho\ and Bg/ll sites 
used to clone in the PF08_0008 fragment are boxed, as are the Xmn\ and EcoRI 
sites that were used to generate the probe for Southern blot analysis. The Seal 
site in the plasmid backbone is also indicated.
b) The pHH1-PF08_0008HA3 vector was digested with Xmn\ and EcoRI in order 
to generate an 807 bp fragment for use as a probe in a Southern blot analysis. 
The products of the digest were analysed by agarose gel electrophoresis. The 
size of the remaining plasmid backbone is 5901 bp. The probe (arrowed) was gel 
purified and again analysed by agarose gel electrophoresis (ii). Molecular sizes 
are given in kb.
c) The pHH1-PF08_0008HA3 vector was digested with Xho\ and Bg/ll in order to 
generate an 841 bp fragment for use as a probe in Southern blot analysis. The 
products of the digest were analysed by agarose gel electrophoresis. The size of 
the remaining plasmid backbone is 5867 bp. The probe (arrowed) was gel 
purified and again analysed by agarose gel electrophoresis (ii). Molecular sizes 
are given in kb.
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9.2 Transfection of parasites
A ring stage P. falciparum culture was transfected with 100 pg purified plasmid 
DNA. Drug pressure, in the form of a 10 nM WR99210 antifolate supplement, was 
applied approximately 24 hours later. The culture was maintained on drug 
pressure until drug resistant parasites appeared. Genomic DNA was obtained 
from these parasites and stocks were made. A process of drug cycling was then 
started. This consisted of culturing parasites in the absence of drug for three 
weeks, followed by culture in the presence of drug until resistant parasites 
appeared. This ‘off/on’ drug pressure represents one cycle. In total, parasite 
cultures were subjected to three drug cycles. At the end of each cycle, when drug 
resistant parasites appeared, parasite stocks were made, and genomic DNA 
obtained from the population. Drug cycling allows a parasite population to 
become enriched in parasites that have integrated a copy of the plasmid into the 
genome, rather than those that carry an episomal copy.
9.3 Southern blot analysis
Following three rounds of drug cycling, individual clones were obtained from the 
parasite population by limiting dilution. Genomic DNA was obtained from a 
number of clones selected for analysis by Southern blot.
Two different probes were generated for Southern blot analysis. The 
pHH1-PF08_0008HA3 vector was digested with Xmn\ and EcoRI in order to 
generate an 807 bp product, and with Xho\ and BglW in order to excise an 841 bp 
product (figures 9.2b and 9.2c).
Genomic DNA from P. falciparum 3D7 parasites, along with DNA from parasite 
populations obtained at the end of each drug cycle, and from individual clones, 
was digested with Seal and Swal and subjected to Southern blot analysis using 
the two probes described above.
Following digestion with Seal and Stval, the two probes should detect a different 
combination of DNA fragments (figure 9.3a). The 807 bp probe is derived from 
the plasmid backbone, and so would detect plasmid DNA in the form of a 6.7 kb 
episome, or a 5.8 kb fragment in the case of an integrated plasmid. The 841 bp 
probe is derived from the 3’ end of the PF08_0008 coding sequence, and so
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would detect a 3.8 kb fragment in the case of an unmodified PF08_0008 locus, or 
4.8 kb and 5.8 kb bands in the case of an integrated plasmid.
The results of the Southern blot are shown in figure 9.3b and it can be seen that 
in the case of four out of five parasite clones analysed, there appears to have 
been integration of the pHH1-PF08_0008HA3 plasmid into the endogenous 
PF08J0008 locus, with no remaining episome evident. Clone B4 was chosen for 
use in future experiments. The integration event was confirmed by sequencing a 
PCR product amplified from clone B4 genomic DNA using a forward primer from 
outside the region of PF08J0008 that was cloned into the pHH1-T996HA3 vector, 
and a reverse primer from the plasmid, downstream of the triple HA tag coding 
sequence. This confirmed that the sequence of PF08_0008 was in-frame with the 
triple HA tag coding sequence.
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Figure 9.3: Southern blot analysis of parasites transfected with pHH1-PF08_0008HA3
a) Schematic representation of the integration plasmid pHH1-PF08_0008HA3 and a single­
crossover homologous recombination event. Integration reconstitutes a full-length PF08J0008 
gene with a triple HA tag at the 3’ end. The correct transcription termination and 
polyadenlyation of this gene is regulated by the presence of the P. berghei dihydrofolate 
reductase 3’ untranslated region (UTR) (PbDT 3’ UTR). The Seal and Swal sites are indicated, 
as well as the size of the fragments obtained following a double restriction digest with these 
enzymes, in the case of an unmodified PF08_0008 locus (3.8 kb), an episome (6.7 kb) and a 
single-crossover integration event (4.8 kb and 5.8 kb). The position of the two probes used is 
indicated: probe I (produced by the Xho\IBgl\\ digest of pHH1-PF08_0008HA3) will recognise 
the 3.8kb, 4.8 kb and 5.8 kb fragments, and probe II (produced by the EcoR\IXmn\ digest of 
pHH1-PF08_0008HA3) will recognise the 5.8 kb and 6.7 kb fragments.
b) Southern blots of Scal/Swal-digested genomic DNA from: wild-type 3D7 parasites (3D7), 
the first population of WR92210-resistant parasites that appeared following transfection 
(cycle 0), the populations of resistant parasites present after one, two or three rounds of drug 
cycling (cycle 1, cycle 2 and cycle 3) and five clones derived by limiting dilution (9, B4, F8, C7 
and C9). Blots were probed with i) probe I or ii) probe II. Molecular sizes are indicated in kb.
i) 3D7 parasites show reactivity with probe I, with a band at approximately 3.8 kb, 
consistent with an unmodified PF08J0008 locus (labelled WT). Cycles 0-3 and clone 
9 show evidence of episome in the form of a 6.7 kb band (E), and also an unmodified 
PF08_0008  locus. Cycles 1-3 and clone 9 also appear to contain parasites with an 
integrated plasmid, represented by the two bands at 4.8 kb and 5.8kb (I), and are thus 
mixed populations at this stage. Only clones B4, F8, C7 and C9 demonstrate an 
absence of an unmodified PF08J0008 locus, confirming that they are true clonal 
populations. Episome is also absent from these 4 clones.
ii) 3D7 parasites do not react with probe II, as expected since the probe is derived 
from the plasmid backbone. Episome is present in cycles 0-3 (E), and also in clone 9. 
Cycles 1-3 and clone 9 also appear to contain parasites with an integrated plasmid, 
represented by the band at 5.8 kb (I), and are thus mixed populations. Clones B4, F8, 
C7 and C9 show evidence of an integrated plasmid in the absence of episome. In 
parasites from cycles 1-3, and in clone 9, there are also additional unexpected bands 
present of sizes 5 kb, 3 kb and 2.5 kb (labelled *). The presence of these bands 
cannot be explained by an event such as concatemerisation of the transfection 
plasmid and are of unknown origin. Importantly, they are absent from the clonal 
parasite populations.
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9.4 Western blot analysis
Western blot analysis was carried out on clone B4 schizont material (figure 9.4a) 
using the anti-HA antibody 3F10. The results are consistent with the processing 
model that was discussed in chapter 6. This antibody recognises two 
polypeptides fragments: one with an approximate molecular mass of 80 kDa and 
another with an approximate molecular mass of 52 kDa. The un-tagged 
PF08_0008 protein and the C-terminal primary processing product have apparent 
molecular masses of 72 kDa and 49 kDa respectively. The 33 amino acids of the 
triple HA tag would add approximately 3-4 kDa onto the molecular mass of a 
protein, and this appears to be true in the case of p49. However, there appears to 
be an approximately 8 kDa difference between the molecular mass of the 
untagged and tagged full-length PF08_0008. This is likely to be due to a previous 
underestimation of the molecular mass of the full length protein - calculations 
were performed using molecular mass standards of 62 kDa and 188 kDa, with no 
intermediate, whereas subsequent calculations utilised a different marker with a 
98 kDa standard. Therefore it appears that PF08_0008-HA3 is processed in the 
same way as the un-tagged protein.
9.5 Indirect immunofluorescence assays (IFA)
Smears of clone B4 schizonts were prepared and analysed by I FA using the 
anti-HA antibody 3F10 (figure 9.4b). It can be seen that the fluorescent signal is 
apically-restricted. The distribution of PF08_0008-HA3 in schizonts appears to be 
the same as that of un-tagged protein in 3D7 parasites.
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Figure 9.4: Western blot and indirect immunofluorescence analyses of 
transgenic parasites expressing PF08_0008-HA3
i) Clone B4 schizont samples were lysed directly into reducing sample buffer, 
separated by SDS-PAGE, transferred to nitrocellulose and probed with the 
anti-HA monoclonal antibody 3F10. Molecular mass is indicated in kDa.
ii) The distances travelled along the gel by the protein standards were 
measured and used to plot a standard curve of distance against 
logio(molecular mass). Data points are connected in black, and the trendline 
displayed in red. This enabled the calculation of the molecular mass of the 
two polypeptides shown in i), using their migration distances and the equation 
displayed. The R2 value is also indicated on the graph. The table shows the 
data used to produce the standard curve. The values marked with an asterisk 
represent data for the two polypeptides.
b) Smears of clone B4 schizonts were fixed with formaldehyde and probed with the 
rat anti-HA monoclonal antibody 3F10. 3F10 was detected with an anti-rat Alexa 
Fluor 488 conjugate. Parasite nuclei were stained with DAPI (blue). Scale bar 
indicates 5 pm.
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9.6 Solubility of PF08 0008-HA3
In order to determine whether epitope-tagged PF08_0008 is still membrane- 
associated, like the wild-type protein, clone B4 schizont material was treated with 
a high pH carbonate buffer, and the soluble and insoluble fractions were 
analysed by Western blot with the anti-HA antibody 3F10 (figure 9.5). It is evident 
that the vast majority of epitope-tagged PF08_0008 is no longer associated with 
membrane, as it is present in the carbonate-soluble fraction. The low level of 
protein detected in the carbonate-insoluble fraction could either be due to an 
incomplete solubilisation of proteins with the high pH carbonate buffer, or the 
presence of a proportion of epitope tagged protein that is membrane anchored. 
The detection of a low level of MSP3, which is a peripheral merozoite surface 
protein, in the carbonate-insoluble fraction suggests that the former is likely.
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Figure 9.5: Separation of membrane-associated and soluble proteins from 
transgenic parasites expressing PF08_0008-HA3
Clone B4 schizont preparations were treated with a high pH carbonate buffer 
(100 mM Na2C03 buffer (pH 11.0)). Fractions of protein soluble (S/N) and 
insoluble (P) in this buffer were obtained, and were separated under reducing 
conditions by SDS-PAGE. Proteins were transferred to nitrocellulose, and probed 
with the anti-HA monoclonal antibody 3F10 (a), as well as antibodies raised 
against the soluble merozoite surface protein MSP3 (b), and the transmembrane 
protein PTRAMP (c). Molecular masses are given in kDa.
The majority of PF08_0008-HA3 appears in the carbonate-soluble fraction, 
indicating a lack of membrane association. A small proportion is present in the 
carbonate-insoluble fraction, which could be an indication of incomplete 
solubilisation, or a subset of PF08_0008-HA3 that is membrane-anchored. MSP3 
appears almost entirely in the carbonate-soluble fraction, as expected. The 
presence of a small amount in the carbonate-insoluble fraction is likely to be due 
to an incomplete solubilisation of protein in the carbonate buffer. PTRAMP 
appears exclusively in the carbonate insoluble fraction, indicating a membrane 
association.
a) b) c)
kDa ^  *
3F10 anti-MSP3 anti-PTRAMP
97 kDa kDa 
51 —
64 —
51—
39
39 —
161
Chapter 9: Epitope tagging of endogenous PF08_0008 with a C-terminal triple haemagglutinin tag
9.7 Conclusions
Transgenic parasites expressing an epitope tagged version of PF08_0008 have 
been generated through targeted homologous recombination. None of the clones 
exhibited any growth defect relative to the parental 3D7 clone, suggesting that 
neither the fusion of the triple haemagglutinin tag to the C-terminus of 
PF08_0008, nor the replacement of the endogenous PF08_0008 3’ UTR with the 
heterologous P. berghei sequence, had any detrimental effect on parasite 
replication.
One notable difference from wild-type parasites is the solubility of PF08__0008- 
HA3 in high pH carbonate buffer. This suggests that the protein is no longer 
membrane anchored in the transgenic parasites. This is consistent with a GPI- 
rather than transmembrane-anchorage of PF08_0008 in 3D7 parasites. As 
discussed earlier, GPI-anchor addition begins with the translocation of the entire 
polypeptide chain into the lumen of the endoplasmic reticulum, where the GPI 
signal sequence is recognised by a transamidase complex. Even when the 
hydrophobic region of the GPI signal sequence is followed by an authentic 
charged cytosolic tail sequence, as is the case with transmembrane signal 
sequences, the entire polypeptide chain is still translocated into the lumen of the 
ER (Dailey and Bulleid, 2003a). This indicates that a GPI-anchor signal sequence 
cannot be converted to a transmembrane domain through the addition of an 
authentic cytosolic tail sequence, and that the hydrophobic region itself is 
sufficient to allow the translocon to recognise it as a GPI signal sequence. 
Therefore, in the case of the parasites expressing epitope-tagged PF08_0008, 
the tag itself is unlikely to prevent the total translocation of the entire polypeptide 
chain into the lumen of the ER during GPI-anchor addition.
However, the same study showed that the activity of the transamidase complex is 
reduced to a low level when the GPI signal sequence is followed by a tail 
sequence. One might therefore expect the presence of the 33 amino acid triple 
HA tag sequence C-terminal of the GPI-anchor addition sequence of PF08_0008 
to impair the ability of the transamidase complex to efficiently recognise the GPI 
signal sequence, resulting in PF08_0008 that is mostly soluble in its 
epitope-tagged form.
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The tagged form of the protein appears to be processed in the same way as the 
un-tagged form. The full length protein is detectable by Western blot in schizont 
extracts, as well as what is likely to be a tagged version of the p49 primary 
processing product. These results are also consistent with the two-step 
processing described in chapter 6.9. 3F10 would not be expected to detect the N- 
terminal p37 fragment due to the location of the triple HA epitope at the extreme 
C-terminus of the protein, and for the same reason one would not expect the p42 
shed fragments to be detected either.
PF08_0008-HA3 also appears to be apically restricted, like its non-tagged 
counterpart, although immuno-electron microscopy would be necessary to 
confirm the specific sub-cellular location. These results suggest that PF08_0008 
need not be membrane anchored in order to be trafficked correctly or 
proteolytically processed. Moreover, the presence of a membrane-bound form of 
PF08_0008 is not essential for parasite growth, or clones would not have been 
established.
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10. Discussion
The data that have been presented here suggest that PF08_0008 is a GPI- 
anchored microneme protein that is proteolytically processed within schizonts and 
ultimately shed from the surface of merozoites. Culture supernatant depletion 
experiments have also shown that PF08_0008 binds specifically to the surface of 
erythrocytes.
PF08_0008 is the twelfth GPI-anchored protein to be identified in the asexual 
blood stage of P. falciparum, and the second to be found to be micronemal 
following immunofluorescence analysis. Nine out of the twelve previously 
identified GPI-anchored proteins appear to be surface-resident proteins. 
PF08_0008, RAMA and ASP may be part of a subset of GPI-anchored proteins 
that are initially present in the apical organelles rather than on the merozoite 
surface.
It is likely that PF08_0008 is a micronemal protein. Micronemes discharge their 
contents following the reorientation of the parasite. However, it is thought that low 
levels of protein are released from apical organelles onto the surface of the 
parasite prior to reorientation and the formation of the tight junction, and may 
contribute to initial attachment. PF08_0008 is also shed from the surface of the 
parasite into culture supernatant and these two observations are suggestive of 
PF08_0008 functioning either in the initial attachment of the merozoite to the 
erythrocyte, and/or at some point between the formation of the tight junction and 
the completion of invasion, at which point the protein is presumably shed from the 
surface of the parasite.
Anti-PF08_0008 antibodies do not inhibit erythrocyte invasion in the 
concentration range tested. This does not appear to be consistent with 
PF08_0008 playing a role in invasion; antibodies against EBA175 and EBA181, 
which are both known erythrocyte-binding proteins, MSP1, which is presumed to 
be an erythrocyte-binding protein, and AMA1, which is critical in invasion, have all 
been shown to inhibit invasion. It could be argued, however, that antibodies 
raised against PF08_0008 would only inhibit invasion if they directly or indirectly 
interfered with a critical physical interaction necessary for the functioning of the 
protein. For example a receptor-ligand interaction could be disrupted, or a
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processing site blocked. However, it is entirely possible that regions of the protein 
important in maintaining the functionality of the protein lie outside of the regions 
against which antibodies were raised. Indeed, less than one third of the 
PF08_0008 sequence was included in the recombinant proteins against which 
antibodies were raised. Additionally, PF08_0008 may not be sufficiently exposed 
to antibody during the invasion process, if for example, it is concentrated at the 
moving junction, which would be largely inaccessible to antibody.
Moreover, the anti-NTD and anti-CTD antibodies that have been generated 
during this project were both raised against insoluble, denatured protein. One 
might expect that such antibodies do not detect native parasite PF08_0008 in its 
correctly folded state. Although I FA has shown that this is certainly not the case, 
with these antibodies specifically detecting an apically-located parasite protein, it 
is possible that the binding of these antibodies to their epitope might be impaired 
relative to any antibodies raised against correctly folded protein. The anti-NTD 
and anti-CTD antibodies may be able to detect native parasite protein by I FA, but 
may not be of sufficiently high avidity to disrupt the functioning of the protein.
Since PF08_0008 binds specifically to erythrocytes, it could be acting as an 
adhesin that is connected to the motor complex, albeit indirectly due to its GPI- 
anchorage, and allows productive invasion to occur, in the same manner as 
proteins such as EBA175.
It has been demonstrated in P. knowlesi that AMA1 is essential for the parasite to 
reorientate, possibly via a concentration gradient of adhesive interactions, and it 
is likely to be distributed on the surface of the merozoite before the formation of 
the tight junction (Mitchell et al., 2004). The vast majority of free merozoites 
analysed with anti-PF08_0008 antibodies displayed a punctuate or ‘cap’-like 
apical staining pattern, with few displaying any circumferential distribution. This is 
consistent with a model in which PF08_0008 is released upon formation of the 
tight junction with the erythrocyte, rather than before initial attachment.
The moving junction is believed to function to exclude host cell membrane 
proteins from entering the nascent parasitophorous vacuole membrane (PVM) 
(Mordue et al., 1999), as well as being the site of removal of merozoite surface 
molecules such as MSP1 during invasion. In T. gondii, the moving junction 
complex is minimally composed of TgAMAI and TgRON4 (Alexander et al.,
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2005), and a comparable complex is believed to exist in P. falciparum (Alexander 
et al., 2006).
The moving junction originates at the tight junction formed between the 
erythrocyte and the parasite’s apical end. Proteins resident in the apical 
organelles are therefore likely to be components of the moving junction, for 
example the micronemal protein AMA1 and RON4 which originates from the 
rhoptry neck. Although PF08_0008 is apically-restricted, there is no evidence 
from immunoprecipitation experiments to suggest that this protein exists in a 
complex with any other proteins, for instance, components of the moving junction. 
However, this cannot be categorically confirmed - interactions with other proteins 
that are not resistant to the detergent solubilisation conditions employed in 
immunoprecipitation experiments may indeed exist. If present at the moving 
junction, the demonstrated binding of PF08_0008 to erythrocytes could in theory 
serve to exclude a particular host cell molecule from the developing PVM. A 
model of the apicomplexan moving junction is shown in figure 10.1. The nature of 
the moving junction - an electron-dense region where the two cells are in intimate 
contact, makes it extremely difficult to study, and little can be determined from 
immunofluorescence analyses performed on purified free merozoites, as in the 
absence of erythrocytes and productive invasion, it is unlikely that they accurately 
represent what occurs in vivo.
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Figure 10.1: Schematic model of the apicomplexan moving junction.
Figure adapted from Carruthers and Boothroyd (2007). The parasite’s 
transmembrane adhesins (pink) and their respective ligands in the host cell 
membrane (grey) are thought to sit behind the moving junction complex, relative 
to the direction of parasite movement during invasion. These adhesins generate 
the force for movement via a connection with the molecular motor, which is 
anchored into the inner membrane complex (IMC) of the cell and consists of 
aldolase, filamentous actin (F-actin), a myosin light chain (MLC) (MTIP in P. 
falciparum), myosin A (MyoA), GAP45 and GAP50, as discussed in chapter 1.
In T. gondii, the moving junction is known to be minimally composed of AMA1 
(red), RON2 (medium green), RON4 and RON5 (light and dark green). The 
arrangement of the AMA1-associated RON proteins shown is hypothetical. The 
moving junction of P. falciparum is also believed to contain the orthologous AMA1 
and RON4 proteins, and perhaps further as yet unidentified proteins of which 
PF08_0008 could be one. It remains to be determined whether any connection 
between the components of the moving junction and the molecular motor of the 
parasite exists, or whether any moving junction components have ligands on the 
host cell.
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All known adhesive, microneme-resident proteins that have been described 
previously are type I integral membrane proteins containing a short cytoplasmic 
domain. In the proposed molecular mechanism of erythrocyte invasion, parasite 
proteins that bind erythrocyte surface molecules are indirectly anchored to the 
actin-myosin motor. Adhesins are presumed to be linked to the motor through an 
interaction with MTRAP, which has been shown to bind to the F-actin-binding 
protein aldolase (Baum et al., 2006). It has been shown that in the case of 
EBA175, the cytoplasmic domain is essential for the molecule to act as an 
adhesin (Gilberger et al., 2003a), and presumably the motor linkage occurs in this 
region. In the case of GPI-anchored PF08_0008, there could be no such 
interaction in the cytoplasm, suggesting that if this protein is linked to the motor 
complex, it is linked by way of a unique association in the protein ectodomain.
The proteolytic processing and shedding of microneme proteins, such as 
PF08_0008, is common in P. falciparum. However, the parasite-derived enzymes 
that are responsible for the primary processing and shedding of PF08_0008 are 
yet to be identified. To date, no parasite proteases responsible for the extensive 
primary processing of proteins such as MSP1 and AMA1 have been identified. 
However, three Plasmodium enzymes have been identified that are capable of 
shedding proteins from the surface of the parasite: SUB2, ROM1 and ROM4. 
SUB2 is believed to be responsible for removing the surface coat at the moving 
junction, with the rhomboids disengaging adhesive interactions between 
erythrocyte ligands and parasite receptors at the rear of the parasite.
If PF08_0008 functions as an adhesin, it would be expected that it too would be 
cleaved at the rear of the parasite. However, although the protease responsible 
for shedding PF08_0008 seems largely calcium-independent, a feature that is 
shared with the Plasmodium rhomboids, PF08_0008 is GPI-anchored and thus 
cannot be cleaved by either ROM1 or ROM4 which cleave within transmembrane 
domains. It therefore seems likely that PF08_0008 is shed by an alternative 
protease that remains to be identified.
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Future work
The data presented implicate PF08_0008 in having a role as an adhesin, but also 
raise many questions as to how it could function in this capacity.
In order to confirm the erythrocyte-binding function of PF08_0008, a binding 
partner from erythrocytes needs to be identified. If it is assumed that the 
erythrocyte receptor is a protein or glycoconjugate, this could be achieved 
through the use of enzyme-treated erythrocytes that are deficient in particular 
molecules. For example, treatment of erythrocytes with neuraminidase removes 
the sialic acid residues from carbohydrate moieties that are required for binding. 
Another good starting point could be to use overlay assays to estimate the size of 
any potential erythrocyte-binding partners.
It would also be interesting to determine which region of PF08_0008 is 
responsible for the erythrocyte-binding activity, especially as PF08_0008 is not 
predicted to contain any classical protein domains. It has been shown that p42 
can be depleted from culture supernatant following the addition of erythrocytes, 
but since p42 and p37 remain in a complex following primary processing, it is 
possible that the depletion of p42 is due to its association with p37, which may be 
the erythrocyte-binding fragment. The erythrocyte-binding region could be 
determined by using sequential peptides spanning the length of PF08_0008 in 
erythrocyte-binding assays. The binding of EBA175 to glycophorin A is mediated 
by N-terminal cysteine rich domains (Sim et al., 1994), and one might therefore 
speculate that the N-terminal region of PF08_0008 is responsible for its 
erythrocyte-binding activity, since this is where 7 of the 8 conserved cysteine 
residues are located.
In order to confirm the sub-cellular location of PF08_0008 and PF08_0008-HA3 
in schizonts and free merozoites, it will be necessary to perform immuno-electron 
microscopy using PF08_0008-specific antibodies, since the small dimensions of 
the parasite and the close proximity of the rhoptry ducts and micronemes can 
make it difficult to unambiguously assign parasite proteins to particular sub- 
cellular compartments by IFA alone. For example, AMA1 was initially thought to 
be located in the rhoptries (Crewther et al., 1990), but has now been shown to be 
a micronemal protein by immuno-electron microscopy (Bannister et al., 2003).
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It has been shown that the trafficking of the EBL proteins to the micronemes is 
dependent on a cysteine-rich domain, close to the transmembrane anchor in the 
protein ectodomain (Treeck et al., 2006). Other micronemal proteins such as 
AMA1, PTRAMP, MTRAP, SUB2 and now PF08_0008, do not contain such a 
domain in this location, and this is suggestive of there being multiple mechanisms 
for microneme targeting. If targeting of PF08_0008 is sequence-dependent, the 
minimal sequence requirements could be determined using a transgenic 
approach.
PF08_0008 was initially identified as the protein for study partly because it was 
detected in both merozoite and sporozoite stages in the proteomic study 
published in 2002 (Florens et al., 2002). AMA1 was also detected in merozoites 
and sporozoites, and further investigation showed that it is subject to the same 
processing and shedding events in both stages (Silvie et al., 2004). It will be 
interesting to confirm the proteomic data for PF08_0008 and determine if like 
AMA1, it is expressed, processed and shed in sporozoites as well as merozoites. 
When searching for a PF08_0008 binding partner on erythrocytes, it may be 
important to consider the possibility that this protein could perform a host-cell 
binding function in both erythrocytes and hepatocytes, perhaps binding a generic 
non-erythrocyte-specific cell-surface molecule.
In order to further investigate whether PF08_0008 exists in the parasite as a part 
of a complex, as would be expected if it is linked to the motor complex, 
immunoprecipitations could be carried out using less stringent solubilisation 
conditions, in order to preserve any interactions that may have been disrupted 
using the methods utilised in this project.
The transgenic parasites expressing HA-tagged PF08_0008 were originally 
generated with a view to purifying parasite protein and determining the sites of 
cleavages responsible for the primary processing and shedding events. However, 
it is now evident that the protein is GPI-anchored, and that the addition of a triple 
haemagglutinin tag to the C-terminus has resulted in a soluble rather than 
membrane-bound PF08_0008. Nevertheless, it appears that the primary 
processing at least is still occurring as it would in wild-type parasites. The 
monoclonal antibody 3F10 can therefore hopefully be used in the future to purify 
the p49 form of PF08_0008-HA3 from parasites, to enable the determination of 
the primary processing cleavage site, through N-terminal sequencing.
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Cleavage site sequence information could also be useful in investigating the 
identity of the protease responsible for primary processing, perhaps by drawing 
comparisons with previously elucidated primary processing sites. The importance 
of this processing for host cell invasion could be also be investigated by 
attempting the generation of cleavage-resistant mutants, since it is possible that 
processing ‘activates’ the protein by revealing a functional, e.g. 
erythrocyte-binding, domain.
The protease responsible for shedding of PF08_0008 from the surface of the 
merozoites also remains to be identified, but evidence suggests that it is distinct 
from ROM1, ROM4, and SUB2. 92 putative proteases were identified in the 
P. falciparum genome, from all major classes including serine, aspartic, cysteine, 
metallo and threonine (Wu et al., 2003). Repeating the merozoite processing 
assay with a range of protease inhibitors targeting different functional classes of 
enzyme could give clues as to the identity of the enzyme responsible for 
PF08_0008 shedding.
Purified p49 could also be of use in determining if PF08_0008 is exposed to the 
immune system of infected individuals. Western blots could be performed on 
purified parasite protein using serum from hyperimmune individuals to determine 
if this protein is immunogenic. If this is the case, PF08_0008-specific antibodies 
could in theory be purified from the hyperimmune serum and used in erythrocyte 
invasion inhibition assays to determine if they are protective.
Given the apparent soluble nature of PF08_0008-HA3, it would be interesting to 
determine if GPI-anchorage of PF08_0008 is necessary for its redistribution onto 
the surface of free merozoites, shedding into culture supernatant and erythrocyte- 
binding ability. EBA175 lacking its membrane anchor has been shown to be shed 
into culture supernatant in the same manner as wild-type protein, and retains an 
erythrocyte-binding ability (Reed et al., 2000a), suggesting that membrane 
anchorage is not essential for adhesins to be discharged from the micronemes, 
and binding to erythrocyte ligands is still possible, although in the case of 
EBA175 at least, a membrane anchor is necessary for binding to be functional 
(Gilbergeret al., 2003a).
Attempting to disrupt the endogenous PF08_0008 gene would reveal if the 
protein is essential for parasite viability. None of the genes encoding the
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DBL-EBP or PfRH proteins is essential for parasite growth, as they can all be 
successfully disrupted individually (Duraisingh et al., 2003a, Duraisingh et al., 
2003b, Gilberger et al., 2003b, Reed et al., 2000a, Stubbs et al., 2005, Triglia et 
al., 2005). If PF08_0008 also acts as an adhesin, it might be expected that the 
gene encoding it could be successfully disrupted, although it is important to note 
that unlike the DBL-EBP and PfRH proteins, PF08_0008 is not encoded by a 
member of a gene family.
These experiments could all serve to determine if the functioning of PF08_0008 is 
critical for host cell invasion, and if the protein has any suitability as a future 
vaccine or chemotherapeutic target.
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